Web Catalog CRS

List of European Pharmacopoeia Reference Standards
Order
Reference Standard
Code
New Y0001414 Human Hepatitis B immunoglobulin
Effective from 2013/7/30

Batch n
1
Quantity Sale
per vial Unit
100 mg
1 55 IU/vial
Information
Monograph
Leaflet
Storage
Extra
Price
charges
90
c
0722, 0338
Yes
-20C
0673
Yes
+5C
79
2439
Yes
+5C
79
Yes
+5C
79
+5C
79
Y0001484 Medroxyprogesterone acetate for peak identification
25 mg
Y0001523 Ursolic acid
25 mg
Y0001532 Norethisterone acetate for system suitability
2.585 mg
0850
Y0001562 Doxylamine hydrogen succinate
60 mg
1589
Y0001565 Recombinant Major Allergen rBet v 1
0.01025 mg 1
10.25 micrograms of rBet v 1
1063
Yes
-20C
90
Y0001566 Recombinant Major Allergen rPhl p 5a
0.00856 mg 1
8.56 micrograms of rPhl p 5a
1063
Yes
-20C
90
Y0001567 Docusate sodium
10 mg
Y0001570 Nitrofural impurity B
30 mg
Y0001571 Naloxone impurity D
25 mg
Y0001572 Atovaquone
270 mg
Y0001573 Atovaquone for system suitability
10 mg
Y0001574 Mesalazine for system suitability
10 mg
Y0001575 Bupivacaine impurity F
70 mg
2,6-dimethylaniline
Y0001577 Isoprenaline impurity A
15 mg
1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino]ethanone
Y0001580 Rocuronium bromide
94.0 % CHO
1418
+5C
79
1135
Yes
+5C
79
0729
Yes
+5C
79
2192
Yes
+5C
79
2192
Yes
+5C
79
1699
Yes
+5C
79
0541
+5C
79
1332
+5C
79
-20C
79
+5C
79
+5C
79
+5C
79
94.8 % CHON; (5-nitrofuran-2-yl)methylene diacetate

99.3% CHClO
10 mg
New Y0001581 Alimemazine for system suitability
5 mg
New Y0001583 Alimemazine hemitartrate
15 mg
Y0001585 Cellulose acetate butyrate
60 mg
New Y0001587 Atomoxetine for impurity A identification
10 mg
New Y0001588 Atomoxetine impurity B
10 mg
New Y0001589 Atomoxetine impurity D
5 mg
New Y0001591 Flutamide for system suitability
10 mg
New Y0001592 Ivy leaf dry extract HRS
70 mg
New Y0001594 Megestrol acetate impurity K
0.01 mg
New Y0001596 Diacerein impurity B
20 mg
2409
New Y0001597 Diacerein impurity mixture
0.014 mg
2409
New Y0001598 Dutasteride
150 mg
2641
New Y0001599 Wedelolactone
15 mg
2564
New Y0001603 Dutasteride for system suitability
10 mg
2641
New Y0001604 Finasteride for peak identification
15 mg
New Y0001605 Eucommia bark HRS
2100 mg
1 mg
Y0001609 Norflurane - reference spectrum
1764
Yes
2650
Yes
79
79
79
16% of CHO
94,4%
1423
Yes
+5C
2148
Yes
2412
79
-20C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
Yes
+5C
79
Yes
-20C
79
Yes
+5C
79
Yes
+5C
79
Yes
-20C
79
79
New Y0001612 Esculin
25 mg
+5C
79
New Y0001633 Ethylcellulose
100 mg
0822
+5C
79
20 mg
2589
+5C
79
Y0001561 Abacavir sulfate

Council of Europe, all rights reserved 2013
92,4% CHO
2452
Yes
For extra charges, please see supply terms and conditions.

Order
Reference Standard
Code
Y0001551 Abacavir for system suitability

Batch n
1
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
Storage
2589
Yes
+5C
Yes
+5C
Y0001552 Abacavir for peak identification
10 mg
2589
Y0000055 Acamprosate calcium - reference spectrum
n/a
1585
Y0000116 Acamprosate impurity A
50 mg
3-aminopropane-1-sulphonic acid
1585
Y0000500 Acarbose
94.7 mg
94.7 mg CHNO
2089
Y0000354 Acarbose for identification
10 mg
Y0000427 Acarbose for peak identification
20 mg
A0040000 Acebutolol hydrochloride
50 mg
Y0000359 Acebutolol impurity B
10 mg
-[3-acetyl-4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]
acetamide (diacetolol)
Y0000127 Acebutolol impurity C
20 mg
Y0000128 Acebutolol impurity I
0.004 mg
Y0000056 Aceclofenac - reference spectrum
n/a
1281
Y0001094 Aceclofenac for peak identification
10 mg
1281
Y0000085 Aceclofenac impurity F
20 mg
benzyl[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate
Y0000086 Aceclofenac impurity H
10 mg
[[[[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl] oxy]acetyl]oxy]
acetic acid
Y0000810 Acemetacin
100 mg
Y0000811 Acemetacin impurity A
10 mg
Y0000842 Acemetacine impurity mixture
0.06 mg
A0070000 Acesulfame potassium
50 mg
A0070020 Acesulfame potassium impurity B
15 mg
A0100000 Acetazolamide
100 mg
Y0001084 Acetazolamide for system suitability
0.0068 mg
0454
Y0000002 Acetylcholine chloride
50 mg
1485,1971
A0150000 Acetylcysteine
50 mg
A0152000 Acetylcysteine impurity C
10 mg
88.5% CHNOS; N,N'-diacetyl-L-cystine
0967
A0153000 Acetylcysteine impurity D
10 mg
N,-diacetyl-L-cysteine
Y0000565 -Acetyldigoxin
50 mg
98.6% CHO
Y0000642 -Acetyldigoxin for peak identification
10 mg
2168
A0200000 Acetylsalicylic acid
15 mg
0309
Y0001460 Acetylsalicylic acid for peak identification
10.26 mg
0309
A0208000 N-Acetyltryptophan
125 mg
1383
A0202000 N-Acetyltyrosine
200 mg
Y0001462 Acetylsulfadiazine
0.002 mg
Extra
Price
charges
79
a
a
79
79
+5C
79
+5C
79
+5C
79
+5C
79
0871
+5C
79
0871
+5C
79
N-(3-acetyl-4-hydroxyphenyl)butanamide
0871
+5C
79
N-[3-acetyl-4-[(2RS)-3-(ethylamino)-2-hydroxypropoxy]phenyl]
butanamide
0871
+5C
79
79
+5C
79
1281
+5C
79
1281
+5C
79
1686
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
2089
2089
Batch 1 is valid until 1 May 2013

propoxy]phenyl]
Yes
Yes
1686
4-chlorobenzoic acid
1686
Yes
1282
5-chloro-6-methyl-1,2,3-oxathiazin-4(3)-one 2,2-dioxide ; Batch 3 is valid
until 31 August 2013
1282
Yes
0454
Yes
+5C
79
-20C
79
+5C
79
+5C
79
0967
+5C
79
2168
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
1384
+5C
79
0294
+5C
79
0967
Yes
Yes
Yes

Order
Reference Standard
Code
Y0000693 Acholeplasma laidlawii BRP

Batch n
1
Quantity Sale
per vial Unit
1 ml
1
Information
Monograph
Leaflet
Storage
20607
Yes
-80C
0968
Extra
Price
charges
120
d
A0220000 Aciclovir
75 mg
+5C
79
Y0001271 Aciclovir for peak identification 1
0.303 mg
Batch 1 is valid until 31 August 2012
0968
Yes
+5C
79
Y0001269 Aciclovir for peak identification 2
0.004 mg
Batch 1 is valid until 30 September 2012
0968
Yes
+5C
79
Y0001264 Aciclovir for system suitability
10 mg
+5C
79
A0225000 Acitretin
100 mg
Y0001464 Actaea racemosa dry extract for system suitability HRS
1200 mg
Y0001543 Actaea racemosa for assay CRS
300 mg
Y0001463 Actaea racemosa HRS
1200 mg
Y0001121 Adapalene
100 mg
99.9% CHO
Y0001120 Adapalene impurity C
6 mg
1-[2-(methyloxy)phenyl]tricyclo[3.3.1.1]decane
Y0001119 Adapalene for peak identification
2.022 mg
2445
A0230000 Adenine
50 mg
0800,1486
A0230200 Adenosine
50 mg
Y0000110 Adipic acid
50 mg
Y0000882 Adrenaline
5 mg
A0300000 Adrenaline tartrate
100 mg
Y0000740 Adrenaline impurity mixture
Y0000707 Adrenaline tartrate with impurity A

Y0000883 Adrenaline with impurity F
0968
1385
+5C
g(b)
79
2069
Yes
-20C
79
2069
Yes
+5C
79
2069
Yes
+5C
79
2445
+5C
79
2245
+5C
79
+5C
79
+5C
79
1486
+5C
79
1586
+5C
79
2303
+5C
79
0254, 0285,
0732
+5C
79
0.005 mg
0254,2303
Yes
+5C
79
15 mg
0254
Yes
+5C
79
10 mg
2303
Yes
+5C
79
Y0000728 Agnus castus fruit standardised dry extract
200 mg
2147
Yes
-20C
79
A0325000 Alanine
60 mg
0614,0752
+5C
79
A0325100 Albendazole
50 mg
1386
+5C
79
A0325200 Alcuronium chloride
50 mg
1285
-20C
g(c)
79
A0325450 Alfacalcidol
99.7% CHO
74.7% CHNO; Monoammonium glycyrrhizate
0.13% CHO
5 mg
New Y0001601 Alfacalcidol for system suitability
2.5 mg
A0325451 Alfacalcidol - reference spectrum
n/a
A1225000 Alfadex
150 mg
A0325500 Alfentanil hydrochloride - reference spectrum
n/a
1062
A0325800 Alfuzosin hydrochloride
10 mg
1287
Y0000832 Alfuzosin for system suitability
10 mg
1287
A0349000 Allantoin
60 mg
1288
A0350000 Allopurinol
100 mg
99.9% CHNO
0576
A0350010 Allopurinol impurity A
10 mg
5-amino-1H-pyrazole-4-carboxamide
0576
A0350020 Allopurinol impurity B
10 mg
5-formylamino-1H-pyrazole-4-carboxamide ; Batch 2 is valid until 31

December 2012
0576
99.8% CHO ; Batch 7 is valid until 31 December 2012
Yes
1286
Yes
-20C
e(d)
300
1286
Yes
-20C
e(d)
79
79
+5C
79
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
1286
1070,1487
89.7% [CH0]
Yes
Yes

Order
Reference Standard
Code
A0350030 Allopurinol impurity C

Batch n
3
A0350040 Allopurinol impurity D
G0400000 Glycerol (85 per cent) - reference spectrum

A0350050 Allopurinol impurity E
Quantity Sale
Information
per vial Unit
10 mg
1 5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide ; Batch 2 is valid until 1
May 2013
Monograph
0576
+5C
79
79
+5C
79
n/a
20 mg
A0351000 Allylstrychnine bromide
10 mg
H0215000 Hepatitis C Virus RNA for NAT testing BRP
40 mg
HCV-RNA content 500 IU per vial; For plasma pool testing by NAT
Y0000235 Almagate
25 mg
13.4% carbonic acid
Y0000255 Almagate - reference spectrum
n/a
2010
A0357000 Alprazolam - * psy
100 mg
1065
A0360000 Alprenolol hydrochloride
100 mg
Y0000054 Alprostadil
50 mg
99.4% CHO ; Batch 1 is valid until 31 January 2013
Y0000606 Altizide
150 mg
99.9% CHClNOS
Y0000843 Altizide impurity B
15 mg
3-[(2,2-dimethoxyethyl)sulphanyl]prop-1-ene
Y0000687 Alverine citrate
5 mg
2156
Y0000595 Alverine for peak identification
0.125 mg
2156
Y0000607 Alverine impurity D
10 mg
A0363000 Amantadine hydrochloride
100 mg
A0363700 Ambroxol hydrochloride
125 mg
A0900000 Amfetamine sulfate - reference spectrum
n/a
A0365000 Amidotrizoic acid dihydrate
Y0001461 Amidotrizoic acid for system suitability
A0368000 Amikacin
200 mg
91.7 % CHNO ; Batch 2 is valid until 28 February 2013
Y0001467 Amikacin impurity I
20 mg
(2S)-4-amino-2-hydroxybutanoic acid
1290
A0365900 Amikacin sulfate
200 mg
The batch 3 is not suitable for use in the assay in monograph 1290:07/2012.
Amikacin CRS A0368000 is also needed. See leaflet.
1290
Y0001117 Amikacin for system suitability
10 mg
amikacin for system suitability CRS 1 is suitable for 01/2010:1289 and

01/2010:1290 only. Batch 2 is suitable for 07/2012:1289 and 07/2012:1290.
1289,1290
A0370000 Amiloride hydrochloride
100 mg
Y0000020 Amiloride impurity A
20 mg
Y0000173 4-Aminobenzoic acid
60 mg
A0420000 Aminocaproic acid
50 mg
A0460000 7-Aminodesacetoxycephalosporanic acid
20 mg
A0496000 Aminoglutethimide
125 mg
A0496005 Aminoglutethimide impurity A
20 mg
0496,0497
0576
ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate
Extra
Price
charges
79
g
+5C
Storage
0576
15 mg
ethyl 5-amino-1H-pyrazole-4-carboxylate
Leaflet
1285
See leaflet,
20621
Yes
2010
-20C
g(c)
79
-20C
e(d)
242
+5C
79
79
79
+5C
0628,0876
+5C
79
-20C
g(c)
79
0370,2185
+5C
79
2185
+5C
79
1488
Yes
+5C
79
-20C
79
2156
+5C
79
0463
+5C
79
1489
+5C
79
0368
79
100 mg
0873
+5C
79
0.08 mg
0873
Yes
+5C
79
1289,1290
Yes
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
0651
+5C
79
0651
+5C
79
1687
+5C
79
N-(3-cyclohexylpropyl)-N-ethyl-3-phenylpropan-1-amine
methyl-3,5-diamino-6-chloropyrazine-2-carboxylate ; Batch 2 is valid until 31

August 2013
Cefadroxyl impurity B
(3)-3-(3-aminophenyl)-3-ethylpiperidine-2,6-dione; (3-aminoglutethimide)
4
Yes
0874
+5C
79
0708,0813
+5C
79
1291
+5C
79
1291
+5C
79

Order
Reference Standard
Code
A0496020 Aminoglutethimide impurity D

Batch n
1
Quantity Sale
Information
per vial Unit
10 mg
1 3,3'-[diazenediyldi(4,1-phenylene)]bis(3-ethylpiperidine-2,6-dione);
(azoglutethimide)
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
1291
+5C
0803
+5C
g(b)
79
A0575000 Amiodarone hydrochloride
100 mg
Y0000129 Amiodarone impurity D
20 mg
(2-butyl-benzofuran-3-yl)-(4-hydroxy-3,5-diiodophenyl)methanone
0803
+5C
79
Y0000130 Amiodarone impurity E
20 mg
(2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone ; Batch 2 is valid until

31 August 2012
0803
+5C
79
A0590000 Amisulpride
10 mg
1490
+5C
79
Y0001534 Amisulpride for system suitability
1.0015 mg
A0590004 Amisulpride impurity B
10 mg
Y0000563 Amitriptyline hydrochloride
10 mg
Y0000049 Amlodipine besilate
150 mg
99.7% CHClNOS
1491
Y0001067 Amlodipine for peak identification
15 mg
1491
Y0001068 Amlodipine impurity A
15 mg
3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2Hisoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate ;

Batch 1 is valid until 1 June 2013
1491
Y0001069 Amlodipine impurity B
15 mg
3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-6-methyl-2-[[2-[[2(methylcarbamoyl)benzoyl]amino]ethoxy]methyl]-1,4-dihydropyridine-3,5dicarboxylate ; Batch 1 is valid until 30 November 2013
Y0001070 Amlodipine impurity G
15 mg
dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5dicarboxylate ; Batch 1 is valid until 1 June 2013
Y0000302 Ammonio methacrylate copolymer(type A) - reference

spectrum
n/a
Y0000303 Ammonio methacrylate copolymer(type B) - reference

spectrum
n/a
A0650000 Amobarbital - * psy
A0700000 Amobarbital sodium - * psy
A0800000 Amoxicillin trihydrate
+5C
79
1490
+5C
79
0464
+5C
79
Yes
+5C
79
Yes
+5C
79
Yes
+5C
79
1491
+5C
79
1491
+5C
79
2081
79
2082
79
500 mg
0594
+5C
79
500 mg
0166
+5C
79
200 mg
86.2% CHNOS
0167,0168,02
60,
0577,0578,08
13, 1140,1653
+5C
79
Y0000005 Amphotericin B
100 mg
Batch 4 is not suitable for microbiological assay (see leaflet).
1292
Yes
-20C
79
Y0001014 Amphotericin B for peak identification
10 mg
1292
Yes
-20C
79
Y0001361 Amphotericin B for microbiological assay
100 mg
944 IU per mg
20702
Yes
-20C
79
220 mg
97.7% CHNOS ; Batch 4 is valid until 31 December 2013
0167,0168,05
78, 1168,1169
Yes
+5C
79
A1100000 Ampicillin trihydrate
150 mg
+5C
79
Y0001522 Anastrozole
100 mg
+5C
79
New A1000000 Ampicillin (anhydrous)
1490
4-amino-N-[[(2RS)-1-ethylpyrrolidin-2-yl]methyl]-5-(ethyl sulphonyl)-2hydroxybenzamide
Yes
0168,0260,05
77,
0578,0808,22
11, 2212
100.0% CHN
5
2406
Yes

Order
Reference Standard
Code
Y0001531 Anastrozole impurity E

Batch n
1
Quantity Sale
Information
per vial Unit
10 mg
1 2,2'-[5-(hydroxymethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)
Monograph
2406
Y0001386 Angelica dahuria root
160 mg
A1200000 Anhydrotetracycline hydrochloride
15 mg
93.3% CHNO
Y0001244 Amylmetacresol
285 mg
99.5% CHO
Y0001245 Amylmetacresol for peak identification
10 mg
Y0001466 Anhydrous Docetaxel
15 mg
A1210000 Antazoline hydrochloride
50 mg
A1220000 Alpha-apo-oxytetracycline
20 mg
Y0001465 Apomorphine hydrochloride hemihydrate
15 mg
Y0001471 Apomorphine impurity B (morphine sulfate) * - narc
40 mg
88.2% CHNOS,5HO; morphine sulfate
A1230000 Beta-apo-oxytetracycline
20 mg
88,0% CHNO ; Batch 4 is valid until 31 July 2012
A1250000 Aprotinin solution BRP
0.5 ml
22.3 Ph. Eur. Units per ml
Y0001154 Aprotinin for system suitability
2.7 mg
A1269000 L-Arabinitol
10 mg
Y0000806 Arbutin
100 mg
93.5% CHO
1054
A1270000 Arginine
50 mg
99.8% CHNO
0806,0930,16
54, 2114,2566
Y0000304 Arginine aspartate
20 mg
A1271000 Arginine hydrochloride
50 mg
Y0001323 Aristolochia
140 mg
Y0001185 Aristolochic acid I
1 mg
Y0001175 Aristolocholic acid for system suitability
1 mg
Y0000079 Articaine hydrochloride
100 mg
Y0000080 Articaine impurity A
15 mg
Y0000081 Articaine impurity E
10 mg
A1300000 Ascorbic acid
100 mg
Vitamin C ; Batch 3 is valid until 31 December 2012
Y0001024 Ascorbic acid impurity C
20 mg
Y0001170 Ascorbic acid impurity D
10 mg
Y0000800 Ascorbyl palmitate
10 mg
Y0000305 Asparagine monohydrate
60 mg
A1320000 Aspartame
40 mg
A1321000 Aspartame impurity A
10 mg
A1330000 Aspartic acid
50 mg
Leaflet
2556
Storage
+5C
Yes
0210,0211,16
54
Extra
Price
charges
79
a
+5C
79
+5C
79
2405
Yes
+5C
79
2405
Yes
+5C
79
2593
+5C
79
+5C
79
+5C
79
0972
0198
Batch 4 is valid until 31 December 2013
Yes
0136
+5C
79
0136
Yes
+5C
90
0198
Yes
+5C
79
0579,0580
Yes
+5C
79
0580
Yes
+5C
79
1381
+5C
79
+5C
79
+5C
79
2096
+5C
79
0805,0885,09
98
+5C
79
Yes
20821
Yes
+5C
79
20821
Yes
+5C
79
20821
Yes
+5C
79
1688
+5C
79
methyl3-[[2-(propylamino)acetyl]amino]-4-methylthiophene-2- carboxylate
1688
+5C
79
methyl 4-methyl-3-[[(2RS)-2-[(1-methylethyl)amino]propanoyl]amino]
thiophene-2-carboxylate
1688
+5C
79
0253,0958,17
91
+5C
79
D-xylo-hex-2-ulosonic acid (D-sorbosonic acid)
0253,1791
+5C
79
methyl D-xylo-hex-2-ulosonate (methyl D-sorbosonate) ; Batch 1 is valid until

31 December 2012
0253,1791
+5C
79
0807
+5C
79
2086
+5C
79
0973
+5C
79
0973
+5C
79
0750,0797
+5C
79
1.00 mg CHNO
2-(5-benzyl-3,6-dioxopiperazin-2-yl) acetic acid (diketopiperazine)

6

Order
Reference Standard
Code
Y0001171 Astragaloside IV

Batch n
1
Quantity Sale
per vial Unit
40 mg
1 97.8% CHO
Information
Monograph
Leaflet
2435
Storage
-20C
Extra
Price
charges
79
c
A1340000 Atenolol
100 mg
0703
+5C
79
Y0001089 Atenolol for system suitability
5 mg
0703
Yes
+5C
79
110 mg
99,9% CHClNO
2640
Yes
+5C
79
150 mg
95.3% CHCaFNO ; Batch 1 is valid until 30 November 2013
2191
Yes
+5C
79
New Y0001328 Atorvastatin impurity A
10 mg
desfluoroatorvastatin
2191
+5C
79
Y0001329 Atorvastatin impurity B
10 mg
3-epi-atorvastatin ; Batch 1 is valid until 30 November 2013
2191
+5C
79
Y0001330 Atorvastatin impurity C
10 mg
fluoroatorvastatin
2191
+5C
79
Y0001331 Atorvastatin impurity D
10 mg
3-[(4-fluorophenyl)carbonyl]-2-(2-methylpropanoyl)-N,3-diphenyloxirane-2carboxamide ; Batch 1 is valid until 31 August 2013
2191
+5C
79
Y0001332 Atorvastatin impurity E
10 mg
ent-atorvastatin ; Batch 1 is valid until 28 February 2013
2191
+5C
79
Y0000424 Atracurium besilate
120 mg
98.5% CHNOS
Y0000105 Rutoside trihydrate
100 mg
87.6% CHO
Y0000503 Atracurium for impurity F identification
5 mg
Y0000504 Atracurium for peak identification
Y0000878 Atropine
Y0000845 Atropine for peak identification
0.25 mg
Batch 1 is valid until 31 January 2013
0068,2056
Y0000816 Atropine impurity B
10 mg
(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl (2RS)-3-hydroxy-2-phenylpropanoate
(noratropine)
0068,2056
A1400000 Atropine sulfate
20 mg
Y0000029 Azaperone
50 mg
A1500000 Azathioprine
100 mg
Y0001240 Azathioprine impurity A
10 mg
Y0001246 Azathioprine impurity G
5 mg
Y0000326 Azelastine hydrochloride
25 mg
Y0000327 Azelastine impurity B
5 mg
Y0000328 Azelastine impurity D
5 mg
Y0000329 Azelastine impurity E
5 mg
200 mg
15 mg
0.05 mg
Batch 5 is valid until 31 October 2013
New Y0001586 Atomoxetine hydrochloride

Y0001327 Atorvastatin calcium trihydrate
New Y0000306 Azithromycin

Y0000637 Azithromycin for peak identification
New Y0000641 Azithromycin for system suitability
1970
Yes
+5C
g(b)
79
Yes
+5C
79
1795,1874,21
84,
2427,2639
1970
Yes
+5C
g(b)
79
5 mg
1970
Yes
+5C
g(b)
79
30 mg
2056
+5C
79
+5C
79
+5C
79
0068
+5C
79
1708
+5C
79
0369
+5C
79
1-methyl-4-nitro-1H-imidazol-5-amine
0369
+5C
79
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purin-2-amine
(thiamiprine)
0369
+5C
79
1633
+5C
79
1-benzoyl-2-[(4RS)-1-methylhexahydro-1H-azepin-4-yl]diazane
1633
+5C
79
4-(4-chlorobenzyl)phthalazin-1(2H)-one
1633
+5C
79
3-(4-chlorobenzilidene)isobenzofuran-1(3H)-one
1633
+5C
79
94.4% CHNO ; Batch 3 is valid until 31 December 2013
1649
Yes
+5C
79
1649
Yes
+5C
79
1649
Yes
+5C
79
+5C
79
Yes
-20C
e(d)
242
+5C
79
Y0000307 Azithromycin impurity A
10 mg
6-demethylazithromycin
Y0000285 B19 virus DNA for NAT testing BRP
150 mg
B19 virus DNA content log 5.8 IU per ml for plasma pool testing by NAT
See leaflet,
0557,
1527,1646
B0070000 Bacampicillin hydrochloride
120 mg
92.9% CHClNOS
0808,0852
Yes
1649

Order
Code
B0100000 Bacitracin zinc
Reference Standard

Batch n
2
Quantity Sale
per vial Unit
150 mg
1 62.9 IU per mg
Information
Monograph
Leaflet
Storage
Extra
Price
charges
79
b
0465,0466,20
702
-20C
0653
+5C
79
B0200000 Baclofen
50 mg
B0200050 Baclofen impurity A
50 mg
91.4% CHClNO; ()-4-amino-3-(4-chlorophenyl)butyric acid lactam ;

0653
Yes
+5C
79
Y0001273 Baicalin
10 mg
88.5% CHO
2438
Yes
+5C
79
B0250000 Bambuterol hydrochloride
100 mg
1293
+5C
79
B0300000 Barbital - * psy
500 mg
0170
+5C
79
Y0001525 Basic butylated methacrylate copolymer
20 mg
1975
+5C
79
Y0000295 Basic butylated methacrylate copolymer -reference

spectrum
n/a
1975
79
B0305000 Beclometasone dipropionate anhydrous
150 mg
+5C
79
Y0000351 Beclometasone dipropionate monohydrate
10 mg
Y0000352 Beclometasone dipropionate for system suitability
15 mg
Y0000469 Beclometasone dipropionate for peak identification
10 mg
Y0001073 Beclometasone dipropionate impurities F and N
0.052 mg
New Y0001607 Belamcanda chinensis rhizome HRS
Yes
99.2% CHClO ; Batch 3 is valid until 1 June 2013
0654,1449,
1709
+5C
79
Batch 2 is valid until 28 February 2013
0654,1709
Yes
+5C
79
0654,1709
Yes
+5C
79
0654,1709
Yes
+5C
79
2561
Yes
+5C
79
+5C
79
110 mg
Y0001025 Benazepril hydrochloride
160 mg
Y0001038 Benazepril for system suitability
0.016 mg
Y0001026 Benazepril impurity A
10 mg
B0400000 Bendroflumethiazide
100 mg
Y0000564 Bendroflumethiazide impurity A
5 mg
Y0000044 Benfluorex hydrochloride
50 mg
Y0000043 Benfluorex hydrochloride for system suitability
360 mg
B0470000 Benperidol
100 mg
B0477000 Benserazide hydrochloride
B0477010 Benserazide impurity A

Y0001071 Benserazide impurity C
Yes
1709
2388
99.5 % CHClNO
+5C
79
2388
+5C
79
0370
+5C
79
0370
+5C
79
1601
+5C
79
1601
+5C
79
1010,1172,12
54, 1708
+5C
79
50 mg
1173
+5C
79
20 mg
(2RS)-2-amino-3-hydroxypropanohydrazide
1173
+5C
79
10 mg
(2RS)-2-amino-3-hydroxy-2'-[(1EZ)-(2,3,4-trihydroxybenzylidene)]
propanohydrazide
1173
+5C
79
Y0001079 Benserazide for peak identification
10 mg
1173
Yes
+5C
79
Y0001064 Benzaldehyde
150 mg
0372,0371
Yes
+5C
79
Y0001060 Benzalkonium chloride for system suitability
20 mg
0371,0372
Yes
+5C
79
B0490000 Benzarone
10 mg
(2-ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone
1393
+5C
79
B0500000 Benzathine benzylpenicillin
200 mg
90.7% CHNOS
24.1% CHN (N,N'-dibenzylethylenediamine)
0373
+5C
79
2388
[(3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2-oxo-2,3,4,5tetrahydro-1H-1-benzazepin-1-yl]acetic acid
4-amino-6-(trifluoromethyl)benzene-1,3-disulphonamide
Yes
Yes

Order
Reference Standard
Code
Y0000775 Benzbromarone

Batch n
1
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
Storage
1393
+5C
Extra
Price
charges
79
g
B0550000 Benzethonium chloride
100 mg
0974
+5C
79
B0600000 Benzocaine
50 mg
0011,1088
+5C
79
Y0001470 Benzoic acid
30 mg
0934
+5C
79
Y0000647 Benzophenone
40 mg
1784
+5C
79
Y0000167 Benzyl alcohol
50 mg
+5C
79
B0670000 Benzyl benzoate - reference spectrum
n/a
0705
79
B0680000 S-Benzylmercaptoacetyltriglycin
10 mg
1372
+5C
79
B0700000 Benzylpenicillin potassium
100 mg
0113,0148,01
49
+5C
79
B0900000 Benzylpenicillin sodium
200 mg
99.4% CHNNaOS; Penicillin G sodium
Y0001149 Berberine chloride
20 mg
84.3% CHClNO
B0950000 Betadex
200 mg
88.4% [CHO]
Y0000391 Betahistine dihydrochloride
50 mg
B0990000 Betahistine mesilate
100 mg
B1000000 Betamethasone
75 mg
B1030000 Betamethasone acetate
B1040000 Betamethasone dipropionate
0256,0371,03
72,1827
See leaflet
Yes
0113,0114,01
48, 0149
Yes
+5C
79
1831,2500
Yes
+5C
79
1070,1487,18
04
+5C
79
1665
+5C
79
1071
+5C
79
0312,0354,03
88, 0561,0811
+5C
79
100 mg
0548,0975
+5C
79
150 mg
Y0001416 Betamethasone dipropionate for peak identification
10 mg
Y0001418 Betamethasone dipropionate for system suitability
10 mg
B1045000 Betamethasone sodium phosphate
B1054000 Betamethasone 17-valerate
B1055000 Betamethasone 21-valerate

Y0001027 Betamethasone valerate for system suitability
0809
Yes
+5C
79
0809
Yes
+5C
79
0809
Yes
+5C
79
100 mg
0549,0810
+5C
79
100 mg
0322,0811
+5C
79
15 mg
0811
+5C
79
25 mg
0811
+5C
79
Y0001065 Betamethasone valerate impurity mixture
0.018 mg
0811
+5C
79
B1103000 Betaxolol hydrochloride
60 mg
1072
+5C
79
B1103100 Betaxolol impurity A
10 mg
(2RS)-1-(4-ethylphenoxy)-3-[(1-methylethyl)amino]propan-2-ol
1072
+5C
79
Y0001354 Betaxolol impurity C
5 mg
2-[[4-[2-(cyclopropylmethoxy)ethyl]phenoxy]methyl]oxirane
1072
-20C
79
Y0001360 Betaxolol for peak identification
15 mg
1072
+5C
79
B1115000 Bezafibrate
100 mg
1394
+5C
79
Y0001444 Bicalutamide
100 mg
2196
Yes
+5C
79
Y0001448 Bicalutamide for system suitability
15 mg
2196
Yes
+5C
79
Y0001078 Bicisate labelling kit
24 mg
2123
+5C
79
99.5% CHFO; Betamethasone dipropionate CRS 2 is suitable for

monograph 01/008:0809 only.
99.8% CHFNOS
Yes
Yes

Order
Code
B1110000 Bifonazole
Reference Standard

Batch n
1
Quantity Sale
per vial Unit
100 mg
1
B1110004 Bifonazole impurity B
10 mg
Y0001421 Bifonazole for system suitability
10 mg
Y0001059 Bilberry dry extract
250 mg
B1116000 Biotin
20 mg
B1120000 Biperiden hydrochloride
60 mg
B1121000 Biperiden impurity A
20 mg
B1140000 Bisacodyl
50 mg
Y0000608 Bisacodyl for peak identification
Y0000694 Bisacodyl for system suitability
Y0000812 Bisoprolol fumarate

Y0000877 Bisoprolol for peak identification
Information
Monograph
Leaflet
1395
Storage
+5C
+5C
79
1395
Yes
+5C
79
3.44% of cyanidin 3-O-glucoside chloride (CHClO)
2394
Yes
-20C
79
Vitamin H
1073
+5C
79
1074
+5C
79
1074
+5C
79
0595
+5C
79
10 mg
0595
+5C
79
5 mg
0595
+5C
79
50 mg
+5C
79
1.007 mg
Bisoprolol for system suitability method A CRS has been renamed as

Bisoprolol for peak identification CRS. ; Batch 1 is valid until 31 August 2012
1710
Yes
+5C
79
Y0000813 Bisoprolol for system suitability
1.005 mg
Bisoprolol for system suitability method B CRS has been renamed as

Bisoprolol for system suitability CRS
1710
Yes
+5C
79
B1141000 Bleomycin sulfate
7 mg
8910 IU per vial; bleomycin A : 67.0%; Bleomycin B : 29.2%;

demethylbleomycin A : 2.6%
0976,20702
Yes
-20C
79
Y0000434 Boldine
30 mg
98.8% CHNO
1396, 1816
Yes
+5C
79
B1142000 Bordetella pertussis mouse antiserum BRP
0.5 mg
Anti-PT: 19.5 ELU/vial Anti-FHA: 69 ELU/vial

Anti-69k: 17 ELU/vial Anti-Fim 2/3: 28 ELU/vial
See leaflet,
20716
Yes
-20C
90
B1143000 Bromazepam - * psy
60 mg
0778,0879
+5C
79
Y0000645 Bromazepam for system suitability - * psy
10 mg
0879
+5C
79
B1145000 Bromhexine hydrochloride
100 mg
0706
+5C
79
Y0000200 Bromhexine impurity C
15 mg
0706
+5C
79
B1150000 Bromocriptine mesilate
30 mg
0596
-20C
g(c)
79
Y0000677 Bromocriptine mesilate for system suitability
5 mg
0596
-20C
g(c)
79
B1152000 Bromperidol
100 mg
0616,1178
+5C
79
B1152050 Bromperidol decanoate
60 mg
1397,1431
+5C
79
B1153000 Brompheniramine maleate
100 mg
0977,1196
+5C
79
Y0000468 Brotizolam - * psy
10 mg
2197
+5C
79
Y0000470 Brotizolam impurity B
10 mg
2197
+5C
79
B1155000 Brucella melitensis Rev. 1 strain BRP - * MOT (Biotox)
1 mg
B1157300 Budesonide
110 mg
Y0001148 Budesonide for system suitability
10 mg
B1156000 Bufexamac
100 mg
1179
4-[(RS)-(biphenyl-4-yl)phenylmethyl]-1H-imidazole trifluoroacetate
(1RS)-1-[(1SR,2SR,4SR)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl- 3(piperidin-1-yl)propan-1-ol (endo form)
1395
Extra
Price
charges
79
a
Yes
1710
N-(2-aminobenzyl)-N-methylcyclohexanamine ; Batch 2 is valid until 1 June

2013
2-bromo-4-(2-chlorophenyl)-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]
diazepine (demethylbrotizolam)
99.7% CHO
10
Yes
Yes
0793
Yes
+5C
e(b)
79
1075
Yes
+5C
79
1075
Yes
+5C
79
+5C
79

Order
Reference Standard
Code
B1157400 Buflomedil hydrochloride
Quantity Sale
per vial Unit
100 mg
1
Y0001529 Buflomedil for peak identification
0.45 mg
B1157410 Buflomedil impurity B
20 mg
B1158000 Bumetanide
150 mg
Y0000309 Bumetanide impurity A
5 mg
3-nitro-4-phenoxy-5-sulphamoylbenzoic acid
Y0000310 Bumetanide impurity B
5 mg
3-amino-4-phenoxy-5-sulphamoylbenzoic acid
B1160000 Bupivacaine hydrochloride
100 mg
Y0000088 Bupivacaine impurity B
20 mg
Y0000089 Bupivacaine impurity E
20 mg
Y0001108 Buprenorphine - * psy
10 mg
Y0001109 Buprenorphine hydrochloride - * psy
10 mg
Y0001122 Buprenorphine for system suitability - * psy
10 mg
B1168000 Buserelin
2 mg
B1168020 D-His-Buserelin
0.5 mg
Y0000131 Buspirone hydrochloride
5 mg
Y0000471 Buspirone for system suitability
2 mg
1711
B1170000 Busulfan
50 mg
0542
Y0001487 Butyl methacrylate
100 mg
1975
Y0001304 Butyl methanesulfonate
30 L
20537,20538,
20539
Yes
B1217000 Butyl parahydroxybenzoate
100 mg
See leaflet
0881,1216
Yes
Y0001357 Butyl parahydroxybenzoate impurity E
15 mg
2-methylpropyl 4-hydroxybenzoate (iso-butyl parahydroxybenzoate)
B1212000 Butylhydroxyanisole
60 mg
B1215000 Butylhydroxytoluene
50 mg
Y0000472 Cabergoline
100 mg
C0100000 Caffeine
New Y0000787 Caffeine for system suitability
Batch n
Information
Monograph
Leaflet
1398
1398
Storage
+5C
+5C
79
1398
+5C
79
1076
+5C
79
1076
+5C
79
1076
+5C
79
0541
+5C
79
(2RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
0541
+5C
79
6-(butylamino)-N-(2,6-dimethylphenyl)hexanamide
0541
+5C
79
1180
+5C
79
1181
+5C
79
4-(pyrrolidin-1-yl)-1-(4-hydroxy-2,6-dimethoxyphenyl)butan-1-one
1180,1181
Yes
Extra
Price
charges
79
a
+5C
79
1077
-20C
79
1077
-20C
79
1711
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
0881
+5C
79
0880
+5C
79
Plastic additive 07
0581,30103,
30105,30106,
30107
+5C
79
99.8% CHNO
1773
Yes
-20C
79
70 mg
See leaflet
0267,0268,15
04
Yes
+5C
79
0267, 0268
Yes
+5C
79
1295
Yes
-20C
e(d)
150
2.00 mg per vial of CHNO
Yes
Yes
10 mg
Batch 2 is valid until 30 November 2013
C0166000 Calcifediol
5 mg
95.3% CHO ; Batch 3 is valid until 28 February 2013
C0166001 Calcifediol - reference spectrum
n/a
1295
79
Y0000499 Calcipotriol (anhydrous) - reference spectrum
n/a
2011
79
Y0000473 Calcipotriol monohydrate
10 mg
79
Y0000474 Calcipotriol monohydrate - reference spectrum
n/a
79
C0200000 Calcitonin (salmon)
1 mg
0471
-20C
79
Y0000632 Calcitonin-Gly
1 ml
About 0.9 mg per ml
0471
-20C
79
94.3% CHO ; Batch 1 is valid until 31 August 2013
2011,2284
Yes
+5C
2284
11
Yes

Order
Reference Standard
Code
C0200010 N-acetyl-cys1-calcitonin

Batch n
4
C0225000 Calcitriol
C0226000 Calcitriol - reference spectrum
C0249000 Calcium ascorbate - reference spectrum

C0250000 Calcium folinate
C0299000 Calcium glucoheptonate
C0300000 Calcium gluconate
Quantity Sale
Information
per vial Unit
0.1 mg
1 about 0.1mg N-acetyl-cys-1-calcitonin per vial
10 mg
1 99.8% CHO ; Batch 7 is valid until 31 July 2012
Monograph
Leaflet
0471
0883
Storage
-20C
Yes
n/a
n/a
100 mg
60 mg
100 mg
C0340000 Calcium levulinate dihydrate
250 mg
C0350000 Calcium oxalate monohydrate
500 mg
C0400000 Calcium pantothenate
60 mg
C0405000 Camphor (racemic)
50 mg
Y0001388 Candesartan cilexetil
60 mg
2375
Y0001387 Candesartan cilexetil for peak identification
10 mg
2375
Yes
Y0001389 Candesartan cilexetil for system suitability
10 mg
2573
Yes
C0410000 Canrenone
50 mg
0688
C0426000 Caprylic acid
200 mg
Y0000671 Capsaicin
50 mg
C0430000 Captopril
10 mg
Y0001182 Captopril for system suitability
20 mg
Y0001219 Captopril impurity B
10 mg
Y0001220 Captopril impurity C
10 mg
Y0001221 Captopril impurity D
Y0000435 Captopril impurity E
Y0001450 Captopril impurity J
Y0000113 Carbachol
New C0450000 Carbamazepine
-20C
0883
e(d)
1000
79
79
85.5 % CHCaNO
0978,1606
+5C
79
1399
+5C
79
Calcium digluconate
0172,0658,09
79,1399,2161
,2162,2164,2
364
1296
+5C
79
+5C
79
+5C
79
0470
+5C
79
0655,1600
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
1079
+5C
79
1079
+5C
79
87.4% CHBrNO; (2S)1-[(2S)-3-bromo-2-methylpropanoyl]pyrrolidine-2carboxylic acid
1079
+5C
79
84.8% CHOS; (2RS)-2-methyl-3-sulphanylpropanoic acid
1079
+5C
79
10 mg
85.4% CHBrO; (2RS)-3-bromo-2-methylpropanoic acid
1079
+5C
79
10 mg
(2S)-1-isobutyryl-pyrrolidine-2-carboxylic acid
1079
+5C
79
10 mg
92.5% CHNOS; (2S)-1-[(2S)-3-(acetylsulfanyl)-2-methylpropanoyl]

pyrrolidine-2-carboxylic acid (acetylcaptopril)
1079
+5C
79
50 mg
+5C
79
200 mg
99.9% CHNO ; Batch 4 is valid until 31 October 2013
0543
+5C
79
Y0000033 Carbamazepine impurity A
10 mg
10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide (10,11dihydrocarbamazepine)
0543
+5C
79
C0451000 Carbasalate calcium - reference spectrum
n/a
1185
79
Y0001161 Carbasalate impurity B
5 mg
1185
+5C
79
C0455000 Carbenicillin sodium
50 mg
0956
+5C
79
C0460000 Carbidopa
50 mg
0755
+5C
79
C0465000 Carbimazole
120 mg
+5C
79
1182
Extra
Price
charges
79
c
20234
Loss of 12.1% m/m (U= 0.2%, n=10, k=2.23)
Yes
1401,1471
98,7% CHNO ; (E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8methylnon-6-enamide ; Batch 1 is valid until 1 April 2013
1859,2336,23
37
Yes
Yes
1971
99.7% CHNOS
12
0884
Yes
Yes

Order
Code
C0470000 Carbocisteine
Reference Standard

Batch n
2
Quantity Sale
per vial Unit
60 mg
1
Information
Monograph
Leaflet
0885
Storage
+5C
Extra
Price
charges
79
a
C0499900 Carbon dioxide - reference spectrum
n/a
0375
79
C0550000 Carboplatin - reference spectrum
n/a
1081
79
Y0000475 Carboprost trometamol
40 mg
79
Y0000536 Carboprost trometamol - reference spectrum
n/a
79
Y0000035 Carisoprodol
50 mg
Y0000036 Carisoprodol impurity A
10 mg
Y0001214 Carmellose
10 mg
C0580004 Carmustine - reference spectrum
n/a
C0580010 Carmustine impurity A
20 mg
Y0000846 Carprofen for veterinary use
30 mg
Y0000884 Carprofen for system suitability
5 mg
Y0000192 Carteolol hydrochloride - reference spectrum
Y0000193 Carteolol for system suitability
Y0001427 Carvedilol
Y0000075 Carvedilol - reference spectrum
Y0000103 Carvedilol impurity C
Y0001426 Carvedilol for system suitability

C0600000 Casein BRP
1712
99.1% CHNO
-20C
1712
1689
+5C
79
1689
+5C
79
2360
+5C
79
79
1187
-20C
g(c)
79
2201
+5C
79
2201
+5C
79
n/a
1972
79
30 mg
1972
+5C
79
50 mg
1745
+5C
79
n/a
1745
79
10 mg
+5C
79
10 mg
+5C
79
100000 mg
0350
+5C
131
C0630000 Cefaclor
450 mg
94.9% CHClNOS ; Batch 2 is valid until 30 November 2013
0986
C0640000 Delta-3-Cefaclor
20 mg
C0650000 Cefadroxil
250 mg
93,8% CHNOS ; Batch 2 is valid until 1 July 2013
C0675000 Cefalexin monohydrate
150 mg
94.2% CHNOS
C0682000 Cefalotin sodium
100 mg
98.8% CHNNaOS
Y0000505 Cefalotin for impurity B identification
10 mg
C0682300 Cefamandole nafate
125 mg
99.0% CHNNaOS
Y0000240 Cefapirin sodium
100 mg
98.5% CHNNaOS
1650
C0682400 Cefatrizine propylene glycol
150 mg
81.8% CHNOS
1403
C0682410 Cefatrizine impurity A
60 mg
7-amino-(6R,7R)-3-[(2H-1,2,3-triazol-4-yl)sulfanyl]-methyl-8- oxo-5-thia-1azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (7-ACA triazole)
1403
C0682800 Cefazolin
150 mg
99.6% CHNOS
0988
Y0000633 Cefepime dihydrochloride monohydrate
150 mg
95.2% CHClNOS
2126
Y0000634 Cefepime dihydrochloride monohydrate for system

suitability
15 mg
(2RS)-2-(hydroxymethyl)-2-methylpentyl(1-methylethyl)carbamate
1187
1,3-bis(2-chloroethyl)urea
(2RS)-1-[benzyl[2-(2-methoxyphenoxy)ethyl]amino]-3-(9H- carbazol-4-yloxy)
propan-2-ol
Yes
1745
1745
Yes
Yes
0986
79
79
0260,0577,08
13,2342
Yes
+5C
79
0708,0814
Yes
+5C
79
0987
+5C
79
0987
+5C
79
1402
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
2126
13
+5C
-20C
Yes
Yes
Yes

Order
Reference Standard
Code
Y0001336 Cefepime impurity E

Batch n
1
Quantity Sale
Information
per vial Unit
10 mg
1 (6R,7R)-7-amino-3-[(1-methylpyrrolidinio)methyl]-8-oxo-5thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
Monograph
Leaflet
-20C
-20C
79
+5C
79
79
200 mg
88.8% CHNOS
1188
C0684750 Cefoperazone dihydrate
100 mg
94.2% CHNOS
1404
C0684800 Cefoperazone sodium - reference spectrum
n/a
Y0000420 Cefotaxime acid
80 mg
C0685000 Cefotaxime sodium
30 mg
Y0000506 Cefotaxime for peak identification
10 mg
C0688000 Cefoxitin sodium
100 mg
Y0001496 Cefoxitin sodium for peak identification
15 mg
Y0001305 Cefpodoxime proxetil
70 mg
Y0001318 Cefpodoxime proxetil for impurity H identification
10 mg
Y0001306 Cefpodoxime proxetil for peak identification
10 mg
Y0001371 Cefprozil
120 mg
Y0001368 Cefprozil impurity mixture
10 mg
Y0001372 Cefprozil impurity A
20 mg
Y0001367 Cefprozil for peak identification
10 mg
C0690000 Cefradine
300 mg
93.9%
Y0000568 Cefradine for peak identification
15 mg
Y0001174 Cefradine impurity mixture
0.04 mg
C0690500 Ceftazidime
200 mg
Y0001111 Ceftazidime for peak identification
10 mg
1405, 2344
C0691000 Ceftriaxone sodium
100 mg
90.4% CHNNaOS
0991
C0692000 Ceftriaxone impurity A
10 mg
E-isomer
0991
C0694990 Cefuroxime axetil
60 mg
97.3% CHNOS ; Batch 3 is valid until 31 December 2013
1300
Yes
C0695000 Cefuroxime sodium
150 mg
96.7% CHNNaOS
0988,0992
Y0001445 Celecoxib
200 mg
99.9% CHFNOS
2591
Y0001446 Celecoxib impurity A
10 mg
4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]
benzenesulfonamide
Y0001447 Celecoxib impurity B
10 mg
4-[3-(4-methylphenyl)-5-(trifluoromethyl)-1H-pyrazol-1-yl]
benzenesulfonamide
Y0000311 Celiprolol hydrochloride
10 mg
Y0000312 Celiprolol impurity I
0.02 mg
Y0000239 Celiprolol for peak identification
20 mg
1632
Y0000784 Cellulose acetate
40 mg
0887
n/a
Yes
1404
94.3% CHNOS
0989
+5C
79
0708,0989
+5C
79
+5C
79
+5C
79
0989
Yes
0990
97.4% CHNNaOS
Extra
Price
charges
79
g(c)
2126
C0684000 Cefixime
C0698005 Cellulose acetate butyrate - reference spectrum

Storage
0990
Yes
+5C
79
2341
Yes
-20C
79
2341
Yes
-20C
79
2341
Yes
-20C
79
2342
Yes
+5C
79
2342
Yes
+5C
79
+5C
79
97.1% CHNOS
See leaflet CHNOS
2342
(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid
(p-hydroxyphenylglycine)
2342
Yes
+5C
79
Yes
+5C
79
Must be used with Cefradine impurity mixture CRS Y0001174
0167,0168,05
78,
0708,0814
0814
Yes
+5C
79
Must be used with Cefradine for peak identification Y0000568
0814
Yes
+5C
79
85.3% CHNOS
1405
+5C
79
Yes
+5C
79
Yes
+5C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
2591
+5C
79
2591
+5C
79
1632
+5C
79
1632
+5C
79
+5C
79
+5C
79
1-acetyl-1-(4-ethoxyphenyl)-3,3-diethylurea
14
Yes
79
1406
l

Order
Reference Standard
Code
Y0001054 Cellulose acetate phthalate

Batch n
1
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
0314
+5C
0080,0081,00
93,
0094,1530,18
75
+5C
79
C0700000 Cephaline hydrochloride
15 mg
C0980650 Cetirizine dihydrochloride
100 mg
1084
+5C
79
C0980651 Cetirizine impurity A
10 mg
(RS)-1-[(4-chlorophenyl)phenylmethyl]piperazine ; Batch 4 is valid until 31

July 2013
1084
+5C
79
Y0001197 Cetirizine for peak identification
1.01 mg
Replaces Cetirizine impurity mixture CRS
1084
Yes
+5C
79
C0984100 Cetostearyl isononanoate - reference spectrum
n/a
79
C0990000 Cetyl alcohol
300 mg
Yes
+5C
79
Y0000073 Cetyl palmitate 15
60 mg
1906
+5C
79
Y0000074 Cetyl palmitate 95
50 mg
1906
+5C
79
C1000000 Cetylpyridinium chloride
20 mg
0379
+5C
79
C1050000 Chenodeoxycholic acid
125 mg
1189,1275
+5C
79
Y0000104 Chitosan hydrochloride
30 mg
1774
+5C
79
C1100000 Chlorambucil
100 mg
0137
+5C
79
Y0001298 Chlorambucil for system suitability
10 mg
0137
+5C
79
Y0001299 Chlorambucil with impurity G
10 mg
0137
+5C
79
C1200000 Chloramphenicol
500 mg
0071,0473,07
09
+5C
79
C1300000 Chloramphenicol dipalmitate
100 mg
0473
+5C
79
C1350000 Chloramphenicol disodium disuccinate
25 mg
0709
+5C
79
C1400000 Chloramphenicol palmitate isomer
100 mg
0473
+5C
79
C1425000 Chloramphenicol sodium succinate
1500 mg
0709
+5C
79
C1435000 Chlorcyclizine hydrochloride
100 mg
1086
+5C
79
C1450000 Chlordiazepoxide - * psy
50 mg
0656,1974
+5C
79
C1500000 Chlordiazepoxide hydrochloride - * psy
100 mg
0474
+5C
79
Y0000476 Chlordiazepoxide impurity A
10 mg
0474,0656
+5C
79
C1510000 Chlorhexidine
50 mg
0658
+5C
79
C1520000 Chlorhexidine diacetate
10 mg
0657
+5C
79
C1540000 Chlorhexidine dihydrochloride
50 mg
0659
+5C
79
Y0001545 Chlorhexidine for system suitability
5 mg
0658
Yes
+5C
79
C1530000 Chlorhexidine for performance test
50 mg
0657,0658,06
59
Yes
+5C
79
1085
0540,0702,08
01,
0802,0847,09
69, 1411
99.7% CHO ; Batch 1 is valid until 30 November 2013
91.1% CHClNNaO
7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 4-oxide
15
Yes

Order
Reference Standard
Code
Y0000569 Chlorogenic acid

Batch n
1
Quantity Sale
Information
per vial Unit
20 mg
1 96.9% CHO ; (1S,3R,4R,5R)-3-[(3,4-Dihydroxycinnamoyl)oxy]-1,4,5trihydroxycyclohexanecarboxylic acid
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
1821,1822,18
23,
1824,1866,18
97, 2389
+5C
1190
-20C
g(c)
79
C2223030 1-(4-Chlorophenyl)-1-phenylethanol
15 mg
C1650000 Chloroquine sulfate
200 mg
0544,0545
+5C
79
C1700000 Chlorothiazide
100 mg
0385,0394
+5C
79
C1800000 Chlorphenamine maleate
100 mg
0386,0977,10
84, 1196
+5C
79
Y0000436 Chlorphenamine impurity A
0.01 mg
2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino)
ethyl]butanenitrile
0386
+5C
79
Y0000437 Chlorphenamine impurity C
10 mg
(3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1amine
0386
+5C
79
C1900000 Chlorpromazine hydrochloride
200 mg
0475,20303
+5C
79
Y0000507 Chlorpromazine impurity A
15 mg
3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1amine S-oxide (chlorpromazine sulphoxide)
0475
+5C
79
Y0000479 Chlorpromazine impurity D
10 mg
3-(2-chloro-10H-phenothiazin-10-yl)-N-methypropan-1-amine
(demethylchlorpromazine)
0475
+5C
79
Y0000508 Chlorpromazine impurity E
10 mg
2-chloro-10H-phenothiazine
0475
+5C
79
Y0001449 Chlorpromazine impurity F
2 mg
3-(4-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine
0475
+5C
79
C1905000 Chlorpropamide
100 mg
1087
+5C
79
C1905020 Chlorpropamide impurity B
50 mg
1,3-Dipropylurea
1087
+5C
79
C1915000 Chlorprothixene hydrochloride
50 mg
2.0% E-isomer
0815,1365
+5C
79
C1950000 Chlortalidone
150 mg
99.7% CHClNOS ; Batch 2 is valid until 31 August 2013
0546
Yes
+5C
79
1.017 mg
0546
Yes
+5C
79
C2000000 Chlortetracycline hydrochloride
100 mg
92.4% of of CHClNO ; Batch 4 is valid until 31 December 2012
0173
Yes
+5C
79
Y0001451 Chlortetracycline for system suitability
20 mg
0173
Yes
+5C
79
C2100000 Cholecalciferol
480 mg
0072,0574,05
75,
0598,1192,11
93
Yes
-20C
g(c)
79
C2150000 Cholecalciferol for system suitability
1 mL
-20C
g(c)
79
C2155000 Cholesterol
100 mg
+5C
79
C2158000 Cholic acid
60 mg
+5C
79
Y0000280 Chondroitin sulfate sodium
250 mg
+5C
79
Y0000593 Chondroitin sulfate sodium (marine)
100 mg
+5C
79
C2160000 Chymotrypsin BRP
100 mg
6.01 microkatals per mg
Y0001553 Ciclesonide
150 mg
99.8 % CHO
New Y0000779 Chlortalidone for peak identification
Clemastine fumarate impurity C
100% CHO ; Vitamin D3
0072,0082,05
74,
0575,0598
0993,0593
99.5% CHO
Yes
1189
99.6 % HO(CHNNaOS) ; Batch 1 is valid until 1 May 2013
2064,2090
Yes
2064
16
0476,0694
Yes
+5C
79
2703
Yes
+5C
79

Order
Reference Standard
Code
Y0001554 Ciclesonide containing impurity A

Batch n
1
Quantity Sale
Information
per vial Unit
15 mg
1 (2S)-2-cyclohexyl-11b-hydroxy-3,20-dioxo-16bH-[1,3]dioxolo[4,5:16,17]
pregna-1,4-diene-21-yl 2-methylpropanoate (S-epimer of ciclesonide)
Monograph
Leaflet
Storage
2703
+5C
Extra
Price
charges
79
a
Y0001555 Ciclesonide impurity B
10 mg
(2R)-2-cyclohexyl-11b,21-dihydroxy-16bH-[1,3]dioxolo[4,5:16,17]
pregna-1,4-diene-3,20-dione
2703
+5C
79
Y0001556 Ciclesonide impurity C
10 mg
(2R)-2-[(1RS)-cyclohex-3-enyl]-11b-hydroxy-3,20-dioxo-16bH-[1,3]dioxolo
[4,5:16,17]pregna-1,4-diene-21-yl 2-methylpropanoate
2703
+5C
79
Y0000040 Ciclopirox
100 mg
1407
+5C
79
C2162701 Ciclopirox impurity A
40 mg
()-2-(3-cyclohexyl-5-methyl-4,5-dihydroisoxazol-5-yl)acetic acid
1302,1407
+5C
79
C2162702 Ciclopirox impurity B
20 mg
6-cyclohexyl-4-methyl-2H-pyran-2-one
1302,1407
-20C
79
C2162700 Ciclopirox olamine
150 mg
1302
+5C
79
C2163000 Ciclosporin
120 mg
0994
+5C
79
Y0000361 Ciclosporin for system suitability
5 mg
0994
+5C
79
C2170000 Cilastatin sodium
10 mg
1408
+5C
79
C2174000 Cilazapril
50 mg
1499
+5C
79
C2174002 Cilazapril impurity A
25 mg
1,1-dimethylethyl(1S,9S)-9-[[(S)-1-ethoxycarbonyl-3-phenylpropyl]
amino]-10-oxo-octahydro-6H-pyridazino[1,2a][1,2]diazepine-1-caboxylate
1499
+5C
79
C2174005 Cilazapril impurity D
10 mg
(1S,9S)-9-[[(R)-1-ethoxycarbonyl-3-phenylpropyl]amino]-10- oxooctahydro-6H-pyridazino[1,2a][1,2]diazepine-1-carboxylic acid
1499
+5C
79
C2175000 Cimetidine
50 mg
0756
+5C
79
C2175500 Cimetidine hydrochloride
100 mg
1500
+5C
79
Y0001130 Cimetidine for peak identification
10 mg
0756
Yes
+5C
79
Y0001146 Cimetidine for system suitability
0.5085 mg
756
Yes
+5C
79
C2177000 Cinchocaine hydrochloride
60 mg
1088
+5C
79
Y0000176 Cineole
180 mg
1973
+5C
79
C2180000 Cinnarizine
100 mg
0816
+5C
79
Y0000362 Ciprofibrate
5 mg
2013
+5C
79
Y0000363 Ciprofibrate for system suitability
5 mg
2013
+5C
79
Y0000198 Ciprofloxacin
20 mg
1089
+5C
79
C2190000 Ciprofloxacin hydrochloride
100 mg
93.6% CHClFNO
0888,1353
+5C
79
Y0000199 Ciprofloxacin hydrochloride for peak identification
15 mg
+5C
79
C2190050 Ciprofloxacin impurity A
10 mg
7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic
acid (fluoroquinolonic acid)
+5C
79
C2210000 Cisplatin
100 mg
99.7% [PtCl(NH)]
0599
+5C
79
Y0001018 Cisplatin impurity A
15 mg
trans-diamminedichloroplatinum (II)
0599
+5C
79
Y0001019 Cisplatin impurity B
15 mg
94.1% [PtCl(NH)]-; amminetrichloroplatinate(-)
0599
+5C
79
Y0001008 Citalopram hydrobromide
5 mg
2288
+5C
79
Y0001007 Citalopram hydrochloride
5 mg
2203
+5C
79
98.5% CHNO
17
0888,1089
Yes
Yes
0888,1089,22
29
Yes
Yes

Order
Reference Standard
Code
Y0000855 Citalopram for system suitability

Batch n
3
Quantity Sale
Information
per vial Unit
0.065 mg 1 Batch 2 is valid until 30 September 2012
Monograph
Leaflet
Storage
2203,2288
Yes
+5C
Extra
Price
charges
79
g
A1202000 Citric acid (anhydrous)
50 mg
0455
+5C
79
C2219000 Citric acid monohydrate
50 mg
0456
+5C
79
Y0000639 Cladribine
50 mg
+5C
g(b)
79
Y0000609 Cladribine for peak identification
10 mg
+5C
g(b)
79
Y0000610 Cladribine impurity C
5 mg
2-chloro-7H-purin-6-amine
2174
+5C
g(b)
79
Y0000320 Clarithromycin
160 mg
97.7% CHNO
1651
Yes
+5C
79
Y0000321 Clarithromycin for peak identification
40 mg
1651
Yes
+5C
79
Y0000269 Clazuril for system suitability
10 mg
1714
Yes
+5C
79
Y0001193 Clazuril
10 mg
1714
+5C
79
C2221000 Clebopride malate
100 mg
1303
+5C
79
C2223000 Clemastine fumarate
100 mg
1190
+5C
79
C2248000 Clenbuterol hydrochloride
30 mg
1409
+5C
79
C2248010 Clenbuterol impurity B
10 mg
1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino] ethanone
1409
+5C
79
C2250000 Clindamycin hydrochloride
200 mg
94.4% CHClNOS
0582,0583,09
96
+5C
79
C2269000 Clindamycin phosphate
250 mg
95.7% CHClNOPS
0996
+5C
79
Y0000364 Clioquinol
5 mg
2111
+5C
79
Y0000205 Clobazam - reference spectrum
n/a
1974
79
Y0000241 Clobazam impurity A
10 mg
7-chloro-5-phenyl-1,5-dihydro-1,5-dihydro-3H-1,5-benzodiazepine-2,4-dione
1974
+5C
79
Y0000559 Clobetasol propionate
40 mg
99.6% CHClFO
2127
+5C
79
Y0000570 Clobetasol for peak identification
2 mg
Y0000571 Clobetasol impurity J
0.4 mg
C2285000 Clobetasone butyrate
50 mg
Y0001137 Clobetasone butyrate for system suitability
Y0000888 Clodronate disodium tetrahydrate
Y0000885 Clodronate impurity D

Y0000313 Clofazimine
2174
99.1% CHClNO
2174
Yes
+5C
79
2127
+5C
79
1090
+5C
79
30 mg
1090
+5C
79
5 mg
1777
+5C
79
5 mg
1777
+5C
79
150 mg
2054
+5C
79
Y0000358 Clofazimine for system suitability
10 mg
2054
+5C
79
C2300000 Clofibrate
0.5 ml
0318
+5C
79
C2320000 Clomifene citrate
50 mg
+5C
79
C2332000 Clomifene citrate for performance test
50 mg
+5C
79
C2360000 Clomipramine hydrochloride
100 mg
+5C
79
Y0000132 Clomipramine impurity C
10 mg
+5C
79
2127
Yes
(17R)-4'-chloro-5'-ethyl-9-fluoro-11-hydroxy-16-methylspiro
[androsta-1,4-diene-17,2'(3'H)-furan]-3,3'-dione (17 alpha-spiro compound)
(chloromethylene)bis(phosphonic acid)
Yes
Yes
Yes
0997,1046
44% of Z-isomer CHClNO
0997
Yes
0889
94.5% CHClN; 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,Ndimethylpropan-1-amine
18
0889
Yes

Order
Reference Standard
Code
Y0000133 Clomipramine impurity D

Batch n
2
Quantity Sale
Information
per vial Unit
10 mg
1 3-(3,7-dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,Ndimethylpropan-1-amine ; Batch 1 is valid until 31 December 2012
Monograph
Leaflet
Storage
0889
Yes
+5C
Y0000134 Clomipramine impurity F
5 mg
C2385000 Clonazepam - * psy
50 mg
Y0000286 Clonazepam - reference spectrum
n/a
C2385015 Clonazepam impurity B
5 mg
C2400000 Clonidine hydrochloride
100 mg
Y0000801 Clonidine impurity B
20 mg
Y0000833 Clopamide
40 mg
Y0000848 Clopamide for system suitability
10 mg
1747
Y0001333 Clopidogrel hydrogen sulfate
60 mg
2531
Y0001335 Clopidogrel impurity A
10 mg
Y0001334 Clopidogrel for system suitability
100 mg
2531
Y0000392 Closantel sodium dihydrate
20 mg
1716
Y0000393 Closantel for system suitability
20 mg
1716
Yes
C2424400 Clostridia (multi-component) rabbit antiserum(for

vaccines-vet.use)BRP
1 mg
see information on the accompanying leaflet
0362,0363,03
64, 0697
C2424550 Clostridium tetani guinea pig antiserum (for vaccines human use) BRP
1 mg
0.20 IU per vial (determined using toxin neutralisation test)
C2424500 Clostridium tetani guinea pig antiserum (for vaccines vet. use) BRP
1 mg
C2425600 Clostridium tetani rabbit antiserum (for vaccines - vet.

use) BRP
1 mg
C2430000 Clotrimazole
100 mg
Y0000818 Clotrimazole impurity E
15 mg
Y0000849 Clotrimazole for peak identification
1.005 mg
C2450000 Cloxacillin sodium
200 mg
93.9% CHClNNaOS
C2460000 Clozapine
60 mg
Y0000758 Clozapine for peak identification
0.41 mg
Y0001472 Coagulation Factors V, VIII, XI and XIII plasma
1 mg
Y0000162 Cocaine hydrochloride - reference spectrum
n/a
C2480000 Cocoyl caprylocaprate
40 mg
Y0000722 Codeine - * narc
20 mg
C2500000 Codeine - reference spectrum
n/a
Extra
Price
charges
79
a
0889
+5C
79
1974,0415
+5C
79
0890
79
3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
0890
+5C
79
0477
+5C
79
0477
+5C
79
1747
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
Yes
-20C
90
20708
Yes
-20C
90
34 IU per vial
See leaflet,
0697
Yes
-20C
90
15 IU per vial
See leaflet,
0697
Yes
-20C
90
0757
+5C
79
0757
+5C
79
3-Amino-4-(2-chlorophenyl)-6-nitro-1-quinolin-2-one
1-acetyl-2-[(2,6-dichlorophenyl)amino]-4,5-dihydro-1H-imidazole
(2S)-(2-chlorophenyl)[6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl]acetic acid
Yes
2531
0757
Yes
+5C
79
0661,0663,06
68, 2260
+5C
79
1191
+5C
79
Yes
+5C
79
Yes
-20C
90
79
+5C
79
+5C
79
79
1191
Factor V : 0.73 IU per vial, Factor VIII : 0.74 IU per vial, Factor XI : 0.59 IU per 0903,1646,20
vial, Factor XIII : 0.79 IU per vial
740,20722
Yes
0073
1411
0076,1839,18
41
See leaflet
0074,0075,00
76
19
Yes

Order
Reference Standard
Code
Y0000334 Codeine impurity A
C2500100 Codeine hydrochloride dihydrate - reference spectrum

Batch n
3
1
Quantity Sale
Information
per vial Unit
15 mg
1 7,8-didehydro-4,5 alpha-epoxy-3,6 alpha-dimethoxy-17-methylmorphinan
n/a
Monograph
Leaflet
0074,0075,00
76, 1412
Storage
+5C
1412
Extra
Price
charges
79
a
l
79
New C2510000 Codergocrine mesilate
60 mg
1416,2060
+5C
79
Y0001500 Coix seed HRS
1300 mg
2454
+5C
79
C2580000 Colchicine
15 mg
0758
+5C
79
Y0000209 Colchicine for system suitability
10 mg
0758
+5C
79
Y0000374 Colestyramine
10 mg
1775
+5C
79
C2600000 Colistimethate sodium
20 mg
285000 IU per vial CHNNaOS
0319,20702
+5C
79
Y0000277 Colistin sulfate
25 mg
33.7% colistin E2, 2.6% colistin E3, 3.3% colistin E1-I, 3.1% colistin
E1-7MOA, 44.2 % colistin E1.
25.0 mg of colistin sulfate per vial
0320
Yes
-20C
79
C2700000 Colistin sulfate for microbiological assay
25 mg
576 000 IU per vial; For microbiological assay only
0320
Yes
-20 C
79
C2725000 Copovidone - reference spectrum
n/a
0891
79
C2800000 Cortisone acetate
250 mg
0321,0736,07
67
+5C
79
Y0000438 Coumarin
80 mg
2120
+5C
79
C2900000 Cotton wool standard for neps
1000 mg
0036
+5C
79
Y0001053 Crospovidone
5 mg
0892
+5C
79
C2970000 Crotamiton
100 mg
99.2% CHNO (sum of E and Z-isomers); 3.5% Z-isomers CHNO
1194
-20C
79
C2970005 Crotamiton impurity A
70 mg
N-ethyl-N-(2-methylphenyl)but-3-enamide
1194
-20C
79
Y0001061 Cyanidin chloride
25 mg
93.3% CHClO ; Batch 1 is valid until 31 August 2013
C3000000 Cyanocobalamin
20 mg
Vitamin B12
C3090000 Cyclizine hydrochloride
50 mg
Y0000886 Cyclizine impurity A
15 mg
Y0000887 Cyclizine impurity B
10 mg
C3200000 Cyclobenzaprine hydrochloride
100 mg
C3230000 Cyclohexa-1,4-dienylglycine
15 mg
C3245000 Cyclopentolate hydrochloride
50 mg
1093
Y0001088 Cyclopentolate for system suitability
60 mg
1093
C3250000 Cyclophosphamide
50 mg
0711
C3280000 Cyproheptadine hydrochloride
30 mg
Y0001095 Cyproheptadine impurity C
5 mg
C3283000 Cyproterone acetate
30 mg
1094
Y0001390 Cyproterone acetate for peak identification
5 mg
1094
Yes
Y0001223 Cyproterone impurity mixture
0.01 mg
1094
Yes
99.9% CHO
2394
Yes
+5C
79
0269,0270,05
47,
0710,1505
1092
Yes
+5C
79
+5C
79
1-methylpiperazine
1092
+5C
g(b)
79
diphenylmethanol (benzhydrol)
1092
+5C
79
0408,0464
86.7% CHNO; (2R)-amino(cyclohexa-1,4-dienyl)acetic acid (ddihydrophenylglycine)
20
+5C
79
-20C
79
+5C
79
+5C
79
+5C
79
0817,0846
+5C
79
0817
+5C
79
+5C
79
+5C
79
+5C
79
0814
Yes
Yes

Order
Reference Standard
Code
New C3290000 Cysteine hydrochloride monohydrate

Batch n
2
Quantity Sale
Information
per vial Unit
100 mg
1 Batch 1 is valid until 31 December 2013
Monograph
Leaflet
Storage
0895
+5C
Extra
Price
charges
79
g
C3300000 Cystine
100 mg
0998
+5C
79
C3350000 Cytarabine
150 mg
0760
+5C
79
Y0000733 Dacarbazine
20 mg
+5C
79
Y0000734 Dacarbazine impurity A
20 mg
89.4% CHNO; 3,7-dihydro-4H-imidazo[4,5-d]-1,2,3-triazin-4-one (2azahypoxanthine)
1691
Yes
+5C
79
Y0000735 Dacarbazine impurity B
10 mg
87.9% CHO; 5-amino-1H-imidazole-carboxamide
1691
Yes
+5C
79
D0070000 Dalteparin sodium
250 mg
+5C
79
Y0000600 Danaparoid sodium
10 mg
+5C
79
D0100000 Dapsone
100 mg
+5C
79
D0125000 Daunorubicin hydrochloride
120 mg
98.5% CHClNO
0662
+5C
79
D0120000 Daunorubicinone
10 mg
Daunorubicin aglycone
0662
+5C
79
D0160000 Deferoxamine mesilate
30 mg
0896
-20C
79
D0201000 Dehydrohexetidine
50 mg
1221
+5C
79
Y0000611 Dembrexine hydrochloride monohydrate
10 mg
2169
+5C
79
D0300000 Demeclocycline hydrochloride
100 mg
0176
+5C
79
D0350000 N-Demethylerythromycin A
10 mg
+5C
79
Y0000228 Demethylflumazenil - reference spectrum
n/a
0179,0274,04
90,
0552,1098
1917
79
D0406200 Deptropine citrate
60 mg
1308
+5C
79
D0430000 Dequalinium chloride
50 mg
1413
+5C
79
D0431000 Dequalinium chloride for performance test
50 mg
1413
+5C
79
Y0001321 Dermatan sulfate and oversulfated chondroitin sulfate
1 mL
-20C
79
D0480000 Desacetylvinblastine
1 mg
1276
-80C
g(d)
79
Y0000879 Desflurane - reference spectrum
n/a
1666
79
Y0000807 Desflurane impurity A
1 ml
D0500000 Desipramine hydrochloride
100 mg
D0600000 Deslanoside
150 mg
100 mg
30 mg
1133
5 mg
2570
Yes
D0650000 Desmopressin
0.94 mg
0.94 mg per vial of CHNOS ; Batch 7 is valid until 1 March 2013
0712
Yes
Y0000509 Desogestrel
50 mg
99.9% CHO
1717
Yes
Y0000510 Desogestrel for system suitability
10 mg
1717
Yes
D0400000 Desoxycortone acetate
100 mg
New Y0001584 Desloratadine

D0630000 Desmethylmetrifonate
New Y0001582 Desloratadine for system suitability
1691
0828
147 anti-factor Xa units per ampoule, 4.3 anti-factor IIa units per ampoule
2090
Yes
0077
2-ethyl-N-[[1-(2-ethylhexyl)-4-methyl-4,5-dihydro-1H-imidazol-4-yl]methyl]
hexan-1-amine
92.4% CHClNO
0332,0333
Dermatan sulfate 10 mg/mL

Oversulfated chondroitin sulfate 2.5 mg/mL
1,1'-oxybis(1,2,2,2-tetrafluoroethane)
Yes
1666
+5C
79
0481
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
-20C
79
+5C
79
+5C
79
0482
98.8% CHO
2570
21
Yes
Yes
79
0322,0809,08
+5C
a
50, 1327

Order
Reference Standard
Code
Y0000001 Detomidine hydrochloride

Batch n
2
Quantity Sale
per vial Unit
100 mg
1
Information
Monograph
Leaflet
Storage
Extra
Price
charges
79
g
1414
+5C
1414
+5C
79
0312,0388,05
48,
0768,1376,22
37,0549
+5C
79
+5C
79
D0660020 Detomidine impurity B
20 mg
(RS)-(1-benzyl-1H-imidazol-5-yl)(2,3-dimethylphenyl)methanol
D0700000 Dexamethasone
50 mg
10 mg
0388
D0710000 Dexamethasone acetate
100 mg
0548,0933,09
75, 2237
+5C
79
Y0001169 Dexamethasone acetate impurity E
0.013 mg
0548
+5C
79
Y0001177 Dexamethasone for system suitability
10 mg
0388
+5C
79
Y0000538 Dexamethasone isonicotinate
10 mg
2237
+5C
79
Y0000511 Dexamethasone isonicotinate for impurity C identification
10 mg
2237
+5C
79
D0718000 Dexamethasone pivalate
50 mg
1327
+5C
79
D0720000 Dexamethasone sodium phosphate
100 mg
Y0001477 Dexamethasone sodium phosphate for peak identification
10 mg
D0720800 Dexchlorpheniramine maleate
60 mg
D0730000 Dexpanthenol
5 mg
D0731000 Dextran
25 mg
D0731005 Dextran 1
50 mg
D0732000 Dextran Vo
10 mg
D0733000 Dextran 4 for calibration
50 mg
M 3050-M 3850
50 mg
50 mg
50 mg
50 mg
D0738000 Dextran 40 for performance test
50 mg
D0739000 Dextran 60/70 for performance test
50 mg
Y0000744 Dextranomer
50 mg
D0740000 Dextromethorphan hydrobromide
100 mg
Y0000261 Dextromethorphan impurity A
5 mg
ent-3-methoxymorphinan
Y0001058 Dextropropoxyphene hydrochloride - * narc
10 mg
Y0001150 Dextropropoxyphene for system suitability - * narc
5 mg
0713
D0940000 Diazepam - * psy
30 mg
0022
New Y0001593 Dexamethasone for peak identification
9-fluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregn-4-en-21-yl
acetate
Yes
Yes
Yes
0549,0735,08
10
Yes
+5C
79
0549
Yes
+5C
79
1196
+5C
79
0761
+5C
79
0999,1000,10
01
+5C
79
+5C
79
20239
+5C
79
20239
+5C
79
M 8800 - M 10450
20239
+5C
79
M 30500- M 40900
20239
+5C
79
M 58900- M 70300
20239
+5C
79
M 121800- M 238200
20239
+5C
79
20239
+5C
79
20239
+5C
79
2338
+5C
79
0020
+5C
79
0020
+5C
79
0713
+5C
79
+5C
79
+5C
79
88.3 % CHFNaOP ; Batch 4 is valid until 31 October 2012
Average molecule mass : 930-1000

Fraction with less than 3 glucose units : 8.0 to 10.5%
Fraction with more than 9 glucose units : 10.0 to 12.5%
22
1506
Yes
Yes

Order
Reference Standard
Code
Y0000596 Diazepam for system suitability - * psy

Batch n
2
Quantity Sale
Information
per vial Unit
0.5 mg
1 Batch 1 is valid until 31 August 2012
Monograph
Leaflet
Storage
0022
Yes
+5C
Extra
Price
charges
79
j
D0950000 Diazoxide
50 mg
0550
+5C
79
D0970000 Dibenzocycloheptene
20 mg
0817
+5C
79
D1000000 Dibenzosuberone
100 mg
0464,0817,09
41
+5C
79
Y0000480 Dibrompropamidine diisetionate
10 mg
2300
+5C
79
Y0000481 Dibrompropamidine for system suitability
20 mg
2300
+5C
79
D1010000 Dibutyl phthalate
1 ml
0762
+5C
79
Y0000275 Dichlorodiaminocyclohexaneplatinum
15 mg
2017
+5C
79
Y0000264 Diclazuril for veterinary use - reference spectrum
n/a
1718
79
Y0000259 Diclazuril for system suitability
20 mg
1718
+5C
79
D1039990 Diclofenac potassium
100 mg
1508
+5C
79
New D1040000 Diclofenac impurity A
0.005 mg
1-(2,6-dichlorophenyl)-1,3-dihydro-2H-indol-2-one ; Batch 7 is valid until 31

December 2013
1002,1281,15
08
+5C
79
D1050000 Dicloxacillin sodium
250 mg
94.7% CHClNNaOS ; Batch 4 is valid until 31 July 2012
0661,0663,06
68
+5C
79
D1060000 Dicycloverine hydrochloride
100 mg
1197
+5C
79
Y0000439 Didanosine
10 mg
2200
+5C
79
Y0000440 Didanosine for system suitability
10 mg
2200
+5C
79
Y0000441 Didanosine impurity A
10 mg
1,7-dihydro-6H-purin-6-one (hypoxanthine)
2200
+5C
79
Y0000442 Didanosine impurity G
10 mg
9-(2,3-dideoxy--D-glycero-pentofuranosyl)-9H-purin-6-amine (2',3'dideoxyadenosine)
2200
+5C
79
D1200000 Dienestrol
150 mg
100% CHO
0483,0484
+5C
79
D1300000 Diethylcarbamazine citrate
250 mg
99.9% CHNO
0271
+5C
79
Y0000217 Diethylene glycol (monoethyl ether) - reference spectrum
n/a
79
D1410000 Diethyl phthalate
1 ml
D1500000 Diethylstilbestrol
100 mg
D1600000 Diethylstilbestrol dimethyl ether
10 mg
D1700000 Diethylstilbestrol monomethyl ether
10 mg
Y0001423 Difloxacin hydrochloride
60 mg
Y0001429 Difloxacin impurity G
15 mg
D1750000 Diflunisal
30 mg
D1800000 Digitoxin
200 mg
Y0000640 Digoxigenin
5 mg
D1900000 Digoxin
30 mg
Y0000554 Digoxin for peak identification
10 mg
n/a
D1940001 Dihydralazine sulfate (hydrated) - reference spectrum

Batch 3 is valid until 1 April 2013
Yes
Yes
Yes
1198
0897
+5C
79
0483,0484
+5C
79
0484
+5C
79
0484
+5C
79
2239
+5C
79
2239
+5C
79
0818,0864
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
Dried at 100-105C for 2 h. 100% CHO
7-chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic
acid
99.4% CHO ; Batch 2 is valid until 30 October 2012
0078,0117
Yes
0079
98.5% CHO
0079
0079
23
Yes
79
1310
l

Order
Reference Standard
Code
Y0000232 Dihydralazine for system suitability

Batch n
1
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
Storage
1310
Yes
+5C
Y0000216 Dihydrocodeine hydrogen tartrate - reference spectrum
n/a
Y0000053 17 alpha-dihydroequilin
10 mg
D1945000 Dihydroergocristine mesilate
250 mg
D1950000 Dihydroergotamine mesilate
100 mg
Y0000831 Dihydroergotamine for peak identification
10 mg
D1952000 Dihydroergotamine tartrate
150 mg
100.0% CHNO. Dried at 100-105C at constant weight
0600
D1954000 Dihydrostreptomycin sulfate
25 mg
23.9 mg per vial of CHNOS
0485
Y0000544 Dihydrotachysterol
30 mg
99.6% CHO
2014
Y0000482 Dihydrotachysterol for system suitability
5 mg
2014
D1980000 Diltiazem hydrochloride
300 mg
1004
Y0001141 Diltiazem for system suitability
10 mg
Replaces Diltiazem impurity A CRS ; Batch 1 is valid until 31 August 2013
Y0001439 Diltiazem impurity F
10 mg
(2S,3S)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3dihydro-1,5-benzothiazepin-4(5H)-one
D2000000 Dimenhydrinate
100 mg
Y0000234 N,N-Dimethylacetamide - reference spectrum
Y0001103 Dimenhydrinate for peak identification
D2050000 Dimethyl sulfoxide
Y0001489 2-(Dimethylamino)ethyl methacrylate
D2200000 Dimeticone
200 mg
D2205000 Dimetindene maleate
50 mg
D2255000 Dinoprost trometamol
60 mg
98.2% CHNO
1312
D2250000 Dinoprostone
100 mg
99.8% CHO
1311
D2250015 Dinoprostone impurity C
10 mg
(E)-7-[(1S,2R,3R)-3-hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]- 5oxocyclopentyl]-hept-5-enoic acid (5-trans-PGE2 ; (5E)-PGE2)
Y0000094 Diosmin
70 mg
Y0000095 Diosmin for system suitability
5 mg
1611
D2600000 Diphenhydramine hydrochloride
100 mg
Y0000135 Diphenhydramine impurity A
10 mg
D2630000 Diphenoxylate hydrochloride - reference spectrum
n/a
0819
Y0001415 Diphenoxylate hydrochloride - * narc
15 mg
0819
Y0001430 Diphenoxylate for system suitability - * narc
10 mg
0819
1776
Extra
Price
charges
79
a
l
79
1512
-20C
79
1416,2060
+5C
79
0551
+5C
79
+5C
79
+5C
79
-20C
79
-20C
g(d)
79
-20C
g(d)
79
+5C
79
1004
+5C
79
1004
+5C
79
0601
+5C
79
n/a
1667
79
1 mg
0601
+5C
79
1 ml
0763
+5C
79
50 mg
1975
+5C
79
+5C
79
+5C
79
-20C
79
-20C
79
-20C
240
+5C
79
+5C
79
0023,0601,11
90
+5C
79
0023,0601
+5C
79
79
+5C
79
+5C
79
98.2% CHO
0551
0138,1470
99.9% dimeticone
Yes
Yes
Yes
Yes
Yes
1417
2-(diphenylmethoxy)-N-methylethanamine
24
Yes
1311,1488
1611
Yes

Order
Reference Standard
Code
Y0000258 Diphtheria toxin BRP

Batch n
1
Quantity Sale
Information
per vial Unit
1 ml
1 Nominal concentration of Diphtheria toxin: 1 Lf/ml (0.4l/ml)
Systemic toxicity: 77.6 LD/ml (determined in the subcutaneous challenge
test in guinea pigs)
Maximum intradermal toxicity: 75,000Lr/Lf (determined in the guinea pig
intradermal skin test)
Toxicity in the Vero cell assay: concentrations of 5x10- Lf/ml and below
cause cytotoxic effects.
Monograph
Leaflet
Storage
Extra
Price
charges
90
g(b)
See leaflet,
0443
Yes
+5C
See leaflet,
20706
Yes
-20C
90
D2700000 Diphtheria vaccine (adsorbed) BRP
32 mg
97 IU per vial
Y0000376 Dipivefrine hydrochloride
100 mg
99.3% CHClNO
1719
+5C
79
Y0000394 Dipivefrine for system suitability
10 mg
1719
+5C
79
D2750100 Dipotassium clorazepate - reference spectrum
n/a
0898
79
D2800000 Diprophylline
100 mg
0486
+5C
79
D2850000 Dipyridamole
50 mg
+5C
79
Y0000802 Dipyridamole for peak identification
2.04 mg
1199
+5C
79
D2880000 Dirithromycin
100 mg
97.4% CHNO
1313
+5C
79
D2900000 Disodium edetate
100 mg
0232
+5C
79
D2920000 Disopyramide
100 mg
1006
+5C
79
D2922000 Disopyramide phosphate
100 mg
1005
+5C
79
D2950000 Disulfiram
100 mg
0603
+5C
79
D2953000 Dithranol
55 mg
1007
+5C
79
D2953025 Dithranol impurity C
15 mg
Dithranol-dimer
4,4',5,5'-tetrahydroxy-9,9'-bianthracenyl-10,10'(9H,9'H)-dione ; Batch 2 is
valid until 1 June 2013
1007
+5C
79
New D2953050 Dithranol impurity D
20 mg
94.9% CHO; 1-hydroxyanthracen-9(10H)-one ; Batch 3 is valid until 31

December 2013
1007
+5C
79
D2954000 Dobutamine hydrochloride
100 mg
1200
+5C
79
Y0001239 Dobutamine impurity mixture
0.1 mg
1200
Yes
+5C
79
160 mg
93.5% CHNO ; Batch 1 is valid until 30 November 2013
2449,2593
Yes
+5C
79
Y0001155 Docetaxel for system suitability
10 mg
Batch 1 is valid until 1 March 2013
2449,2593
Yes
+5C
79
Y0001452 Docetaxel impurity E
15 mg
5,20-epoxy-4-(acetyloxy)-1,7,10,13-tetrahydroxy-9-oxotax-11-en-2-yl
benzoate (10-desacetyl-baccatin III)
+5C
79
D2954600 Docosahexaenoic acid ethyl ester
150 mg
93.1% DHA ethyl ester
-20C
79
D2954500 Docusate sodium - reference spectrum
n/a
1418
79
Y0000365 Dodecyl gallate
30 mg
2078
+5C
79
D2955000 Domperidone
150 mg
1009
+5C
79
D2957000 Domperidone maleate
150 mg
1008
+5C
79
D2960000 Dopamine hydrochloride
50 mg
0664,1200
+5C
79
Y0000612 Dopexamine dihydrochloride
10 mg
1748
+5C
79
New Y0001133 Docetaxel trihydrate
1199
25
Yes
Yes
2593
2063,20429
Yes

Order
Reference Standard
Code
Y0000613 Dopexamine impurity B

Batch n
1
Quantity Sale
Information
Monograph
per vial Unit
10 mg
1 2-methoxy-4-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]phenol
1748
10 mg
1 4-chloro-5-[2-[[6-[(2-phenylethyl)amino]hexyl]amino]ethyl]benz -ene-1,2-diol
1748
Leaflet
Storage
-20C
Y0000614 Dopexamine impurity F
Y0000726 Dorzolamide hydrochloride
50 mg
Y0000727 Dorzolamide impurity A
5 mg
Y0000750 Dorzolamide for system suitability
5 mg
2359
D2962000 Dosulepin hydrochloride
100 mg
1314
D2962005 Dosulepin impurity A
50 mg
1314
Y0001385 Angelica pubescent root
500 mg
2557
D2963000 Doxapram hydrochloride
50 mg
1201
Y0000208 Doxapram impurity B
10 mg
(4RS)-1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenylpyrolidin-2-one
Y0000553 Doxazosin mesilate
60 mg
99.2% CHNOS
Y0000551 Doxazosin impurity D
10 mg
6,7-dimethoxyquinazoline-2,4(1H,3H)-dione
2125
Y0000552 Doxazosin impurity F
10 mg
2-chloro-6,7-dimethoxyquinazolin-4-amine
2125
Y0000838 Doxepin hydrochloride
5 mg
1096
Y0000851 Doxepin for system suitability
1 mg
1096
Yes
D2975000 Doxorubicin hydrochloride
150 mg
99.4% CHClNO
0714,0662,15
90
D3000000 Doxycycline hyclate
50 mg
92.9% CHClNO corresponding to 85.9% CHNO
Y0001492 Doxylamine for system suitability
100 mg
Y0000163 Doxylamine hydrogen succinate - reference spectrum
n/a
1589
D3100000 Droperidol
150 mg
Y0001105 Drospirenone
60 mg
Y0001115 Drospirenone impurity E
0.06 mg
Y0001453 Duloxetine hydrochloride
Y0001454 Duloxetine for system suitability
Y0001455 Duloxetine impurity A

Y0001004 Dydrogesterone
Extra
Price
charges
79
c
-20C
79
2359
+5C
79
2359
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
1201
+5C
79
2125
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
Yes
-20C
g(c)
79
0272,0820
Yes
+5C
79
1589
Yes
+5C
79
79
1008,1009,10
10, 1172
+5C
79
99.9% CHO
2404
+5C
79
3-oxo-6alpha,7alpha,15alpha,16alpha-tetrahydro-3'H,3''H-dicyclopropa
[6,7:15,16]pregn-4-ene-21,17- carbolactone (17-epidrospirenone)
2404
+5C
79
120 mg
99.8 % CHClNOS
2594
Yes
+5C
79
40 mg
2594
Yes
+5C
79
10 mg
(3R)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine
2594
+5C
79
50 mg
99.5% CHO
2357
+5C
79
Y0001005 Dydrogesterone impurity A
6 mg
9,10-pregna-4,6,8(14)-triene-3,20-dione
2357
+5C
79
Y0001006 Dydrogesterone impurity B
5 mg
pregna-4,6-diene-3,20-dione
2357
+5C
79
Y0000249 Ebastine - reference spectrum
n/a
79
Y0000247 Ebastine impurity C
10 mg
4-(diphenylmethoxy)piperidine
2015
+5C
79
Y0000248 Ebastine impurity D
10 mg
1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one
2015
+5C
79
Y0001236 Econazole
10 mg
2049
+5C
79
(4R,6R)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2sulphonamide 7,7-dioxide
(E)-3-(6,11-dihydrodibenzo[b,e]thiepin-11-ylidene)-N,N'dimethylpropan-1-amine -oxide
Yes
Yes
Yes
2015
26

Order
Reference Standard
Code
E0050000 Econazole nitrate

Batch n
3
Quantity Sale
per vial Unit
100 mg
1
Information
Monograph
Leaflet
0513,0665,09
21, 0935,
1017,1018
+5C
Y0000254 Econazole for system suitability
20 mg
E0085000 Eicosapentaenoic acid ethyl ester
200 mg
Y0000537 Emedastine difumarate
10 mg
Y0000512 Emedastine impurity E
10 mg
E0100000 Emetine hydrochloride
100 mg
E0110000 Enalapril for system suitability
20 mg
Y0001211 Enalapril impurity mixture
0.06 mg
E0109000 Enalapril maleate
50 mg
Y0000615 Enalaprilat dihydrate
100 mg
Y0000629 Enalaprilat for system suitability
10 mg
Y0000678 Enalaprilat impurity G
0.005 mg
Y0000136 Enilconazole
60 mg
Y0000137 Enilconazole impurity E
20 mg
(1RS)-1-(2,4-dichlorophenyl)-2-(-1H-imidazol-1-yl)ethanol
1720
E0150000 Endotoxin standard BRP
10 mg
10 000 IU per vial ; Batch 4 is valid until 31 December 2012
20614
Yes
E0180000 Enoxaparin sodium
200 mg
0828,1097
Yes
E0180500 Enoxolone
100 mg
1511
Y0001259 Enrofloxacin
5 mg
2229
Y0001160 Enrofloxacin for system suitability
10 mg
2229
Yes
Y0001249 Entacapone
160 mg
99.9% CHNO
2574
Yes
Y0001250 Entacapone impurity A
10 mg
Z isomer of entacapone
2574
E0200000 Enterokinase BRP
100 mg
E0305000 Ephedrine hydrochloride (racemic) - * Drug Precursor
50 mg
E0300000 Ephedrine hydrochloride - * Drug Precursor
150 mg
99.8% CHClNO
0487,0488,04
89,1367,2451
E0400000 4-Epianhydrotetracycline hydrochloride
20 mg
87.1% CHNO.HCl
0210,0211,16
54
E0440000 4-Epidemeclocycline hydrochloride
20 mg
E0500000 6-Epidoxycycline hydrochloride
50 mg
Y0001139 Epinastine hydrochloride
20 mg
2411
Y0001128 Epinastine hydrochloride for system suitability
10 mg
2411
E0530000 4-Epioxytetracycline
40 mg
93.6% EPA ethyl ester CHO

1-(2-ethoxyethyl)-2-(hexahydro-1H-1,4-diazepin-1yl)benzimidazole.
0665,2049
Yes
+5C
79
Yes
-20C
79
2242
+5C
79
2242
+5C
79
0080,0081,00
93,
0094,1530,18
75
+5C
79
+5C
79
+5C
79
1420
+5C
79
1749
+5C
79
1420
1749
(2SR)-2-[(3SR,8aRS)-3-methyl-1,4-dioxohexahydropyrrolo[1,2-a] pyrazin-2
(1H)-yl]-4-phenylbutanoic acid
81.1% CHNO
27
Extra
Price
charges
79
a
2063,20429
1420
Storage
Yes
+5C
79
1749
+5C
79
1720
+5C
79
+5C
79
-20C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
0350
+5C
79
0715
+5C
79
Yes
+5C
79
Yes
+5C
79
0176
+5C
79
0272,0820
+5C
79
+5C
79
+5C
79
+5C
79
0198,0199
Yes
Yes

Order
Reference Standard
Code
E0550000 Epirubicin hydrochloride

Batch n
6
Quantity Sale
per vial Unit
100 mg
1 96.4% CHClNO
Information
Monograph
Leaflet
Storage
0662,0714,15
90
Yes
-20C
E0600000 4-Epitetracycline hydrochloride
30 mg
Y0000052 Equilin
15 mg
Y0001325 Equisetum palustre
200 mg
E0850010 Eq Influenza Subtype 1 Strain A/eq/Newmarket/77 Horse

Antiserum BRP
1 mg
Assigned SRH antibody titre: 125 mm +/-20%; Common standard OIE

Strain A/eq/Newmarket/77
See leaflet,
0249
Yes
E0850021 Eq Influenza Subtype 2 American-like/Newmarket Horse

Antiserum BRP
1 mg
Assigned SRH antibody titre: 180 mm +/- 20%; Common standard OIE
Strain A/eq/Newmarket/1/93
See leaflet,
0249
Yes
E0850022 Eq Influenza Subtype 2 European-like/Newmarket Horse

Antiserum BRP
1 mg
Assigned SRH antibody titre: 155 mm +/- 20%; Common standard OIE
Strain A/eq/Newmarket/2/93
See leaflet,
0249
Y0000712 Eq Influenza Subtype 2 American-like/South Africa Horse

Antiserum BRP
1 mg
E0900000 Ergocalciferol
500 mg
E1000000 Ergometrine maleate - * Drug Precursor
50 mg
E1100000 Ergosterol
20 mg
E1200000 Ergotamine tartrate - * Drug Precursor
100 mg
Y0000051 Erysipelas ELISA coating antigen BRP
0.4 mg
0.5ml Freeze dried (0.367g protein)
Y0000177 Erythritol
1000 mg
E1300000 Erythromycin for microbiological assay
250 mg
E1305000 Erythromycin A
250 mg
97.0% CHNO
0179,0274,02
93,
0490,0552,10
98
E1310000 Erythromycin B
50 mg
98.4% CHNO
E1320000 Erythromycin C
50 mg
97.6% CHNO
0179,0274,04
90,
0552,1098
0179,0274,04
E1400000 Erythromycin estolate
100 mg
90,
0552,1098
0552
E1500000 Erythromycin ethylsuccinate
10 mg
0274
E1500800 Erythromycin stearate
50 mg
E1515000 Erythropoietin BRP
37.5 mg
Y0000324 Esketamine hydrochloride - reference spectrum
n/a
Y0000338 Esketamine impurity D
10 mg
Y0001028 Esomeprazole magnesium trihydrate
10 mg
Extra
Price
charges
79
c
0210,0211,16
54
+5C
79
1512
-20C
79
+5C
79
-20C
90
-20C
90
Yes
-20C
90
See leaflet,
0249
Yes
-20C
90
0082,0574,05
75,
0598,1192,11
93
Yes
-20C
g(c)
79
0223
+5C
79
0082
-20C
g(c)
79
0224, 0551
+5C
79
-20C
90
99.7% CHO
1825
99.7% CHO ; Vitamin D2 ; Batch 7 is valid until 31 August 2013
See leaflet,
0064
Yes
99.8% CHO
1803
Yes
960 IU per mg
20702
Yes
Yes
0490
79
79
-20C
79
-20C
79
-20C
79
+5C
79
+5C
79
+5C
79
-20C
150
79
1742
+5C
79
2372
+5C
79
1316
35280 IU per vial
+5C
-20C
Yes
1742
(2R)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone ((R)-ketamine)
28

Order
Code
Y0000749 Essential oil
Reference Standard

Batch n
1
Quantity Sale
per vial Unit
1000 mg
1
Information
Monograph
Leaflet
Storage
2098
Yes
+5C
E1600000 Estradiol benzoate
250 mg
0139
Y0000852 Estradiol benzoate for system suitability
10 mg
0139
Y0000045 Estradiol butyrate
10 mg
E1620000 Estradiol hemihydrate
100 mg
Y0000314 Estradiol for peak identification
10 mg
0821
Y0000046 Estradiol valerate
50 mg
1614
E1680000 Estriol
50 mg
E1680005 Estriol impurity A
20 mg
9,11-didehydroestriol ; Batch 1 is valid until 31 August 2013
E1700000 Estrone
15 mg
100.0% CHO
E1800000 Etacrynic acid
100 mg
0457
Y0001263 Etacrynic acid for system suitability
10 mg
0457
E1830000 Etamsylate
30 mg
1204
E1840000 Ethacridine lactate monohydrate
50 mg
E1850000 Ethambutol hydrochloride
250 mg
Y0000803 Ethambutol for system suitability
10 mg
A1202800 Ethanol (anhydrous) - reference spectrum
n/a
E1860100 Ethanol 96% - reference spectrum
n/a
E1900000 Ethinylestradiol
200 mg
99.8% CHO
Y0001124 Ethinylestradiol for system suitability
1.0124 mg
E2000000 Ethionamide
100 mg
E2150000 Ethosuximide
30 mg
E2250000 Ethosuximide impurity A
30 mg
E2195000 Ethyl acetate - reference spectrum
n/a
E2195900 Ethylcellulose - reference spectrum
n/a
E2202000 1-N-Ethylgaramine sulfate
50 mg
77.6% of 1-N-Ethylgaramin sulphate ; Batch 2 is valid until 18 September 2012
E2205500 1,1'-Ethylidenebistryptophan
0.002 mg
0.00182 mg per vial of CHNO ; Batch 4 is valid until 1 May 2013
Y0000617 Ethyl indole-3-carboxylate
10 mg
2102
E2300000 Ethylmorphine hydrochloride - reference spectrum
n/a
0491
E2400000 Ethylnicotinamide
150 mg
E2425000 Ethyl parahydroxybenzoate
150 mg
E2450000 Etifenin
25 mg
E2451000 Etilefrine hydrochloride
75 mg
Extra
Price
charges
79
g
+5C
79
+5C
79
1614
+5C
79
0821,1203
+5C
79
+5C
79
+5C
79
Yes
Yes
1203
+5C
79
1203
Yes
+5C
79
1512,0140
Yes
+5C
79
+5C
79
+5C
79
+5C
79
1591
+5C
79
0553
+5C
79
0553
+5C
79
1318
79
Yes
1317
(2RS)-2-ethyl-2-methylbutanedioic acid
79
0140,0821,09
40
Yes
+5C
79
0140
Yes
+5C
79
0141
+5C
79
0764
+5C
79
0764
+5C
79
79
0899
0822
79
1351
Yes
+5C
79
1272,1383
Yes
+5C
79
+5C
79
79
0233
+5C
79
0409,0431,09
00,
1262,1263,21
34
+5C
79
0585
+5C
79
1205
+5C
79
100.0% CHO; batch 2 valid until 31/12/10 excepted for use with
monograph 0900.
29

Order
Reference Standard
Code
E2451010 Etilefrine impurity A

Batch n
1
Quantity Sale
Information
per vial Unit
20 mg
1 2-ethylamino-1-(3-hydroxyphenyl)ethanone
Monograph
Leaflet
Storage
1205
+5C
Extra
Price
charges
79
g
Y0000572 Etidronate disodium
10 mg
1778
+5C
79
E2470000 Etodolac
60 mg
1422
+5C
79
E2470050 Etodolac impurity H
10 mg
+5C
79
Y0000768 Etodolac for peak identification
10 mg
1422
+5C
79
E2499900 Etofenamate
40 mg
1513
+5C
79
E2499901 Etofenamate for peak identification
20 mg
1513
+5C
79
E2499914 Etofenamate impurity G
25 mg
1513
+5C
79
E2500000 Etofylline
100 mg
0492
+5C
79
E2503000 Etomidate
50 mg
1514
+5C
79
E2503004 Etomidate impurity B
25 mg
methyl 1-[(1RS)-1-phenylethyl]-1H-imidazole-5-carboxylate
1514
+5C
79
E2600000 Etoposide
150 mg
98.4% CHO
0823
+5C
79
Y0001365 Etoposide for for system suitability
10 mg
0823
+5C
79
E5000000 Eugenol
500 l
1100
+5C
79
F0005000 Famotidine
100 mg
1012
+5C
79
Y0000382 Famotidine for system suitability
10 mg
1012
+5C
79
Y0000409 Famotidine impurity D
10 mg
3-[[[2-[(diaminomethylene)amino]thiazol-4-yl]methyl]sulphanyl]propanamide
1012
+5C
79
Y0000556 Febantel
110 mg
99.9% CHNOS
2176
+5C
79
Y0000660 Febantel for system suitability
10 mg
2176
+5C
79
Y0000731 Felbinac
10 mg
2304
+5C
79
Y0000732 Felbinac impurity A
20 mg
2304
+5C
79
F0030000 Felodipine
120 mg
1013
+5C
79
Y0000415 Felypressin
0.994 mg
F0040000 Fenbendazole
150 mg
F0040010 Fenbendazole impurity A
20 mg
F0040020 Fenbendazole impurity B
25 mg
F0041000 Fenbufen
100 mg
F0048000 Fenofibrate
100 mg
100.0% CHClO
F0048005 Fenofibrate impurity A
20 mg
F0048010 Fenofibrate impurity B
10 mg
F0048035 Fenofibrate impurity G
25 mg
Y0000756 Fenoterol for peak identification
1.2 mg
F0050000 Fenoterol hydrobromide
100 mg
F0054990 Fentanyl - reference spectrum
n/a
1210
Y0001509 Fentanyl for system suitability - * narc
25 mg
1210,1103
1422
2-(7-ethylindol-3-yl)ethanol
2-hydroxyethyl 2-[[3-(trifluoromethyl)phenyl]amino]-benzoate ; Batch 1 is

valid until 30 November 2013
4-acetyl biphenyl
1634
Yes
Yes
Yes
Yes
-20C
79
1208,1458
+5C
79
methyl(1-benzimidazol-2-yl)carbamate
1208
+5C
79
methyl[5(6)-chlorobenzimidazol-2-yl]carbamate
1208
+5C
79
1209
+5C
79
1322
+5C
79
(4-chlorophenyl)(4-hydroxyphenyl)methanone
1322
+5C
79
2[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (fenofibric acid)
1322
+5C
79
1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]
oxy]-2-methylpropanoate
1322
+5C
79
0901
+5C
79
0901
+5C
79
79
+5C
79
0.994 mg CHNOS
contains 1.3% of impurity A
30
Yes
Yes

Order
Reference Standard
Code
F0055000 Fentanyl citrate - reference spectrum

Batch n
1
Quantity Sale
per vial Unit
n/a
1
Information
Monograph
Storage
1103
F0060000 Fenticonazole nitrate
50 mg
F0060040 Fenticonazole impurity D
0.01 mg
F0100000 Ferrous gluconate
100 mg
Y0001013 Ferulic acid
20 mg
99.8% CHO
Y0000789 Fexofenadine hydrochloride
60 mg
99.8% CHClNO
2280
Y0000751 Fexofenadine impurity A
5 mg
2-[4-[4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butanoyl]phenyl]-2methylpropanoic acid
Y0000752 Fexofenadine impurity B
0.01 mg
Y0000753 Fexofenadine impurity C
5 mg
Y0001173 Filgrastim
Y0000090 Finasteride
Y0000091 Finasteride for system suitability
Y0000736 Flavoxate hydrochloride
Y0000737 Flavoxate impurity A

Y0000738 Flavoxate impurity B
New F0120000 Flecainide acetate
Leaflet
Extra
Price
charges
79
l
1211
+5C
79
1211
+5C
79
0493
+5C
79
+5C
79
+5C
79
2280
+5C
79
2-[3-[(1RS)-1-hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl]
phenyl]-2-methylpropanoic acid
2280
+5C
79
(1RS)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]-1-[4-(1-methylethyl)
phenyl]butan-1-ol
2280
+5C
79
0.2 ml
1.95 mg per ml of CHNOS
2206
-80C
79
60 mg
99.7% CHNO
1615
+5C
79
120 mg
Contains 0.9% of impurity A ; Batch 2 is valid until 31 August 2013
1615
10 mg
10 mg
10 mg
()-1-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]-3-[4-(phenyl suphanyl)
benzyl]imidazolium nitrate ; Batch 1 is valid until 30 November 2013
1834,2558
Yes
Yes
+5C
79
1692
Yes
+5C
79
3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid
1692
+5C
79
ethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate
1692
+5C
79
10 mg
1324
+5C
79
F0120005 Flecainide impurity A
50 mg
3-[2,5-bis(2,2,2-trifluoroethoxy)phenyl]-1,5,6,7,8,8a-hexahydroimidazo[1,5a]pyridine ; Batch 2 is valid until 1 May 2013
1324
+5C
79
F0120010 Flecainide impurity B
25 mg
(RS)-(piperidin-2-yl)methanamine
1324
+5C
79
Y0001274 Flecainide for system suitability
10 mg
1324
Yes
+5C
79
300 mg
2433
Yes
+5C
79
Y0000138 Flubendazole
25 mg
1721
+5C
79
Y0000139 Flubendazole for system suitability
20 mg
1721
+5C
79
Y0000892 Flucloxacillin magnesium octahydrate
5 mg
2346
+5C
79
Y0000889 Flucloxacillin impurity C
5 mg
6-aminopenicillanic acid
2346
+5C
79
Y0000890 Flucloxacillin impurity D
5 mg
3-(2-chloro-6-fluorophenyl)-5-methylisoxazole-4-carboxylic acid
2346
+5C
79
Y0000891 Flucloxacillin impurity E
5 mg
6-aminopenicillanic acid flucloxacillin amide
2346
Yes
+5C
79
F0150000 Flucloxacillin sodium
250 mg
95.1% CHClFNNaOS
0661,0663,06
68,2346
Yes
-20C
79
Y0000557 Fluconazole
50 mg
2287
+5C
79
Y0000558 Fluconazole for peak identification
10 mg
2287
+5C
79
Y0000573 Fluconazole impurity B
10 mg
93.2% CHNOF ; 2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis

(1H-1,2,4 -triazol-1-yl)propan-2-ol
2287
+5C
79
Y0000574 Fluconazole impurity C
5 mg
1,1'-(1,3-phenylene)di-1H-1,2,4-triazole
2287
+5C
79
New Y0001606 Fleeceflower root HRS
31
Yes
Yes
Yes

Order
Code
F0175000 Flucytosine
Reference Standard

Batch n
1
Quantity Sale
per vial Unit
100 mg
1
Y0001262 Flucytosine for system suitability
0.3 mg
Y0000419 Fludarabine phosphate
120 mg
Y0001536 Fludarabine for system suitability
15 mg
F0180000 Fludrocortisone acetate
100 mg
F0188000 Flumazenil - reference spectrum
n/a
Y0000335 Flumazenil impurity B
5 mg
F0189000 Flumequine
60 mg
F0189020 Flumequine impurity B
0.1 mg
F0188500 Flumetasone pivalate
100 mg
F0189900 Flunarizine dihydrochloride
100 mg
Y0000265 Flunarizine dihydrochloride - reference spectrum
Y0000266 Flunarizine dihydrochloride for system suitability
F0190000 Flunitrazepam - * psy
Y0000169 Flunitrazepam - reference spectrum
Y0000443 Flunixin meglumine

Y0000444 Flunixin impurity B
Y0000445 Flunixin impurity C
F0200000 Fluocinolone acetonide
Information
Monograph
Leaflet
0766
Storage
+5C
+5C
79
1781
Yes
+5C
79
1781
Yes
+5C
79
0767
+5C
79
79
1326
+5C
79
1517
+5C
79
1517
+5C
79
1327
+5C
79
0816
+5C
79
n/a
1722
79
20 mg
1722
+5C
79
100 mg
1280
+5C
79
n/a
0717
79
10 mg
1696
+5C
79
10 mg
2-methyl-3-(trifluoromethyl)aniline
1696
+5C
79
50 mg
ethyl 2-chloropyridine-3-carboxylate
1696
+5C
79
100 mg
0494
+5C
79
F0230000 Fluocortolone pivalate
100 mg
1212
+5C
79
Y0000796 Fluorescein
120 mg
99.2% CHO
2348
+5C
79
Y0000804 Fluorescein impurity C
0.01 mg
2-(2,4-dihydroxybenzoyl)benzoic acid
2348
+5C
79
Y0000454 Diacetylfluorescein
100 mg
99.6% CHO
1213
+5C
79
F0245000 Fluoresceine sodium - reference spectrum
n/a
1213
79
F0250000 Fluorouracil
40 mg
0611,0766
+5C
79
Y0000762 Fluorouracil impurity A
10 mg
pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid)
0611
+5C
79
Y0000763 Fluorouracil impurity B
15 mg
dihydropyrimidine-2,4,5(3H)-trione (isobarbituric acid or 5-hydroxyuracil)
0611
+5C
79
Y0000764 Fluorouracil impurity C
10 mg
pyrimidine-2,4(1H,3H)-dione (uracil)
0611
+5C
79
Y0000765 Fluorouracil impurity F
10 mg
2-ethoxy-5-fluoropyrimidin-4(1H)-one (2-ethoxy-5-fluorouracil)
0611
+5C
79
Y0000791 Fluorouracil impurity mixture
0.0002 mg
+5C
79
F0253000 Fluoxetine hydrochloride
250 mg
99.9% CHClFNO
1104
+5C
79
F0253020 Fluoxetine impurity B
10 mg
methyl(3-phenylpropyl)amine
1104
+5C
79
F0253030 Fluoxetine impurity C
5 mg
()-methyl-[3-phenyl-3-(3-trifluoromethylphenoxy)-propyl] amine
1104
+5C
79
Y0000064 Flupentixol dihydrochloride
100 mg
43.6% of Z-isomer CHClFNOS
1693
+5C
79
0766
Extra
Price
charges
79
a
98.3% CHFNOP ; Batch 1 is valid until 30 September 2012
1326
ethyl 8-hydroxy-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]
benzodiazepine-3-carboxylate
ethyl(RS)-9-fluoro-5-methyl-1-oxo-6,7-dihydro-1H,5H-benzo[i,j]
quinolizine-2-carboxylate
0611
32
Yes
Yes

Order
Reference Standard
Code
Y0000067 Flupentixol impurity D

Batch n
1
Quantity Sale
Information
per vial Unit
15 mg
1 2-[2-[4-[3-[(EZ)-2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl]
piperazin-1-yl]ethoxy]ethanol
Y0000078 Flupentixol impurity F
25 mg
F0260000 Fluphenazine decanoate
60 mg
80.9% CHFNOS; 2-[4-[(EZ)-3-[(9RS)-2-(trifluoromethyl)-9Hthioxanthen-9-yl] prop-2-enyl]piperazin-1-yl]ethanol
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
1693
+5C
1693
+5C
79
1014,1015
+5C
g(b)
79
1014,1015
+5C
79
0904,1014
+5C
79
Y0000009 Fluphenazine enantate
100 mg
New F0280000 Fluphenazine dihydrochloride
50 mg
Y0000708 Fluphenazine impurity mixture
0.07 mg
0904
+5C
79
Y0000298 Fluphenazine octanoate
20 mg
1014,1015
+5C
79
Y0000299 Fluphenazine sulfoxide
10 mg
0904,1014,10
15
+5C
79
Y0000211 Flurazepam monohydrochloride - reference spectrum
n/a
0905
79
F0285200 Flurbiprofen
50 mg
1519
+5C
79
25 mg
1519
+5C
79
Y0000236 Fluspirilene
20 mg
1723
+5C
79
Y0000375 Fluspirilene impurity C
10 mg
1723
+5C
79
F0285600 Flutamide
50 mg
1423
+5C
79
F0285603 Flutamide impurity C
20 mg
N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
1423
+5C
79
Y0000284 Fluticasone propionate
100 mg
99.6% CHFOS
1750
+5C
79
Y0000221 Fluticasone impurity D
20 mg
S-methyl 6a,9a-difluoro-11b-hydroxy-16a-methyl-3-oxo-17apropionyloxy-androsta-1,4-diene-17-carbothioate
(S-methyl derivative)
1750
+5C
79
F0290000 Flutrimazole
100 mg
1424
+5C
79
F0290010 Flutrimazole impurity B
60 mg
1424
+5C
79
Y0001090 Fluvastatin sodium
110 mg
2333
+5C
79
Y0001082 Fluvastatin for system suitability
0.5 mg
2333
+5C
79
Y0000854 Fluvoxamine maleate
5 mg
1977
+5C
79
Y0000853 Fluvoxamine for system suitability
1.004 mg
+5C
79
Y0000916 Fluvoxamine impurity D
10 mg
5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one
1977
+5C
79
Y0000386 Foeniculin for peak identification
100 mg
Anise oil
0804
Yes
+5C
79
F0300000 Folic acid
300 mg
91.3 % CHNO
0067
Yes
+5C
79
Y0001242 Folic acid impurity A
15 mg
(2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid (N-(4-aminobenzoyl)-lglutamic acid)
0067
+5C
79
Y0001243 Folic acid impurity D
70 mg
4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid
(pteroic acid)
0067
+5C
79
F0372000 Formoterol fumarate dihydrate
10 mg
1293,1724
+5C
79
Y0000339 Formoterol for impurity I identification
10 mg
1724
+5C
79
New F0285202 Flurbiprofen impurity A
(2RS)-2-(biphenyl-4-yl)propanoic acid ; Batch 1 is valid until 30 November

2013
8-[4,4-bis(4-fluorophenyl)butyl]-3-(hydroxymethyl)-1-phenyl-1,3,8triazaspiro[4.5]decan-4-one
(RS)-(2-fluorophenyl)(4-fluorophenyl)phenylmethanol
1977
33
Yes
Yes
Yes
Yes
Yes

Order
Reference Standard
Code
Y0000340 Formoterol fumarate for system suitability

Batch n
1
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
Storage
1724
Yes
+5C
0978,1606
Yes
F0380000 Formylfolic acid
30 mg
F0389000 Foscarnet sodium hexahydrate
50 mg
F0389004 Foscarnet impurity B
10 mg
Y0001222 Foscarnet impurity D
50 mg
Y0001213 Foscarnet impurity mixture
0.012 mg
1520
Y0000782 Fosfomycin calcium
10 mg
1328
F0399950 Fosfomycin sodium - reference spectrum
n/a
F0400000 Fosfomycin trometamol
1500 mg
Y0001227 Fosinopril sodium
60 mg
Y0001228 Fosinopril impurity A
5 mg
(2S,4S)-4-cyclohexyl-1-[[(R)-hydroxy(4-phenylbutyl)phosphoryl]acetyl]
pyrrolidine-2-carboxylic acid
Y0001229 Fosinopril impurity B
5 mg
Y0001230 Fosinopril impurity C
10 mg
Y0001231 Fosinopril impurity D
Y0001232 Fosinopril impurity I
Extra
Price
charges
79
g
-20C
79
1520
+5C
79
1520
+5C
79
1520
+5C
79
+5C
79
+5C
79
79
+5C
79
1751
+5C
79
1751
+5C
79
(2RS,4RS)-4-cyclohexyl-1-[[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)
propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
1751
+5C
79
mixture of (2S,4S)-4-cyclohexyl-1-[[(S)-[(1S)-2-methyl-1-(1-oxopropoxy)
propoxy](4-phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid and
(2S,4S)-4-cyclohexyl-1-[[(R)-[(1R)-2-methyl-1-(1-oxopropoxy)propoxy](4phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
1751
+5C
79
10 mg
(2S,4R)-4-cyclohexyl-1-[[(R)-[(1S)-2-methyl-1-(1-oxopropoxy)propoxy](4phenylbutyl)phosphoryl]acetyl]pyrrolidine-2-carboxylic acid
1751
+5C
79
5 mg
[(RS)-[(1SR)-2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphoryl]
acetic acid
1751
+5C
79
Y0001233 Fosinopril impurity K
5 mg
(2S,4S)-4-cyclohexyl-1-(2,2-dimethyl-1-oxopropyl)pyrrolidine-2-carboxylic
acid
1751
+5C
79
Y0001212 Fosinopril impurity mixture
0.02 mg
F0450000 Framycetin sulfate
25 mg
F0550000 Fructose
100 mg
Y0001399 Fulvestrant
120 mg
Y0001413 Fulvestrant for system suitability
40 mg
F0600000 Fumaric acid
120 mg
Batch 2 is valid until 31 July 2012
F0700000 Furosemide
100 mg
Y0001493 Furosemide for peak identification
10 mg
F0702000 Furosemide impurity A
5 mg
91.4% CHNO; 10-Formylfolic acid

disodium (ethoxyoxydophosphanyl)formate
Yes
1329
1425
99.7% CHNOP
17640 IU per vial CHNO,xHSO
Yes
1751
Yes
+5C
79
0180,0197,20
702
Yes
-20C
79
+5C
79
0177,0178,01
87,
0188,0204,02
09,
0924,1061,15
70
98.8% CHFOS
2443
Yes
+5C
79
2443
Yes
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
0365,0902,11
90, 1592
0391,2185
0391
2-chloro-4-(furfurylamino)-5-sulphamoylbenzoic acid
34
0391
Yes

Order
Code
Y0001411 Fusidic acid
Reference Standard

Batch n
1
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
0798
Storage
-20C
F1000000 Fusidic acid - reference spectrum
n/a
0798,0848
Y0001394 Fusidic acid for peak identification
5 mg
0798,0848
Yes
-20C
Y0001384 Fusidic acid impurity mixture
0.0475 mg
0798,0848
Yes
Y0001280 Gabapentin
300 mg
99.9% CHNO
2173
Yes
Y0001281 Gabapentin impurity A
20 mg
2-azaspiro[4.5]decan-3-one
Y0001348 Gabapentin impurity B
20 mg
(1-cyanocyclohexyl)acetic acid
Y0001349 Gabapentin impurity D
10 mg
[1-[(3-oxo-2-azaspiro[4.5]dec-2-yl)methyl]cyclohexyl]acetic acid
G0049000 Galactitol
50 mg
G0050000 Galactose
60 mg
Y0001279 Galantamine hydrobromide
10 mg
Y0001190 Galantamine natural for system suitability
Y0001201 Galantamine racemic mixture
Y0001191 Galantamine synthetic for system suitability

G0100000 Gallamine triethiodide
G0150000 Gammacyclodextrin
Y0001129 Ganciclovir
Extra
Price
charges
79
c
l
79
79
-20C
79
+5C
79
2173
+5C
79
2173
-20C
79
2173
+5C
79
1381
+5C
79
1215
+5C
79
2366
+5C
79
10 mg
2366
+5C
79
10 mg
2366
+5C
79
5 mg
2366
+5C
79
100 mg
0181
+5C
79
60 mg
+5C
79
220 mg
+5C
79
Y0001144 Ganciclovir impurity mixture
0.005 mg
+5C
79
Y0000675 Gemcitabine hydrochloride
50 mg
99.9% CHClFNO
2306
+5C
79
Y0000676 Gemcitabine impurity A
20 mg
4-aminopyrimidin-2(1H)-one (cytosine)
2306
+5C
79
Y0000513 Gemfibrozil
5 mg
1694
+5C
79
Y0000514 Gemfibrozil for system suitability
0.196 mg
G0200000 Gentamicin sulfate
25 mg
16500 IU per vial ; Batch 7 is valid until 31 January 2013
Y0001112 Gestodene
100 mg
99.4% CHO
Y0001363 Gentamicin for peak identification
10 mg
Y0001110 Gestodene for system suitability
10 mg
Y0001116 Gestodene impurity I
0.01 mg
Y0001012 Ginkgo dry extract for peak identification
150 mg
Y0001010 Ginkgolic Acids
20 mg
Y0001029 Ginseng dry extract HRS
500 mg
Y0001347 Ginsenoside Rb1
30 mg
G0300000 Gitoxin
30 mg
0078,0079,21
68
G0325000 Glibenclamide
100 mg
0718
Y0001511 Glibenclamide for peak identification
30 mg
0718
1070,1487
91,2% CHO ; Batch 1 is valid until 1 June 2013
Yes
Yes
Yes
1752
1752
88.1 % CHO
35
1694
Yes
+5C
79
0331,20702
Yes
-20C
79
+5C
79
0331
Yes
-20C
79
1726
Yes
+5C
79
+5C
79
1726
13-ethyl-17-hydroxy-5-methoxy-18,19-dinor-5alpha,17alpha-pregn-15-en-20yn-3-one
0.37% of ginkgolic acid C17
Yes
1726
1827
Yes
-20C
79
1827
Yes
-20C
79
2356
Yes
-20C
79
2356
Yes
+5C
79
+5C
79
+5C
79
+5C
79
Yes

Order
Reference Standard
Code
G0325010 Glibenclamide impurity A

Batch n
3
Quantity Sale
Information
per vial Unit
10 mg
1 4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzene- sulphonamide ; Batch 2
is valid until 31 December 2012
Y0000242 Glibenclamide impurity B
20 mg
G0326000 Gliclazide
20 mg
G0326004 Gliclazide impurity B
25 mg
G0326012 Gliclazide impurity F
50 mg
Y0000515 Glimepiride
60 mg
Y0000516 Glimepiride for system suitability
G0340000 Glipizide
G0342000 Glipizide impurity A

Y0000523 Glipizide impurity C
Y0000643 Glipizide impurity D
Y0001140 Glipizide impurity mixture
Y0001406 Glucosamine hydrochloride
Y0000191 Human glucagon
Monograph
Leaflet
0718
+5C
Yes
Extra
Price
charges
79
a
+5C
79
0718,1524
+5C
79
2-nitroso-octahydrocyclopenta[c]pyrrole
1524
+5C
79
1-(hexahydrocyclopenta[c]pyrrol-2(1H)-yl)-3-[(2-methylphenyl) sulphonyl]
urea
1524
+5C
79
99.4% CHNOS
2223
+5C
79
0.012 mg
2223
+5C
79
50 mg
0906
+5C
79
10 mg
4-[2-(5-methylpyrazine-2-carboxamido)ethyl]benzene sulphonamide
0906
+5C
79
10 mg
ethyl [2-[4-[(cyclohexylcarbamoyl)sulphamoyl]phenyl]ethyl] carbamate
0906
+5C
79
10 mg
6-methyl-N-[2-(4-sulphamoylphenyl)ethyl]pyrazine-2-carboxamide
0906
0.002 mg
10 mg
2.94 mg
Y0001381 Glucosamine for system suitability
40 mg
Y0001407 Glucosamine sulfate sodium chloride
15 mg
G0350500 Glucose
100 mg
G0355000 Glutamic acid
Y0000517 Glutathione
G0360000 Glutethimide - * psy
Y0001391 Glycerol formal
Y0000794 Glycerol monocaprylate
methyl [[4-[2-[(5-chloro-2-methoxybenzoyl)amino]ethyl]phenyl]
sulphonyl]carbamate
0718
Storage
Yes
+5C
79
Yes
+5C
79
+5C
79
Yes
-20C
79
2446,2447
+5C
79
2447
+5C
79
0177,0178,01
87,
0188,0204,02
09,
1061,1215,15
70
+5C
79
50 mg
0750,0797,14
45, 2076
+5C
79
10 mg
1670
+5C
79
50 mg
1291
+5C
79
20 mg
1671
+5C
79
500 mg
2213
Yes
+5C
79
Y0000795 Glycerol monocaprylocaprate
500 mg
2392
Yes
+5C
79
G0400006 Glycerol monolinoleate
2000 mg
1429
+5C
79
G0400007 Glycerol mono-oleate
2500 mg
1430
+5C
79
G0400008 Glycerol monostearate 40-55
2000 mg
0495
+5C
79
G0400101 Glyceryl trinitrate - reference spectrum
n/a
1331
79
0.5 ml
G0400100 Glyceryl trinitrate solution

0906
2446
1635
2.94 mg pure human glucagon per vial CHNOS
In the chromatogram supplied within the leaflet (Rev 02) of the current CRS
batch 1, some peaks have been mislabelled, the correct version of the leaflet
(Rev 03) is now available on the website. The quality of the product itself is
not questioned and can still to be used.
1% m/m in ethanol CHNO

36
79
1331,1355
+5C
f

Order
Code
G0450000 Glycine
Reference Standard

Batch n
3
Quantity Sale
per vial Unit
50 mg
1
Information
Monograph
Leaflet
0614,0752
Storage
+5C
Extra
Price
charges
79
a
Y0001308 Glycopyrronium bromide
10 mg
1783
+5C
79
Y0001309 Glycopyrronium for peak identification
10 mg
1783
Yes
+5C
79
Y0001358 Glycopyrronium impurity N
10 mg
1783
Yes
+5C
79
Y0000433 Ammonium glycyrrhizate
70 mg
G0460000 Glycyrrhizate (monoammonium)
300 mg
78.6% CHNO
G0525000 Gonadorelin
5 mg
4.96 mg per vial of CHNO
Y0000125 Goserelin
2 mg
1636
Y0000126 Gosereline - reference spectrum
n/a
1636
Y0000019 4-D-Ser-goserelin
0.1 mg
Y0000194 Goserelin validation mixture
1 mg
Supplied with the Ph. Eur. reference chromatogram
Y0001473 Goserelin for NMR identification
14 mg
replace Y0000126
G0550000 Gramicidin
250 mg
1081 IU per mg
Y0000396 Granisetron hydrochloride
120 mg
99.8% CHClNO
Y0000477 Granisetron impurity A
1 mg
Y0000478 Granisetron impurity B
1 mg
Y0000395 Granisetron impurity E
G0600000 Griseofulvin
New Y0000619 Guaiacol
94.0% CHNO+; (3RS)-3-[(2RS)-(2-cyclopentyl-2-hydroxy-2-phenylacetyl)

oxy]-1,1-dimethylpyrrolidinium
+5C
79
0277,1536,
2378
1772
Yes
+5C
79
0827
Yes
-20C
79
-20C
79
79
-20C
79
-20C
79
-20C
79
+5C
79
1695
+5C
79
2-methyl-N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-2Hindazole-3-carboxamide
1695
+5C
79
N-[(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3carboxamide
1695
+5C
79
15 mg
(1R,3r,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine
1695
+5C
79
50 mg
0182
+5C
79
1636
1636
Yes
1636
0907,1662,20
702
Yes
Yes
1500 mg
G0700000 Guaifenesin
100 mg
Y0000117 Halofantrine hydrochloride
125 mg
99.6% CHClFNO
Y0000118 Halofantrine impurity C
10 mg
[1,3-dichloro-6-(trifluoromethyl)phenantren-9-yl]methanol
H0100000 Haloperidol
60 mg
Batch 1 is valid until 1 July 2013
H0100100 Haloperidol decanoate
60 mg
1397,1431
Y0001518 Haloperidol for peak identification
25 mg
0616
Yes
Y0001517 Haloperidol for system suitability
25 mg
0616
Yes
H0150000 Halothane - reference spectrum
n/a
0393
Y0000673 Harpagoside
99.6% CHO ; Batch 1 is valid until 30 November 2013
1978
Yes
+5C
79
0615
Yes
+5C
79
1979
+5C
79
1979
+5C
79
0616,0995,11
78, 1503
+5C
79
+5C
79
+5C
79
+5C
79
79
1.03 mg
1.01mg per vial CHO
+5C
79
New H0185000 Heparin Low-Molecular-Mass for assay BRP
1 mg
Anti-IIa activity : 31 IU per vial; Anti-Xa activity : 104 IU per vial ; Batch 7 is
valid until 30 November 2013
0828
Yes
+5C
90
New H0190000 Heparin Low-Molecular-Mass for calibration CRS
25 mg
Mna = 3800 ; Batch 2 is valid until 30 November 2013
0828
Yes
+5C
90
2 ml
1010 IU per ml
0569, 20705
Yes
+5C
79
H0200000 Heparin sodium BRP

37
1095, 1871
Order
Reference Standard
Code
Y0001287 Heparin calcium for NMR identification
Batch n
Y0001283 Heparin sodium for NMR identification
30 mg
Y0001282 Heparin for physico-chemical analysis
300 mg
H0205010 Hepatitis A vaccine (inactivated, adsorbed) Type B BRP
0.5 ml
262 IU per ml; Please contact us for information on the type needed for your
use
Y0001192 Hepatitis A Vaccine (Inactivated, Non-Adsorbed) BRP
0.8 ml
To be stored below -50C
Y0001624 Hepatitis A virus Coating Reagent for ELISA - BRR
1 mL
Y0001623 Set of Hepatitis A virus Detection Antibodies for ELISA BRR
420 L
Y0000389 Hepatitis B vaccine (rDNA) BRP method A (thiomersal

free)
0.5 ml
16.6 micrograms per ml
H0210010 Hepatitis B vaccine (rDNA) BRP method B
1 ml
20 micrograms per ml
H0220000 Heptadecanol
600 mg
97.9% CHO
Y0000063 Heptaminol hydrochloride
150 mg
Y0000057 Heptaminol impurity A
20 mg
H0250000 alpha-Hexachlorocyclohexane
10 mg
New Y0001203 Hesperidin
Quantity Sale
per vial Unit
30 mg
1
Information
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
0332
Yes
+5C
0333
Yes
+5C
79
0333
+5C
79
See leaflet,
20714
Yes
+5C
90
20714,1526,1
935, 1107
Yes
-80C
90
Yes
-20C
79
Yes
-20C
79
See leaflet,
20715
Yes
+5C
90
See leaflet,
1056
Yes
+5C
90
0801,0802,08
47
+5C
79
1980
+5C
79
1980
+5C
79
0772
+5C
79
93.4% CHN; (2RS)-6-methylhept-5-en-2-amine
20 mg
89,9% CHO
2430
+5C
79
H0330000 Hexamidine diisetionate
20 mg
1436
+5C
79
H0325000 Hexetidine
100 mg
1221
+5C
79
H0400000 Hexobarbital
500 mg
0183
+5C
79
H0420000 Hexylresorcinol
100 mg
1437
+5C
79
H0500000 Hide powder
500 mg
20814
+5C
79
H0600000 Histamine dihydrochloride
250 mg
0143
+5C
79
H0750000 Histidine
100 mg
0911
+5C
79
H0755000 Histidine hydrochloride monohydrate
100 mg
0910
+5C
79
H0800000 Homatropine hydrobromide
100 mg
0500,0720
+5C
79
H0830000 Homatropine methylbromide
25 mg
0720
+5C
79
Y0001383 Homatropine methylbromide for system suitability
5 mg
0720
+5C
79
H0837000 L-Homocysteine thiolactone hydrochloride - reference

spectrum
n/a
1617
79
Y0001290 Honokiol
20 mg
99.6% CHO
2567
Yes
-20C
g(c)
79
H0900000 Human albumin for electrophoresis BRP
1 ml
96,7% to 99,2% of the total protein is the main band (albumin), protein
content : 5%
0255
Yes
-20C
79
Y0000219 Human anti-D immunoglobulin BRP
40 mg
285 IU anti-D immunoglobulin per ampoule

1uc=40 mg
See leaflet,
20713
Yes
-20C
90
38
Yes
Yes
Order
Reference Standard
Code
Y0000667 Human coagulation factor VII concentrate BRP
Batch n
Monograph
Leaflet
Storage
See leaflet,
20710
Yes
-20C
H0920000 Human coagulation factor VIII concentrate BRP
37 mg
10.4 IU per vial
See leaflet,
20704
Yes
-20C
90
H0920500 Human coagulation factor IX concentrate BRP
30 mg
7.9 IU/vial; Common standard with FDA and WHO (4th IS)
See leaflet,
20711
Yes
-20C
90
H0950000 Human hepatitis A immunoglobulin BRP
10 mg
10.2 IU per vial
See leaflet,
0338, 0769
Yes
-20C
90
Y0001504 Human immunoglobulin BRP (ACA and Molecular size)
1 uc
See leaflet,
0338, 0918
Yes
+5C
90
Y0001512 Human Immunoglobulin BRP (Fc Function and Molecular

size)
9000 mg
See leaflet,
0338, 0918
Yes
+5C
90
H1000000 Human immunoglobulin for electrophoresis BRP
96 mg
75.7% to 80.9% of the total protein is the main band (Ig),

protein content: 5%
0338,0918
Yes
+5C
79
Y0000488 Human immunoglobulin (molecular size) BRP
700 mg
Each vial contains 0.7 gram of immunoglobulin G
See leaflet,
0338,
0918,1928
Yes
+5C
90
H1005000 Human Plasma Pools for NAT validation
3502 mg
Set of 103 plasma pool samples
See leaflet,
20621
Yes
-20C
400
H1100000 Human rabies immunoglobulin BRP
170 mg
91 IU per vial
See leaflet,
0723
Yes
-20C
90
H1110000 Human tetanus immunoglobulin BRP
87 mg
120 IU per vial
0398
Yes
-20C
90
Y0000502 Human vaccinia immunoglobulin
1 ml
23 IU per vial
See leaflet
Yes
-20C
270
H1115000 Hyaluronidase BRP
50 mg
328 IU per mg
0912
Yes
+5C
79
H1120000 Hydralazine hydrochloride
20 mg
+5C
79
Y0001151 Hydrastine hydrochloride
20 mg
91,7% CHClNO
H1200000 Hydrochlorothiazide
300 mg
99.8% CHClNOS ; Batch 6 is valid until 31 August 2013
Y0001494 Hydrochlorothiazide for peak identification
10 mg
Y0000646 Hydrocodone hydrogen tartrate 2.5-hydrate - * narc
10 mg
Y0000710 Hydrocodone for peak identification - * narc
10 mg
1784
H1300000 Hydrocortisone
100 mg
0335,0353,05
61
Y0001092 Hydrocortisone for peak identification
5 mg
H1400000 Hydrocortisone acetate
125 mg
99% CHO; Hydrocortisone acetate CRS 8 is suitable for monographs

0321,0334,03
01/2011:0335, 01/2008:334, 01/2008:0321, 01/2008:0767 and 01/2008:0734
35,
only. ; Batch 8 is valid until 30 September 2012
0734,0767
Y0001482 Hydrocortisone acetate for peak identification
15 mg
0334
H1425000 Hydrocortisone hydrogen succinate
100 mg
H1426000 Hydrogenated wool fat
250 mg
Y0000446 Hydromorphone hydrochloride - * narc
10 mg
Quantity Sale
per vial Unit
25 mg
2 9.9 IU per vial
Information
0829
Extra
Price
charges
79
c
1831,2500
Yes
-20C
79
0394
Yes
+5C
79
0394
Yes
+5C
79
1784
+5C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
Yes
+5C
79
0768,1131
-20C
79
0969
+5C
79
2099
+5C
79
39
0335
Yes

Order
Reference Standard
Code
B0650000 Hydrous benzoyl peroxide - reference spectrum

Batch n
1
Quantity Sale
per vial Unit
n/a
1
Information
Monograph
Storage
0704
H1428000 Hydroxocobalamin
10 mg
Y0000119 Hydroxycarbamide
175 mg
H1429400 Hydroxyethyl salicylate
125 mg
H1429700 4-Hydroxyphenoxymethylpenicillin potassium
20 mg
98.4% CHKNOS
H1430000 D-alpha-(4-Hydroxy-phenyl)glycine
50 mg
(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid - Cefadroxyl impurity A
0813
Y0001277 Hydroxyethyl starch (medium MW)
1200 mg
Average Mw 130100 Da
1785
Y0001322 Hydroxyethyl starch (high Mw)
800 mg
507900 Da
1785
Y0000186 Hydroxypropylbetadex
200 mg
H1435000 Hydroxyzine hydrochloride
600 mg
Y0000011 Hymecromone
100 mg
Y0000012 Hymecromone impurity A
25 mg
Y0000013 Hymecromone impurity B
25 mg
Y0000483 Hyoscine
10 mg
Y0000484 Hyoscine impurity A
10 mg
H1450000 Hyoscine butylbromide
20 mg
Y0000447 Hyoscine butylbromide impurity E
10 mg
H1500000 Hyoscine hydrobromide
50 mg
Y0000448 Hyoscine hydrobromide impurity B
10 mg
H1600000 Hyoscyamine sulfate
100 mg
Y0000449 Hyoscyamine impurity E
10 mg
Y0000915 Hypromellose phthalate
10 mg
I0020000 Ibuprofen
250 mg
B1220000 Ibuprofen impurity B
1.1 mL
solution of 0.06% m/V in acetonitrile - to be diluted as appropriate.; (2RS)-2(4-Butylphenyl)propanoic acid ; Batch 6 is valid until 31 August 2013
Y0000140 Ibuprofen impurity F
5 mg
Y0000881 Ibuprofen for peak identification
0.09 mg
I0050000 Idoxuridine
50 mg
I0060000 Ifosfamide
50 mg
I0060100 Ifosfamide - reference spectrum
n/a
I0060002 Ifosfamide impurity A
100 mg
Leaflet
Extra
Price
charges
79
l
0913,0914,09
15
+5C
79
1616
+5C
79
1225
+5C
79
-20C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
1804
+5C
79
0916,1086,10
92
+5C
79
1786
+5C
79
Resorcinol
1786
+5C
79
7-hydroxy-2-methyl-4H-1-benzopyran-4-one.
1786
+5C
79
2167
+5C
79
2167
+5C
79
0737
+5C
79
0737
+5C
79
0106,0500
+5C
79
0106
+5C
79
0501
+5C
79
0501
+5C
79
347
+5C
79
0721
+5C
79
0721
+5C
79
3-[4-(2-methylpropyl)phenyl]propanoic acid
0721
+5C
79
0721
99.9% CHNO
0148,0149
(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl
(2S)-3-hydroxy-2-phenylpropanoate (norhyoscine)
(1R,2R,4S,5S,7S)-9-butyl -7-[[(2S)-3-hydroxy2-phenylpropanoyl]oxy]-3-oxa -9-azoni atricyclo
[3.3.1.02,4]nonane
(1R,2R,4S,5S,7s)-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl
(2S)-3-hydroxy-2-phenylpropanoate
(1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl(2S)-3-hydroxy-2-phenyl
-propanoate
100.0% CHClNOP
Yes
+5C
79
0669
Yes
+5C
79
1529
+5C
79
79
g(c)
79
1529
3-[(2-chloroethyl)amino]propyl dihydrogen phosphate
40
1529
-20C

Order
Reference Standard
Code
I0060004 Ifosfamide impurity B

Batch n
1
Quantity Sale
Information
per vial Unit
20 mg
1 bis[3-[(2-chloroethyl)amino]propyl] dihydrogen diphosphate
20 mg
2 3-chloro-N-(2-chloroethyl)propan-1-amine
Monograph
Leaflet
Storage
Extra
Price
charges
79
g
1529
+5C
1529
+5C
79
1529
+5C
79
0757,1424,
2270
+5C
79
1226
-20C
79
+5C
79
+5C
79
I0060010 Ifosfamide impurity E
I0060012 Ifosfamide impurity F
10 mg
I0086000 Imidazole
100 mg
I0090000 Imipenem
100 mg
I0100000 Imipramine hydrochloride
50 mg
Y0000893 Imipramine for system suitability
10 mg
0029,0408,08
17,
0889,1787
0029
Y0001153 Immunoglobulin for anti-A, anti-B antibodies limit test BRP
45 mg
20620
Yes
-20C
79
Y0001152 Immunoglobulin panel for anti-A, anti-B antibodies test
96 mg
20620
Yes
-20C
120
Y0000540 Immunoglobulin panel for anti-D antibodies test BRP
2000 mg
See leaflet,
20626
Yes
-20C
90
Y0001205 Imperatorin
20 mg
98.8 % CHO
2556
Yes
+5C
79
I0150000 Indapamide
150 mg
97.6% CHClNOS ; Batch 4 is valid until 31 October 2012
1108
Yes
+5C
79
I0150020 Indapamide impurity B
5 mg
4-chloro-N-(2-methyl-1H-indol-1-yl]-3-sulphamoylbenzamide
1108
+5C
79
Y0000788 Indinavir
100 mg
97.2% CHNO
2214
+5C
79
Y0000880 Indinavir sulfate - reference spectrum
n/a
2214
79
Y0000746 Indinavir for system suitability
20 mg
2214
+5C
79
I0200000 Indometacin
50 mg
0092,0922,16
86
+5C
79
Y0000349 Insulin aspart
8 mg
7.45 mg of insulin aspart + B28iso insulin aspart + A21Asp insulin aspart +

B3Asp insulin
8 aspart + B3iso Asp insulin aspart per vial
I0305000 Insulin (bovine)
7.99 mg
I0310000 Insulin (human)
8 mg
Y0000348 Insulin lispro
(RS)-2-chloro-3-(2-chloroethyl)-1,3,2-oxazaphosphinane 2-oxide
92.9% CHNOS
Yes
2084
Yes
-20C
90
7.99 mg insulin + A21 desamido per vial CHNOS
0854,1637
Yes
-20C
90
6.94 mg insulin + A21 desamido per vial CHNOS
0838,0854,16
37, 1638
Yes
-20C
90
5.75 mg
5.75 mg per vial of CHNOS ; Batch 1 is valid until 1 June 2013
2085
Yes
-20C
90
New Y0001542 Insulin glargine
15 mg
14,98 mg
1571
Yes
-20C
79
New Y0001544 Insulin glargine for peak identification
3.2 mg
I0320000 Insulin (porcine)
8.61 mg
8.61 mg insulin + A21-desamido per vial

see recommandations for use on accompagnying leaflet CHNOS
I0320301 Interferon alfa-2b
200 L
Y0001101 Interferon beta-1a
0.5 mL
I0320330 Interferon gamma 1b
2
3
New I0320331 Interferon gamma-1b validation solution
-20C
79
0838,0854,16
37, 1638
2571
Yes
-20C
90
About 9.74 mg per mL
1110
Yes
-80C
90
335 g of interferon beta-1a per mL CHNOS ; Batch 1 is valid until

30 November 2012
1639
Yes
-80C
90
0.5 mL
about 1 mg per ml
1440
Yes
-80C
90
0.6 mg
The CRS is available in the freeze-dried form.

About 1 mg per ml after reconstitution following instructions provided in the
leaflet. ; Batch 2 is valid until 31 December 2013
1440
Yes
-20C
79
41
Order
Reference Standard
Code
I0328000 Iobenguane sulfate
Batch n
Y0000839 Iobenguane sulfate - reference spectrum
n/a
Y0001294 Iodixanol
60 mg
2215
Y0001292 Iodixanol impurity C
10 mg
5-[acetyl[3-[[3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]
amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6triiodobenzene-1,3-dicarboxamide
2215
Y0001291 Iodixanol impurity E
10 mg
5-[acetyl[3-[acetyl[3-carbamoyl-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6triiodophenyl]amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
Y0001293 Iodixanol impurity H
10 mg
5-[acetyl[3-[acetyl[3-[[3-[3-[acetyl[3,5-bis[(2,3-dihydroxypropyl)
carbamoyl]-2,4,6-triiodophenyl]amino]-2-hydroxypropoxy]-2-hydroxypropyl]
carbamoyl]-5-[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl]
amino]-2-hydroxypropyl]amino]-N,N'-bis(2,3-dihydroxypropyl)-2,4,6triiodobenzene-1,3-dicarboxamide
I0320800 Iohexol
150 mg
I0320810 Iohexol impurity A
50 mg
5-acetamido-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodo benzene-1,3dicarboxamide
I0320820 Iohexol impurity J
125 mg
5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-tri-iodobenzene-1,3dicarboxamide
Y0000672 Iohexol for peak identification
10 mg
I0329000 Iopamidol
50 mg
I0329010 Iopamidol impurity A
10 mg
N,N'-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-5-amino-2,4,6-triiodoisophthalamide
Y0000406 Iopamidol impurity H
10 mg
4-chloro-N,N'-bis(2-hydroxy-1-(hydroxymethyl)ethyl)-5-(2hydroxypropanoyl)amino)2,6-diiodobenzenz-1,3-dicarboxamide
I0330000 Iopanoic acid
100 mg
Y0001297 Iopentol
10 mg
Y0001020 Iopromide
100 mg
98.7% CHINO
1753
Y0001077 Iopromide impurity A
0.125 mg
5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-N-methylbenzene-1,3dicarboxamide
Y0001021 Iopromide for system suitability 1
5 mg
Y0001022 Iopromide for system suitability 2
5 mg
I0340000 Iotalamic acid
150 mg
A0560000 Iotalamic acid impurity A
20 mg
5-Amino-2,4,6-tri-iodo-N-methylisophthalamic acid
Y0000555 Iotrolan
100 mg
97.2%
1754
Y0000658 Iotrolan for system suitability
5 mg
Y0000141 Ioxaglic acid
125 mg
Y0000142 Ioxaglic acid impurity A
20 mg
I0360000 Ipratropium bromide
120 mg
Quantity Sale
per vial Unit
25 mg
1 97.2% CHINOS
Information
Monograph
Leaflet
1111,1112,111
3,2351
Storage
+5C
2351
Extra
Price
charges
79
b
l
79
+5C
79
+5C
79
2215
+5C
79
2215
+5C
79
1114
+5C
79
1114
+5C
79
1114,2215
+5C
79
+5C
79
1115
+5C
79
1115, 1754
+5C
79
1115
+5C
79
0700
+5C
79
+5C
79
+5C
79
1753
+5C
79
1753
+5C
79
1753
+5C
79
0751
+5C
79
0751
+5C
79
+5C
79
+5C
79
1114
Yes
2215
Yes
Yes
1754
2009
3-amino-5-[(2-hydroxyethyl)carbamoyl]-2,4,6-triiodobenzoic acid
42
+5C
79
2009
Yes
+5C
79
0919
+5C
79

Order
Reference Standard
Code
Y0000276 Ipratropium impurity A

Batch n
1
Quantity Sale
Information
per vial Unit
10 mg
1 (1R,3r,5S,8r)-3-hydroxy-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]
octane
Monograph
0919
+5C
79
2465
+5C
79
+5C
79
10 mg
Y0001166 Irbesartan
60 mg
New Y0001156 Irbesartan impurity A
10 mg
1-(pentylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]
cyclopentanecarboxamide ; Batch 1 is valid until 31 October 2013
2465
New Y0001616 Irisflorentin
99,5% CHO
2561
15 mg
200 mg
I0380000 Isoconazole nitrate
200 mg
I0400000 Isoemetine hydrobromide
25 mg
Y0000858 Isoflurane
Y0000037 Isoflurane - reference spectrum
I0460000 Isoleucine
I0465000 Isomalt
Extra
Price
charges
79
a
+5C
I0375000 Isoconazole
Storage
0772
I0361000 Ipratropium bromide impurity B
(1R,3r,5S,8s)-3-[[(2RS)-3-hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1methylethyl)-8-azoniabicyclo[3.2.1]octane
Leaflet
+5C
79
1018
+5C
79
1017
+5C
79
0080,0081
+5C
79
1.4 ml
1666
+5C
79
n/a
1673
79
50 mg
+5C
79
3000 mg
+5C
79
Y0000070 Isomaltooligosaccharide
0.9 mg
1506
+5C
79
I0500000 Isoniazid
100 mg
0146
+5C
79
I0599990 Isoprenaline hydrochloride
50 mg
1332
+5C
79
I0600000 Isoprenaline sulfate
500 mg
0502
+5C
79
I0725000 Isopropyl hexadecanoate
100 mg
94.3% CHO
0839
+5C
79
I0750000 Isopropyl tetradecanoate
2 ml
97.9% CHO
0725
Yes
+5C
79
Y0001568 Isoquercitroside
15 mg
97% CHO
2528,2667
Yes
+5C
79
I0775000 Isosorbide dinitrate
350 mg
40,8% CHNO ; Batch 2 is valid until 1 June 2013
1117,1118
Yes
+5C
79
I0775010 Isosorbide mononitrate
150 mg
99.9% CHNO; Isosorbide-5-nitrate ; Batch 3 is valid until 31 January 2013
1117,1118
Yes
+5C
79
I0775020 Isosorbide-2-nitrate
50 mg
1118
+5C
79
I0800000 Isotretinoin
60 mg
0693,1019
+5C
g(b)
79
Y0001218 Isotretinoin for peak identification
10 mg
1019
+5C
g(b)
79
I0900000 Isoxsuprine hydrochloride
50 mg
1119
+5C
79
Y0000366 Isradipine
125 mg
99.2% CHNO
2110
+5C
79
Y0000367 Isradipine impurity D
5 mg
methyl 1-methylethyl 4-(2,1,3-benzoxadiazol-4-yl)

-2,6-dimethylpyridine-3,5-dicarboxylate
2110
+5C
79
I7000000 Itraconazole
150 mg
1335
+5C
79
Y0001100 Itraconazole for system suitability
25 mg
1335
Yes
+5C
79
I8000010 Ivermectin
150 mg
90.6% of CHO (component H2B1a)
1336
Yes
+5C
79
Y0000575 Ivy leaf standardised tincture
2 ml
0.20% (m/m) of hederacoside C; Ivy leaf standardised tincture CRS has been
replaced with Ivy leaf dry extract HRS Y0001592. ; Batch 1 is valid until 31
October 2013
2148
-20C
g(c)
79
Yes
0770
1531
97.0 % CHO ; Batch 3 is valid until 31 July 2012

43
Yes
Yes
Yes

Order
Code
Y0000041 Josamycin
Reference Standard

Batch n
2
Quantity Sale
per vial Unit
150 mg
1 1000 Ph. Eur. units per mg
Information
Monograph
Leaflet
Storage
1982,1983,20
702
Yes
-20C
Y0000042 Josamycin propionate
150 mg
Y0001315 Josamycin for peak identification
25 mg
1983
K0100000 Kanamycin B sulfate
20 mg
0032,0033,06
45
K0200000 Kanamycin monosulfate
150 mg
Y0000450 Ketamine hydrochloride - * narc
10 mg
K0551000 Ketamine impurity A
50 mg
Y0000246 Ketobemidone hydrochloride - reference spectrum
n/a
Y0000244 Ketobemidone impurity B
5 mg
1-[4-(3-hydroxyphenyl)-1-methylpiperidin-4-yl]ethanone
Y0000245 Ketobemidone impurity C
5 mg
1-[4-(3-hydroxyphenyl)piperidin-4-yl]propan-1-one
K0600000 Ketoconazole
150 mg
K2000000 Ketoprofen
50 mg
K2000010 Ketoprofen impurity A
10 mg
K2000015 Ketoprofen impurity C
15 mg
Y0000486 Ketorolac trometamol
10 mg
Y0000626 Ketorolac trometamol for peak identification
5 mg
Y0000164 Ketotifen hydrogen fumarate - reference spectrum
n/a
Y0000161 Ketotifen impurity G
0.0225 mg
4-(1-methylpiperidin-4-ylidene)-4H-benzo(4,5)cyclohepta(1,2-b)
thiophen-9,10-dione ; Batch 3 is valid until 31 August 2013
Y0001200 Kudzuvine root dry extract
200 mg
See leaflet
L0050000 Labetalol hydrochloride
120 mg
99.6 % CHClNO ; Batch 1 is valid until 31 March 2013
Y0001548 Labetalol impurity A
10 mg
2-hydroxy-5-[1-hydroxy-2-[(1-methyl-3-phenylpropyl)-amino]ethyl]benzoic
acid
L0129000 Lactitol monohydrate
60 mg
93.8% CHO
Y0000257 Lactobionic acid
100 mg
A1206000 Lactose (anhydrous)
100 mg
L0100000 Lactose
100 mg
L0130000 Lactulose
3000 mg
Y0001510 Lactulose for peak identification
2600 mg
1982,1983,20
702
Extra
Price
charges
79
c
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
79
1746
+5C
79
1746
+5C
79
0921,1067,12
70
+5C
79
0922,1157,12
09
+5C
79
1-(3-benzoylphenyl)ethanone
0922
+5C
79
3-[(1RS)-1-carboxyethyl]benzoic acid
0922
+5C
79
1755
+5C
79
+5C
79
79
79
975 Ph. Eur. units per mg
0032,0033,00
53,
0485,0645,12
89,
1290,20702
1020
799 IU per mg of CHNOS,HO
Yes
Yes
1020,1742
1-[(2-chlorophenyl)(methylimino)methyl]cyclopentanol
1746
1755
Yes
1592
1592
Yes
+5C
2434,2483
Yes
-20C
79
0923
Yes
+5C
79
0923
+5C
79
1337
+5C
79
1647
+5C
79
1061
+5C
79
0177,0178,01
87,
0188,0204,02
09,
1215,1570
0924,1230
+5C
79
+5C
79
+5C
79
99.7% CHO
0924
44
Yes

Order
Reference Standard
Code
Y0000188 Lactulose for system suitability

Batch n
3
Quantity Sale
per vial Unit
12 mg
1
Information
Monograph
Leaflet
Storage
0924,1230
Yes
+5C
Extra
Price
charges
79
a
Y0000425 Lamivudine
150 mg
2217
+5C
79
Y0000518 Lamivudine for system suitability 1
10 mg
2217
+5C
79
Y0000426 Lamivudine for system suitability 2
10.3 mg
2217
+5C
79
Y0001030 Lamotrigine
10 mg
1756
+5C
79
Y0001031 Lamotrigine for peak identification
20 mg
1756
Yes
+5C
79
Y0001085 Lamotrigine for system suitability
10 mg
1756
Yes
+5C
79
Y0001032 Lamotrigine impurity E
15 mg
1756
+5C
79
Y0000773 Lansoprazole
60 mg
2219
+5C
79
New Y0000774 Lansoprazole for peak identification
99.7% CHNOS
2,3-dichlorobenzoic acid
1.01 mg
2219
Yes
+5C
79
Y0001474 Lauric acid
1500 mg
97.9%
1848
Yes
+5C
79
Y0000654 Leflunomide
100 mg
100,0% CHFNO
2330
+5C
79
Y0000487 Leflunomide impurity A
25 mg
4-(trifluoromethyl)aniline
2330
+5C
79
Y0000674 Leflunomide for peak identification
1 mg
Y0000685 Letrozole
70 mg
L0375000 Leucine
50 mg
L0376000 Leuprorelin
1 mg
L0376001 Leuprorelin - reference spectrum
n/a
60 mg
L0380000 Levamisole hydrochloride
50 mg
0726
Y0000048 Levamisole - reference spectrum
n/a
1728
Y0001253 Levetiracetam
110 mg
100.0% CHNO
2535
Y0001254 Levetiracetam impurity A
10 mg
(2RS)-2-(2-oxopyrrolidin-1-yl)butanoic acid ; Batch 1 is valid until 1 March

2013
2535
Y0001255 Levetiracetam impurity B
10 mg
(2Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide
Y0001256 Levetiracetam impurity C
10 mg
Y0001257 Levetiracetam impurity D
15 mg
L0390000 Levocabastine hydrochloride
125 mg
L0390008 Levocabastine impurity D
20 mg
L0399900 Levocarnitine
125 mg
L0399905 Levocarnitine impurity A
50 mg
L0400000 Levodopa
100 mg
L0420000 Levodropropizine
60 mg
25 mg
New Y0000047 Levamisole hydrochloride for system suitability
New L0420002 Levodropropizine impurity A

2330
Yes
+5C
79
2334
Yes
+5C
79
0771,0874
+5C
79
1442
-20C
79
79
+5C
79
+5C
79
79
+5C
79
+5C
79
2535
+5C
79
pyridin-2-ol
2535
+5C
79
(2R)-2-(2-oxopyrrolidin-1-yl)butanamide ((R)-etiracetam) ; Batch 1 is valid

until 1 October 2013
2535
+5C
79
1484
+5C
79
1484
+5C
79
1339
+5C
79
1339
+5C
79
0038
+5C
79
1535
+5C
79
1535
+5C
79
99.7% CHN
0.99 mg per vial of pure leuprorelin peptide CHNO
1442
0726,1728
1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic
acid
(E)- or (Z)-4-(trimethylammonio)but-2-enoate
(2R)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol (dextrodropropizine) ; Batch

2 is valid until 30 November 2013
45
Yes
Yes

Order
Reference Standard
Code
Y0001033 Levodropropizine impurity B

Batch n
1
Quantity Sale
per vial Unit
50 mg
1 1-phenylpiperazine
300 mg
1 2,3-epoxypropan-1-ol
Information
Monograph
Leaflet
Storage
1535
+5C
Extra
Price
charges
79
g
Y0001048 Levodropropizine impurity C
1535
-20C
g(c)
79
L0500000 Levomepromazine hydrochloride
100 mg
0505
+5C
79
L0505000 Levomepromazine maleate
50 mg
0925
+5C
79
L0551000 Levonorgestrel
30 mg
0926
+5C
79
Y0001379 Levonorgestrel impurity B
10 mg
+5C
79
Y0001431 Levonorgestrel for system suitability
10 mg
+5C
79
+5C
79
-20C
79
New Y0001618 Levonorgestrel for system suitability 2
13-ethyl-17-hydroxy-18,19-dinor-17-alpha-pregn-5(10)-en-20-yn-3-one
0926
0926
Yes
0926
Yes
10 mg
L0570000 Levothyroxine sodium
100 mg
Y0001382 Levothyroxine for peak identification
10 mg
0401
-20C
79
L0595000 Lidocaine
50 mg
0727
+5C
79
L0600000 Lidocaine hydrochloride
100 mg
0227,1242,13
63
+5C
79
L0650000 Lincomycin hydrochloride
250 mg
Y0001393 Lincomycin hydrochloride for system suitability
10 mg
L0700000 Liothyronine sodium
50 mg
Y0000860 Liothyronine for peak identification
0.0046 mg
0728
L0702000 Lisinopril dihydrate
50 mg
1120
Y0001235 Lisinopril for system suitability
2 mg
Lisinopril for performance test CRS 3 renamed as lisinopril for system

suitability CRS 1 for the implementation of 01/2011:1120 ; Batch 1 is valid
until 30 November 2013
1120
Y0001234 Lisinopril impurity F
0.01 mg
(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-cyclohexylpropyl]amino]
hexanoyl]pyrrolidine-2-carboxylic acid (cyclohexyl analogue)
1120
L0720000 Lithium clavulanate
125 mg
97.6% CHLiNO; 1 mg of CHLiNO corresponds to 1.157 mg of CHKNO
L0720800 Lithocholic acid
60 mg
Y0000112 Lobeline hydrochloride
50 mg
L0745000 Lomustine
50 mg
Y0001438 Long pepper for system suitability HRS
600 mg
L0750000 Loperamide hydrochloride
Y0000322 Loperamide hydrochloride for system suitability

Y0000341 Loperamide oxide monohydrate
0401,0728
89.3% CHINNaO
Yes
95.4% CHClNOS
0582,0583,09
96
Yes
+5C
79
0583
Yes
-20C
79
96.6 % CHINNaO
0401,0728
Yes
-20C
79
-20C
79
+5C
79
+5C
79
+5C
79
+5C
79
1189,1275
+5C
79
1988
+5C
79
0928
+5C
79
2477, 2453
+5C
79
50 mg
0921,0929,17
29
+5C
79
15 mg
0929
+5C
79
20 mg
1729
+5C
79
Y0001498 Lopinavir
200 mg
2615
Yes
+5C
79
Y0001506 Lopinavir for peak identification
10 mg
2615
Yes
+5C
79
Y0001505 Lopinavir for system suitability
10 mg
2615
Yes
+5C
79
Y0000688 Loratadine
60 mg
2124
+5C
79
Y0000603 Loratadine for system suitability
20 mg
2124
+5C
79
95.3 % CHNO
46
1140,1653
Yes
Yes
Yes
Yes

Order
Reference Standard
Code
Y0000604 Loratadine impurity F

Batch n
1
Quantity Sale
Information
per vial Unit
10 mg
1 ethyl 4-[(11RS)-8-chloro-11-fluoro-6,11-dihydro-5H-benzo[5,6]cyclohepta
[1,2-b]pyridin-11-yl]piperidine-1-carboxylate
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
2124
+5C
2124
+5C
79
Y0000605 Loratadine impurity H
50 mg
L0750500 Lorazepam - * psy
100 mg
1121
+5C
79
0.8 mg
1121
+5C
79
Y0000718 Lorazepam impurity D
10 mg
(5RS)-7-chloro-5-(2-chlorophenyl)-4,5-dihydro-1H-1,4-benzodiazepine-2,3dione
1121
+5C
79
Y0001062 Losartan potassium
50 mg
2232
+5C
79
Y0001072 Losartan impurity D
6 mg
2-butyl-4-chloro-1H-imidazole-5-carbaldehyde
2232
+5C
79
Y0001076 Losartan for system suitability
0.0015 mg
L0790000 Lovastatin
60 mg
99.5% CHO
Y0001136 Lovastatin for peak identification
20 mg
Y0001284 Lufenuron
140 mg
Y0001261 Lufenuron for peak identification
0.4028 mg
Y0001265 Lufenuron impurity G
15 mg
L0800000 Lynestrenol
50 mg
Y0001034 Lynestrenol for peak identification
Y0000397 Lysine acetate
L0900000 Lysine hydrochloride
Y0000745 Macrogol 40 sorbitol heptaoleate

Y0001157 Macrogol polyvinyl alcohol grafted copolymer
New Y0000576 Lorazepam for system suitability - * psy
ethyl 4-oxopiperidine-1-carboxylate
99.5% CHClFNO
2232
Yes
+5C
79
1538,1563
Yes
-20C
79
1538
Yes
-20C
79
2177
Yes
+5C
79
2177
Yes
+5C
79
2177
+5C
79
0558
+5C
79
20 mg
0558
+5C
79
60 mg
2114
+5C
79
50 mg
0805,0806,09
30, 1654
+5C
79
20 mg
2396
+5C
79
400 mg
2523
+5C
79
Y0001369 Macrogol 30 dipolyhydroxystearate
100 mg
2584
+5C
79
M0088000 Magnesium aspartate dihydrate
60 mg
1445
+5C
79
Y0001289 Magnolol
20 mg
99.5% CHO
2567
-20C
g(c)
79
M0120000 Malathion
250 mg
99.4% CHOPS
1343
+5C
79
M0120005 Malathion impurity A
10 mg
diethyl (2RS)-2-[(methoxy)(methylsulfanyl)-S-phosphinothioyl] butane dioate
1343
-20C
g(c)
79
M0120010 Malathion impurity B
10 mg
diethyl (2RS)-2-(dimethoxy-S-phosphinothioyl)-butanedioate
1343
-20C
g(c)
79
M0100000 Maleic acid
100 mg
0365,0925
+5C
79
Y0000143 Malic acid - reference spectrum
n/a
2080
79
M0160000 Maltitol
1200 mg
99.7% CHO ; Batch 3 is valid until 31 October 2012
M0200000 Mannitol
1200 mg
98.8% CHO
M0206000 Maprotiline hydrochloride
100 mg
M0206040 Maprotiline impurity D
25 mg
Y0000819 Marbofloxacin
10 mg
20 mg
Y0000820 Marbofloxacin for peak identification

2,5-dichloro-4-[[[(2,6-difluorophenyl)carbonyl]carbamoyl]amino]phenyl
phenyl carbonate
3-(9,10-dihydro-9,10-ethanoanthracen-9-yl)-N-methylprop-2- en-1-amine
47
Yes
Yes
1235,1236
Yes
+5C
79
0435,0559,13
81, 1531
Yes
+5C
79
1237
+5C
79
1237
+5C
79
2233
+5C
79
79
2233
Yes
+5C
a

Order
Reference Standard
Code
M0210000 Measles vaccine (live) BRP

Batch n
1
Quantity Sale
Information
per vial Unit
80 mg
1 4.3 log (ie 20000) infective viral units per vial
Monograph
Leaflet
Storage
1057,0213,24
42
Yes
-20C
M0215000 Mebendazole
20 mg
1208,1254
Y0000144 Mebendazole for system suitability
20 mg
0845
Y0000168 Mebendazole - reference spectrum
n/a
0845
Y0001086 Mebrofenin
120 mg
2393
M0220000 Meclozine dihydrochloride
150 mg
Renamed for 01/2011:0622 ; Batch 1 is valid until 1 May 2013
0622
Y0001310 Meclozine impurity B
15 mg
4-chlorobenzhydrol
Y0001311 Meclozine impurity H
15 mg
1-(4-chlorobenzhydryl)piperazine
M0240000 Medronic acid
20 mg
Y0001107 Medronic acid impurity A
60 l
Tris(1-methylethoxy)phosphane
Y0001106 Medronic acid impurity B
40 l
New M0250000 Medroxyprogesterone acetate
100 mg
M0250010 Medroxyprogesterone acetate for performance test
50 mg
Y0000598 Medroxyprogesterone acetate for system suitability
10 mg
M0252600 Mefenamic acid
50 mg
Y0001081 Mefenamic acid impurity A
100 mg
2,3-dimethylaniline
M0253000 Mefloquine hydrochloride
100 mg
1241
Y0001514 Megestrol acetate
120 mg
99.1 % CHO
1593
Yes
Y0001524 Megestrol acetate for system suitability
50 mg
1593
Y0001507 Megestrol acetate for peak identification
25 mg
1593
Y0001209 Meglumine
10 mg
Y0001080 Meloxicam
50 mg
Y0001035 Meloxicam impurity A
5 mg
ethyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide
2373
Y0001036 Meloxicam impurity B
5 mg
5-methylthiazol-2-amine
2373
Y0001037 Meloxicam impurity C
5 mg
N-[(2Z)-3,5-dimethylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide 1,1-dioxide
Y0001039 Meloxicam impurity D
5 mg
Y0001158 Melphalan hydrochloride
100 mg
Y0001513 Melphalan - reference spectrum
1 uc
1698
Y0001457 Melphalan for system suitability
10 mg
1698
M0300000 Menadione
100 mg
0507
M0350000 Menthol
150 mg
M0370000 Mepivacaine hydrochloride
100 mg
M0370020 Mepivacaine impurity B
60 mg
M0400000 Meprobamate - * psy
100 mg
Extra
Price
charges
90
c
+5C
79
+5C
79
79
+5C
79
+5C
79
0622
+5C
79
0622
+5C
79
0641, 2350
+5C
79
2350
+5C
79
Tetrakis(1-methylethyl)methhylenediphosphonate
2350
+5C
79
0673
+5C
79
Batch 2 is valid until 28 February 2013
0673
Yes
+5C
79
-20C
79
1240
+5C
79
1240
+5C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
2055
+5C
79
2373
+5C
79
Yes
+5C
79
Yes
+5C
79
2373
Yes
+5C
79
N-[(2Z)-3-ethyl-5-methylthiazol-2(3H)-ylidene]-4-hydroxy-2-methyl-2H-1,2benzothiazine-3-carboxamide 1,1-dioxide
2373
Yes
+5C
79
99.4% CHClNO
1698
Yes
+5C
79
79
+5C
79
+5C
79
0619,0623
+5C
79
1242
+5C
79
1242
+5C
79
0407,1689
+5C
79
0673
(RS)-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
48
Yes
Yes

Order
Reference Standard
Code
M0500000 Mepyramine maleate

Batch n
1
Quantity Sale
per vial Unit
1000 mg
1
Information
Monograph
Leaflet
Storage
0278
+5C
Extra
Price
charges
79
a
Y0000679 Mepyramine impurity A
10 mg
N-(4-methoxybenzyl)pyridin-2-amine
0278
+5C
79
Y0000680 Mepyramine impurity C
10 mg
pyridin-2-amine
0278
+5C
79
Y0001252 Meropenem trihydrate
110 mg
87.0% CHNOS,3HO
+5C
79
Y0000297 Mesalazine
125 mg
1699,1993
+5C
79
Y0001563 Mesalazine impurity A
15 mg
1699
+5C
79
Y0001569 Mesalazine impurity C
15 mg
1699
+5C
79
Y0001040 Mesityl oxide
100 mg
2358
+5C
g(b)
79
Y0000337 Mesna - reference spectrum
n/a
1674
79
Y0000316 Mesna impurity C
10 mg
2-(acetylsulphanyl)ethanesulphonic acid
1674
+5C
79
Y0000317 Mesna impurity D
10 mg
2,2'-(disulphanediyl)bis(ethanesulphonic acid)
1674
+5C
79
Y0000227 Meso-rich exametazime
0.5 mg
1925
Yes
+5C
79
Y0000097 Mesterolone
120 mg
99.8% CHO ; Batch 1 is valid until 30 September 2012
1730
Yes
+5C
79
Y0000096 Mesterolone impurity A
30 mg
17-hydroxy-1alpha-methylandrost-4-en-3-one
1730
+5C
79
M0600000 Mestranol
100 mg
0509
+5C
79
Y0000301 Metacresol - reference spectrum
n/a
2077
79
M0600500 Metacycline hydrochloride
50 mg
0272,0820
+5C
79
M0600900 Metamizole sodium
100 mg
1346
+5C
79
M0600905 Metamizole impurity A
15 mg
4-formylamino-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one
1346
+5C
79
Y0001481 Metamizole impurity E
0.01 mg
4-N-demethylanalgin ; Batch 1 is valid until 31 August 2013
1346
M0605000 Metformin hydrochloride
50 mg
New Y0001590 Metformin impurity A
25 mg
New Y0001600 Metformin impurity F
72 mg
Y0000770 Methacrylic acid-ethyl acrylate copolymer (1:1) - type A
200 mg
Y0000323 Methacrylic acid-ethyl acrylate copolymer (1:1) - type B
200 mg
M0610000 Methacrylic acid-ethylacrylate copolymer(1:1) - reference

spectrum
n/a
M0610030 Methacrylic acid-ethylacrylate copolymer (1:1),

dispersion 30%-ref.sp
M0620000 Methacrylic acid-methylmethacrylate copolymer(1:1)reference spectrum
2234
Yes
+5C
79
0931
+5C
79
Cyanoguanidine
0931
+5C
79
Dimethylamine hydrochloride
N-methylmethanamine
0931
+5C
79
1128
+5C
79
1128
+5C
79
1128
79
n/a
1129
79
n/a
1127
79
M0630000 Methacrylic acid-methylmethacrylate copolymer(1:2)reference spectrum
n/a
1130
79
M0800000 Methadone hydrochloride - reference spectrum
n/a
0408,1787
79
Y0000428 Methanol - reference spectrum
n/a
1989
79
M0900000 Methaqualone - reference spectrum
n/a
0510
79
Y0000754 Methenamine
10 mg
1
49
Yes
79
1545
+5C
g

Order
Code
M0950000 DL-Methionine
Reference Standard

Batch n
1
Quantity Sale
per vial Unit
50 mg
1
Information
Monograph
Leaflet
0624
M0960000 Methionine
50 mg
M1000000 Methotrexate
100 mg
Y0000602 Methotrexate for peak identification
20 mg
Y0000663 Methotrexate impurity C
10 mg
(2S)-2-[[4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]
benzoyl]amino]pentanedioic acid (N-methylfolic acid, methopteridine)
0560
M1000008 Methotrexate impurity D
10 mg
4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]benzoic
acid (N10-methylpteroic acid)
Y0000664 Methotrexate impurity E
10 mg
4-[[(2,4-diaminopteridin-6-yl)methyl]methylamino]benzoic acid (4-aminoN10-methylpteroic acid, APA)
M1300000 Methylatropine bromide
100 mg
M1400000 Methylatropine nitrate
M1450000 Methylcarbidopa
M1470000 Methyl 2-(4-chlorophenoxy)-2-methylpropionate

Y0001488 Methyl methacrylate
Storage
+5C
0788,1027
Extra
Price
charges
79
a
+5C
79
0560
Yes
+5C
79
0560
Yes
+5C
79
+5C
79
0560
+5C
79
0560
+5C
79
0511,0919
+5C
79
100 mg
0512
+5C
79
1 mg
0755
+5C
79
0.5 ml
0318
+5C
79
50 mg
1975
+5C
79
M1500000 Methyldopa
50 mg
0045,0755
+5C
79
Y0001374 Racemic methyldopa
5 mg
0045
+5C
79
Y0001083 Methyldopa for system suitability
0.024 mg
0045
+5C
79
M1550000 Methylene chloride
2 ml
0932
+5C
79
M1551000 2-(1-Methylethyl) pentanoic acid
25 mg
0678,1378
+5C
79
M1556000 Methyl 12-hydroxystearate
100 mg
1497
+5C
79
Y0000398 Methyl nicotinate
25 mg
2129
+5C
79
Y0000776 Methylergometrine maleate
10 mg
1788
+5C
79
Y0000777 Methylergometrine for system suitability
0.53 mg
1788
+5C
79
M1625000 Methylnitrosoindoline
110 mg
1108
+5C
79
M1650000 Methyl parahydroxybenzoate
150 mg
0409,1262,21
34,1999
+5C
79
Y0001017 Methylphenidate hydrochloride - * narc
40 mg
2235
+5C
79
Y0001490 Methylphenidate impurity C
10 mg
2235
+5C
79
Y0000910 Methylphenidate impurity mixture
0.04 mg
2235
+5C
79
M1700000 Methylphenobarbital - * psy
500 mg
0189
+5C
79
M1750000 Methylprednisolone
150 mg
0312,0561
+5C
79
M1755000 Methylprednisolone acetate
100 mg
0933
+5C
79
88.2 % CHNO ; Batch 5 is valid until 31 January 2013
100.0% CHO; batch 2 valid until 31/12/10 for use with monograph 2134
and 1999.
(2RS)-2-phenyl-2-[(2R)-piperidin-2-yl]ethanamide
Yes
Yes
Yes
New Y0001602 Methylprednisolone for system suitability
10 mg
0561
+5C
79
M1755200 Methylprednisolone hydrogen succinate
125 mg
0768,1131
+5C
79
M1755220 Methylprednisolone hydrogen succinate for performance

test
50 mg
1131
+5C
79
100 mg
Y0001376 2-methylpyrazine
50
Yes
79
2446
+5C
g

Order
Reference Standard
Code
Y0000190 N-Methylpyrrolidone - reference spectrum

Batch n
1
Quantity Sale
per vial Unit
n/a
1
Information
Monograph
Leaflet
Storage
1675
Extra
Price
charges
79
l
M1770180 Methyl ricinoleate
125 mg
0051,2367
+5C
79
Y0000418 Methylrosanilinium chloride
40 mg
1990
+5C
79
Y0000407 Methylrosanilinium for system suitability
10 mg
1990
+5C
79
M1770200 Methyl stearate
100 mg
0051,1497
+5C
79
M1800000 Methyltestosterone
100 mg
0410
+5C
79
Y0000861 Methyltestosterone for system suitability
10 mg
0410
+5C
79
M1800900 Methylthioninium chloride
50 mg
1132
+5C
79
M1800902 Methylthioninium impurity A
20 mg
1132
+5C
79
M1808000 Metixene hydrochloride
75 mg
1347
+5C
79
M1824990 Metoclopramide
100 mg
1348
+5C
79
M1825000 Metoclopramide hydrochloride
50 mg
0674,0856,13
03
+5C
79
M1824995 Metoclopramide impurity A
25 mg
4-(acetylamino)-5-chloro-N-(2-diethylaminoethyl)-2-methoxy benzamide ;
1348
+5C
79
M1825010 Metoclopramide impurity E
40 mg
N,N-diethylethane-1,2-diamine
1575
+5C
79
Y0000701 Metolazone
80 mg
99.4% CHClNOS
1757
+5C
79
Y0000702 Metolazone for system suitability
10 mg
1757
+5C
79
Y0000171 Metoprolol succinate - reference spectrum
n/a
1448
79
M1830000 Metoprolol tartrate
60 mg
+5C
79
5 mg
+5C
79
M1845000 Metrifonate
100 mg
1133
+5C
79
M1850000 Metronidazole
50 mg
0675,0934
+5C
79
M1851000 Metronidazole benzoate
50 mg
1424
+5C
79
Y0000069 Metronidazole benzoate - reference spectrum
n/a
79
Y0000087 Metronidazole impurity A
10 mg
0675, 0934
+5C
79
M1860000 Mexiletine hydrochloride
100 mg
1029
+5C
79
Y0000202 Mexiletine impurity C
2 mg
1,1'-[(3,3',5,5'-tetramethylbiphenyl-4,4'-diyl)bisoxy]dipropan-2-amine
1029
+5C
79
Y0000203 Mexiletine impurity D
2 mg
(2RS)-2-(2,6-dimethylphenoxy)propan-1-amine
1029
+5C
79
M1875000 Mianserin hydrochloride
100 mg
0846
+5C
79
Y0001041 Mianserin impurity B
10 mg
0846
+5C
79
Y0000862 Mianserin for system suitability
1.01 mg
0846
+5C
79
M1880000 Miconazole
70 mg
0935
+5C
79
M1900000 Miconazole nitrate
100 mg
0513,1148
+5C
79
M2200000 Midazolam - * psy
50 mg
0936,1065
+5C
79
New Y0000145 Metoprolol impurity A
3-(dimethylamino)-7-(methylamino)phenothiazin-5-ylium
Yes
Yes
Yes
1028
(2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol ; Batch 2 is
valid until 31 December 2013
1028,1448
Yes
0934
2-methyl-4-nitroimidazole
(14bRS)-2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]
azepine-8-sulfonic acid
51
Yes
Order
Reference Standard
Code
Y0000562 Midazolam impurity C
Batch n
Y0000599 Midazolam for system suitability - * psy
1 mg
Y0000539 Milk thistle standardised dry extract
120 mg
Content silibinin A and silibinin B: 26.9 % of ; Batch 2 is valid until 31

December 2012
M2280000 Minocycline hydrochloride
125 mg
90.9 % CHClNO ; Batch 2 is valid until 31 December 2012
M2300000 Minoxidil
50 mg
0937
Y0001432 Minoxidil for system suitability
10 mg
0937
Y0000705 Mirtazapine
10 mg
2338
Y0000721 Mirtazapine for system suitability
10 mg
Y0000490 Misoprostol
60 mg
Y0001162 Misoprostol for system suitability
5 mg
Y0000378 Mitomycin
120 mg
M2305000 Mitoxantrone hydrochloride
50 mg
97.7% CHClNO
M2305005 Mitoxantrone impurity A
5 mg
1-amino-5,8-dihydroxy-4-[[2-[(2-hydroxyethyl)amino]ethyl] amino]
anthracene-9,10-dione
Y0000635 Modafinil
110 mg
100.0% CHNOS
Y0000636 Modafinil for system suitability
0.1 mg
Y0000251 Molgramostim
0.3 ml
Y0000821 Molsidomine
5 mg
1701
Y0000822 Molsidomine impurity B
10 mg
N-nitrosomorpholine
1701
Y0000823 Molsidomine impurity D
10 mg
morpholine-4-carbaldehyde
M2900000 Mometasone furoate
100 mg
Y0001436 Montelukast dicyclohexylamine
150 mg
99.4% CHClNOS
2583
Y0001433 Montelukast racemate
10 mg
2583
Y0001434 Montelukast sodium
20 mg
2583
Y0001435 Montelukast for peak identification
20 mg
2583
Y0000028 Morantel hydrogen tartrate
50 mg
Y0000451 Morphine hydrochloride (trihydrate) - * narc
25 mg
Y0000452 Morphine sulfate - * narc
40 mg
Y0000830 Morphine for system suitability - * narc
15 mg
Y0000772 Moxidectin
70 mg
97.4% CHNO
Y0000747 Moxidectin for system suitability
10 mg
Y0000703 Moxifloxacin hydrochloride
110 mg
Y0000717 Moxifloxacin for peak identification
10 mg
Y0000226 Moxonidine
50 mg
Quantity Sale
Information
per vial Unit
0.08 mg
1 acide 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a]
[1,4]benzodiazepine-3-carboxylique
Monograph
0936
98.5% CHO
13.45 mg protein per ml CHNOS
Leaflet
+5C
Yes
+5C
79
2071,1860
Yes
-20C
79
1030
Yes
+5C
79
+5C
79
+5C
79
+5C
79
Yes
2338
Yes
+5C
79
1731
Yes
-20C
g(c)
79
1731
Yes
-20C
g(c)
79
1655
Yes
+5C
79
1243
+5C
79
1243
+5C
79
2307
+5C
79
2307
Yes
+5C
79
1641
Yes
-80C
79
+5C
79
+5C
g(b)
79
1701
+5C
79
1449
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
Yes
Yes
1546
Yes
1244,1784
96.1 % CHClFNO
99.7% CHClNO
52
Extra
Price
charges
79
g
0936
0097,1839,18
41
See leaflet
Storage
1244, 0097
Yes
+5C
79
1656
Yes
+5C
79
1656
Yes
+5C
79
2254
Yes
+5C
79
2254
Yes
+5C
79
+5C
79
1758

Order
Reference Standard
Code
Y0000222 Moxonidine impurity A

Batch n
1
M3600000 Mumps vaccine (live) BRP
M3805000 Mupirocin - reference spectrum
M3805500 Mupirocin calcium - reference spectrum

M3806000 Mupirocin lithium
Quantity Sale
Information
per vial Unit
10 mg
1 4,6-dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine
165 mg
1 4.6 log (ie40000) infective viral units per vial
Monograph
Leaflet
1758
0538,1057
+5C
Yes
n/a
n/a
100 mg
Y0000489 Mycophenolate mofetil
30 mg
1700
Y0000519 Mycophenolate mofetil for peak identification
10 mg
1700
Yes
Y0000692 Mycoplasma fermentans BRP
1 ml
20607
Y0000690 Mycoplasma hyorhinis BRP
1 ml
20607
Y0000691 Mycoplasma orale BRP
1 ml
Y0000689 Mycoplasma synoviae BRP
1 ml
Y0000485 Myo-inositol
1020 mg
99.8% CHO
1805
N0020000 Nabumetone
60 mg
99.8% CHO
1350
N0020020 Nabumetone impurity D
10 mg
(E)-4-(6-methoxynaphthalen-2-yl)but-3-en-2-one
N0020030 Nabumetone impurity F
10 mg
6,6'-dimethoxy-2,2'-binaphthalenyl ; Batch 3 is valid until 31 May 2013
Y0000146 Nadolol
100 mg
1789
Y0001215 Nadolol impurity mixture
0.01 mg
1789
New N0025000 Nadroparin calcium
Storage
-80C
1450
1451
90
79
79
+5C
79
+5C
79
+5C
79
Yes
-80C
120
Yes
-80C
120
20607
Yes
-80C
120
20607
Yes
-80C
120
+5C
79
+5C
79
1350
+5C
79
1350
+5C
79
+5C
79
+5C
79
+5C
79
79
1450,1451
93.7% CHOLi
Extra
Price
charges
79
g
Yes
Yes
250 mg
Y0000077 Naftidrofuryl - reference spectrum
n/a
Y0000120 Naftidrofuryl impurity A
10 mg
2-[(naphtalen-1-yl)methyl]-3-(tetrahydrofuran-2-yl)propanoic acid
1594
+5C
79
Y0000121 Naftidrofuryl impurity B
25 mg
ethyl 2-[(naphtalen-1-yl)methyl]- 3-(tetrahydrofuran-2-yl)propanoate ; Batch

1 is valid until 31 December 2012
1594
+5C
79
Y0000331 Naftidrofuryl impurity F
10 mg
2-[(diethylamino)ethyl 2-[(naphthalen-2-yl)methyl]-3- (tetrahydrofuran-2-yl)

propanoate
1594
+5C
79
N0050000 Nalidixic acid
100 mg
0701
+5C
79
N0075000 Naloxone hydrochloride dihydrate
100 mg
0729,2099
+5C
79
Y0000695 Naloxone for peak identification
10 mg
0729
+5C
79
Y0000400 Naltrexone hydrochloride
50 mg
1790
+5C
79
Y0000410 Naltrexone impurity C
15 mg
1790
+5C
79
Y0000542 Nandrolone decanoate
5 mg
1992
-20C
79
Y0000547 Nandrolone decanoate for peak identification
10 mg
1992
-20C
79
Y0000548 Nandrolone decanoate for system suitability
10 mg
1992
-20C
79
N0080000 Naphazoline hydrochloride
50 mg
0730,1162
+5C
79
N0100000 Naphazoline nitrate
10 mg
0147
+5C
79
N0200000 Naphazoline impurity A
15 mg
N-(2-aminoethyl)-2-(naphthalen-1-yl)acetamide
(naphthylacetylethylenediamine)
0147,0730
+5C
79
N0250000 Naproxen
100 mg
0731,1702
+5C
79
0828,1134
1594
N-(3-butenyl)-noroxymorphone
53
Yes
Yes

Order
Reference Standard
Code
Y0000399 Naproxen (racemic)

Batch n
1
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
0731,1702
Storage
+5C
Extra
Price
charges
79
g
Y0000631 Naproxen impurity L
10 mg
1-(6-methoxynaphthalen-2-yl)ethanone
1702
+5C
79
Y0001378 Naringin
20 mg
88.3% CHO
2563
Yes
+5C
79
Y0001437 Nateglinide
200 mg
99.9% CHNO
2575
Yes
+5C
79
Y0001440 Nateglinide impurity A
10 mg
trans-4-(1-methylethyl)cyclohexanecarboxylic acid
2575
+5C
79
Y0001441 Nateglinide impurity B
15 mg
N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-Lphenylalanine (Lphenylalanine isomer)
2575
+5C
79
Y0001442 Nateglinide impurity C
10 mg
N-[[cis-4-(1-methylethyl)cyclohexyl]carbonyl]-D-phenylalanine (cis-isomer)
N0300000 Neamine
0.5 mg
76.3% CHNO
N0399000 Neohesperidin-dihydrochalcone
125 mg
N0399004 Neohesperidin-dihydrochalcone impurity B
10 mg
N0400000 Neomycin sulfate
50 mg
Not to be used for microbiological assay
N0401000 Neomycin sulfate for microbiological assay
25 mg
19850 IU per vial ; Batch 3 is valid until 31 August 2013
N0500000 Neostigmine bromide
50 mg
N0550000 Neostigmine metilsulfate
50 mg
N0559000 Netilmicin sulfate
25 mg
14656 IU per vial
Y0000520 Nevirapine (anhydrous)
30 mg
99.8% CHNO
2255, 2479
Y0000521 Nevirapine for peak identification
0.058 mg
Y0001499 Nevirapine hemihydrate
15 mg
Y0000388 Newcastle Disease Vaccine (inactivated) BRP
40 mg
Y0001373 Nicergoline
50 mg
1998
Y0000287 Nicergoline - reference spectrum
n/a
1998
Y0000283 Nicergoline impurity A
10 mg
[(6aR,9R,10aS)-10a-methoxy-4,7-dimethyl-4,6,6a,7,8,9,10,10aoctahydroindol[4,3-fg]quinolin-9-yl]methyl 5-chloropyridine-3-carboxylate
1998
Y0001356 Nicergoline impurity D
20 mg
5-bromopyridine-3-carboxylic acid
Y0001362 Nicergoline for peak identification
1 mg
Y0001352 Nicergoline for system suitability
10 mg
1998
N0560000 Niclosamide (anhydrous)
50 mg
0679,0680
N0600000 Nicotinamide
50 mg
0047
N0590000 Nicotine - reference spectrum
n/a
1452,1792
N0590200 Nicotine ditartrate
120 mg
Y0001425 Nicotine ditartrate dihydrate
15 mg
+5C
79
0180,0197
2575
Yes
+5C
79
89.9% CHO
1547
Yes
-20C
79
86.4% CHO ; 7-[[2-O-(6-deoxy--L-mannopyranosyl) --Dglucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1benzopyran-4-one (neodiosmin)
1547
Yes
+5C
79
0032,0033,00
53,
0180,0197,04
85, 0645
Yes
-20C
79
0197,20702
Yes
-20C
79
+5C
79
0626
+5C
79
1351,20702
-20C
79
0046
+5C
79
Yes
+5C
79
+5C
79
Yes
-20C
180
+5C
79
79
+5C
79
1998
+5C
79
1998
+5C
79
+5C
79
+5C
79
+5C
79
79
+5C
79
+5C
79
2255, 2479
2479
The kit contains :1 vial BRP1 NDV reference antigen, 1 vial BRP1 NDV control
antigen, 1 vial BRP1 NDV coating antibody, 1 vial BRP1 NDV conjugated,
detection antibody
92.8% CHN x 2 CHO ; Batch 3 is valid until 1 May 2013
0870
1792
2599
54
Yes
Yes

Order
Reference Standard
Code
Y0001023 Nicotine for system suitability

Batch n
3
Quantity Sale
per vial Unit
1 mg
1
Information
Monograph
Leaflet
Storage
1452, 1792,
2599
Yes
-20C
N0700000 Nicotinic acid
100 mg
Y0001268 Nicotinic acid impurity mixture
0.12 mg
0459
N0750000 Nifedipine
50 mg
0627,1013
N0750010 Nifedipine impurity A
20 mg
Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)pyridine-3,5-dicarboxylate
N0750015 Nifedipine impurity B
20 mg
Dimethyl 2,6-dimethyl-4-(2-nitrosophenyl)pyridine-3,5-dicarboxylate
Y0000824 Niflumic acid
10 mg
Y0000825 Niflumic acid impurity A
10 mg
2-chloropyridine-3-carboxylic acid
Y0000826 Niflumic acid impurity B
10 mg
2-hydroxy-N-(3-(trifluoromethyl)phenyl)pyridine-3-carboxamide
Y0000827 Niflumic acid impurity E
15 mg
6-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid
Y0000836 Nifuroxazide
10 mg
N0800000 Nikethamide
1 ml
Y0000829 Nilutamide
110 mg
Y0000894 Nilutamide impurity B
5 mg
N0845000 Nimesulide
100 mg
1548
Y0001237 Nimesulide for peak identification
10 mg
1548
N0845008 Nimesulide impurity D
0.004 mg
N0850000 Nimodipine
50 mg
N0850010 Nimodipine impurity A
1 mL
N0900000 Nitrazepam - * psy
100 mg
N0900010 Nitrazepam impurity A
25 mg
N0905000 Nitrendipine
60 mg
Y0001456 Nitrendipine for peak identification
10 mg
N0905005 Nitrendipine impurity A
30 mg
N0930000 Nitric oxide - reference spectrum
n/a
N0950000 Nitrofural
100 mg
Y0001377 Nitrofural for peak identification
0.11 mg
N1000000 Nitrosotriaminopyrimidine
50 mg
N1090000 Nizatidine
250 mg
Y0001278 Nizatidine for system suitability
10 mg
N1090060 Nizatidine impurity F
10 mg
N1080000 Nomegestrol acetate
100 mg
50 mg
N1080005 Nomegestrol acetate impurity A

0459,0859
Extra
Price
charges
79
g(c)
+5C
79
+5C
79
+5C
79
0627
+5C
79
0627
+5C
79
2115
+5C
79
2215
+5C
79
2115
+5C
79
2115
+5C
79
1999
+5C
79
0233
+5C
79
100.0% CHFNO
2256
+5C
79
4-nitro-3-(trifluoromethyl)aniline
2256
+5C
79
+5C
79
+5C
79
1548
+5C
79
1245
+5C
79
+5C
79
0415,0898,11
21
+5C
79
0415
+5C
79
1246
+5C
79
+5C
79
+5C
79
79
4-nitro-2-phenoxyaniline ; Batch 3 is valid until 31 October 2012
1245
2-methoxyethyl 1-methylethyl 2,6-dimethyl-4-(3-nitrophenyl)

pyridine-3,5-dicarboxylate ; Batch 3 is valid until 1 June 2013
3-amino-6-nitro-4-phenylquinol-2-one
1246
ethyl methyl-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5- dicarboxylate;
(nitrophenylpyridine analogue)
Yes
Yes
Yes
Yes
1246
1550
99.8% CHNO
99.3% CHNOS
1135
+5C
79
1135
+5C
79
0058
+5C
79
1453
+5C
79
1453
(EZ)-N,N'-[thiazole-2,4-diylbis(methylenesulphanediylethylene)]bis(N'methyl-2-nitroethene-1,1-diamine)
6alpha-methyl-3,20-dioxo-19-norpregn-4-en-17-yl acetate
55
+5C
79
1453
Yes
+5C
79
1551
+5C
79
79
1551
+5C
a

Order
Code
Y0001314 1-nonadecanol
Reference Standard

Batch n
1
Quantity Sale
per vial Unit
400 mg
1
Information
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
0801,0802,08
47
+5C
1859,2336,23
37, 2529
+5C
79
1454
+5C
79
0254,0285,07
32, 2303
+5C
79
Y0000670 Nonivamide
10 mg
Y0000755 Nonoxinol 9
10 mg
N1100000 Noradrenaline tartrate
200 mg
Y0000681 Noradrenaline impurity D
15 mg
79
10 mg
4[(1R)-2-amino-1-methoxyethyl]benzene-1,2-diol (noradrenaline methyl ether) 0285,0732

2-chloro-1-(3,4-dihydroxyphenyl)ethanone
0285,0732
+5C
Y0000682 Noradrenaline impurity E
+5C
79
Y0000686 Noradrenaline impurity F
10 mg
N-benzyl-1-phenylmethanamine
0285,0732
+5C
79
N1130000 Norcyclobenzaprine
25 mg
0941
+5C
79
N1140000 Nordazepam -* psy
50 mg
0898,1466
+5C
79
N1200000 Norethisterone
50 mg
0234,1212,09
26
+5C
79
N1225000 Norethisterone acetate
100 mg
0850
+5C
79
Y0000522 Norethisterone for system suitability
10 mg
0234
-20C
79
N1230000 Norfloxacin
50 mg
1248
+5C
79
N1230010 Norfloxacin impurity A
20 mg
1460
+5C
79
Y0001015 Norfloxacin for system suitability
8 mg
1248
Yes
+5C
79
Y0001301 Norfloxacin for peak identification
10 mg
1248
Yes
+5C
79
Y0000724 Norgestimate
10 mg
1732
+5C
79
Y0000725 Norgestimate for system suitability
5 mg
1732
+5C
79
N1250000 Norgestrel
30 mg
0940
+5C
79
N1279000 Norpseudoephedrine hydrochloride - * psy
50 mg
0683
+5C
79
N1280000 Nortriptyline hydrochloride
10 mg
0941
+5C
79
Y0001296 Nortriptyline for system suitability
20 mg
0941
+5C
79
N1300000 Noscapine
100 mg
0102,0515,05
16
+5C
79
N1400000 Nystatin
100 mg
-20C
79
O0100900 Octoxinol 10
300 mg
1553
+5C
79
Y0000368 Octyl gallate
30 mg
2057
+5C
79
O0101000 Octyldodecanol
400 mg
O0120000 Ofloxacin
50 mg
O0120010 Ofloxacin impurity A
20 mg
O0120050 Ofloxacin impurity E
20 mg
99.1% CHNO
Dipotassium clorazepate impurity B
7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
(corresponding also to pefloxacin impurity F)
Cathine hydrochloride
0517,1292,20
702
5880 IU per mg ; Batch 6 is valid until 31 August 2013
Yes
Yes
Yes
1136
+5C
79
1455
+5C
79
(RS)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido [1,2,3-de][1,4]
benzoxazine-6-carboxylic acid (FPA)
1455
+5C
79
(RS)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido
[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
1455
+5C
79
94.8% CHO
56

Order
Code
Y0001370 Olanzapine
Reference Standard

Batch n
1
Y0001392 Olanzapine impurity A
Y0001380 Olanzapine for system suitability
Y0001204 Oleanolic acid

Y0001479 Oleic acid
Quantity Sale
Information
per vial Unit
200 mg
1 99.8% CHNS
5 mg
1 5-methyl-2-[(2-nitrophenyl)amino]thiophene-3-carbonitrile
Leaflet
Storage
2258
Yes
+5C
+5C
79
Yes
+5C
79
90.9% CHO
2472
Yes
+5C
79
98.3% CHO
2579
Yes
+5C
79
98.7 % CHO
2454
Yes
-20C
79
82.2% CHO
1878
+5C
79
100 mg
99.3 % CHNO
2600
Yes
+5C
79
10 mg
2600
Yes
+5C
79
20 mg
2000 mg
Y0001113 Triolein
30 mg
Y0000805 Oleuropein
20 mg
Y0001405 Olmesartan medoxomil
Y0001424 Olmesartan medoxomil for system suitability
2258
Extra
Price
charges
79
g
2258
10 mg
New O0146000 Olsalazine sodium
Monograph
70 mg
+5C
79
O0146010 Olsalazine sodium for performance test
60 mg
1457
Yes
+5C
79
O0150000 Omeprazole
50 mg
0942,1032
Yes
-20C
79
Y0001043 Omeprazole magnesium
10 mg
2374
+5C
79
Y0001042 Omeprazole for peak identification
10 mg
0942,2372,23
74
-20C
79
O0151000 Omeprazole impurity D
10 mg
Omeprazole sulphone
-20C
79
Y0000218 Ondansetron hydrochloride dihydrate
200 mg
89,9% CHClNO ; Batch 3 is valid until 1 June 2013
+5C
79
Y0000197 Ondansetron for LC system suitability
10 mg
2016
+5C
79
Y0000196 Ondansetron for TLC system suitability
30 mg
2016
+5C
79
Y0001345 Ondansetron impurity A
10 mg
(3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4Hcarbazol-4-one
2016
+5C
79
Y0000195 Ondansetron impurity D
10 mg
9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one
2016
+5C
79
Y0001326 Ondansetron impurity E
10 mg
Imidazole
2016
+5C
79
Y0001320 Ondansetron impurity F
10 mg
2016
+5C
79
Y0001346 Ondansetron impurity G
10 mg
2016
+5C
79
Y0001125 Orbifloxacin
200 mg
2259
+5C
79
Y0001147 Orbifloxacin impurity mixture
0.0008 mg
2259
+5C
79
O0180000 Orciprenaline sulfate
100 mg
1033,1332
+5C
79
Y0000895 Orciprenaline for system suitability
5 mg
1033
Yes
+5C
79
Y0001501 Orientvine stem HRS
600 mg
2450
Yes
+5C
79
Y0000100 Orphenadrine hydrochloride
100 mg
1760
+5C
79
Y0000101 Orphenadrine citrate
100 mg
1759
+5C
79
Y0001337 Oseltamivir phosphate (impurity B free)
300 mg
Y0001181 Orphenadrine for peak identification
0.42 mg
Y0001338 Oseltamivir impurity A
10 mg
1457
0942,1032
2016
(3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4Hcarbazol-4-one (C-demethylondansetron)
99.7% CHNOP
(3R,4R,5S)-5-acetamido-4-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1carboxylic acid
57
Yes
Yes
Yes
2422
Yes
+5C
79
1759,1760
Yes
+5C
79
+5C
79
2422

Order
Reference Standard
Code
Y0000102 Orphenadrine impurity E

Batch n
2
Quantity Sale
Information
per vial Unit
60 mg
1 (RS)-N,N-dimethyl-2-[(3-methylphenyl)phenylmethoxy] ethanamine (metamethylbenzyl isomer) ; Batch 1 is valid until 1 May 2013
Monograph
Leaflet
Storage
1759,1760
+5C
Extra
Price
charges
79
g
Y0001339 Oseltamivir impurity B
10 mg
ethyl (1R,2R,3S,4R,5S)-4-acetamido-5-amino-2-azido-3(1-ethylpropoxy)cyclohexanecarboxylate
2422
+5C
79
Y0001340 Oseltamivir impurity C
10 mg
(3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohex-1-ene-1carboxylic acid
2422
+5C
79
Y0001341 Oseltamivir impurity H
30 mg
tributylphosphane oxide
2422
+5C
79
Y0001207 Osthole
20 mg
98.3 % CHO
2557
Yes
+5C
79
O0200000 Ouabain
150 mg
80.0% CHO
0048
Yes
+5C
79
Y0000638 Oxacillin sodium monohydrate
110 mg
93.8% CHNNaOS
2260
Y0000560 Oxacillin for peak identification
10 mg
Y0000271 Oxaliplatin
+5C
79
2260
Yes
+5C
79
250 mg
99.9% CHNOPt ; Batch 3 is valid until 1 June 2013
2017
Yes
+5C
79
New Y0000272 Oxaliplatin impurity B
22 mg
94,4% CHNOPt; (SP-4-2)-diaqua[(1R,2R)-cyclohexane-1,2-diaminekN,kN']

platinum (diaquodiaminocyclohexaneplatinum) ; Batch 6 is valid until 31 July
2012
2017
Yes
+5C
79
Y0000273 Oxaliplatin impurity C
25 mg
(OC-6-33)-[(1R,2R)-cyclohexane-1,2-diamine-kN,kN'][ethane-dioato(2-)kO1,kO2]dihydroxyplatinum ; Batch 4 is valid until 1 April 2013
2017
+5C
79
New Y0000274 Oxaliplatin impurity D
10 mg
(SP-4-2)-[(1S,2S)-cyclohexane-1,2-diamine-kN,kN'][ethanedioato(2-)-kO1,kO2]platinum (S,S-enantiomer of oxaliplatin) ; Batch 3 is valid

until 31 December 2013
2017
+5C
79
O0225000 Oxazepam - * psy
50 mg
+5C
79
Y0000543 Oxazepam for peak identification
0.008 mg
Batch 1 is valid until 1 March 2013
0778
Yes
+5C
79
Y0001576 Oxcarbazepine
120 mg
99.8 % CHNO
2577
Yes
+5C
79
Y0001549 Oxcarbazepine impurity mixture
0.008 mg
2577
Yes
+5C
79
Y0000350 Oxeladin hydrogen citrate
50 mg
1761
+5C
79
Y0000404 Oxeladin impurity C
10 mg
2-(diethylamino)ethyl 2-ethyl-2-phenylbutanoate
1761
+5C
79
Y0000390 Oxeladin impurity D
20 mg
2-(2-diethylaminoethoxy)ethyl 2-phenyl-butyrate dihydrogen citrate
1761
+5C
79
O0225800 Oxfendazole for veterinary use
50 mg
1458
+5C
79
Y0000224 Oxfendazole impurity B
10 mg
1458
+5C
79
Y0000225 Oxfendazole with impurity D
10 mg
1458
+5C
79
Y0000709 Oxitropium bromide
50 mg
2170
+5C
79
Y0000715 Oxitropium bromide impurity B
15 mg
(1R,2R,4S,5S,7s)-7-[[(2S)-3-hydroxy-2-phenylpropanoyl]oxy]-9,9dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane (methylhyoscine)
2170
+5C
79
Y0000713 Oxitropium bromide impurity D
10 mg
(1R,2R,4S,5S,7s,9r)-9-ethyl-9-methyl-7-[(2-phenylprop-2-enoyl)oxy]-3oxa-9-azoniatricyclo[3.3.1.02,4]nonane (apo-N-ethylhyoscine)
2170
+5C
79
O0240000 Oxolinic acid
50 mg
1353
+5C
79
O0240005 Oxolinic acid impurity A
20 mg
1353
+5C
79
0778
methyl [5-(phenylsulphonyl)-1H-benzimidazole-2-yl]carbamate
8-hydroxy-1,3-dioxolo[4,5-g]quinoline-7-carboxylic acid
58

Order
Reference Standard
Code
O0240010 Oxolinic acid impurity B

Batch n
1
Quantity Sale
Information
per vial Unit
20 mg
1 ethyl 5-ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g]quinoline-7- carboxylate
Monograph
Leaflet
Storage
1353
+5C
Extra
Price
charges
79
a
O0250000 Oxprenolol hydrochloride
50 mg
0628,0876,10
72
+5C
79
O0260000 Oxibendazole
100 mg
1386
+5C
79
O0270000 Oxybuprocane hydrochloride
150 mg
1251
+5C
79
O0288000 Oxybutynin hydrochloride
150 mg
+5C
79
20 mg
+5C
79
Y0000492 Oxycodone hydrochloride - * narc
100 mg
1793
+5C
79
Y0000453 Oxycodone impurity D
50 mg
1793
+5C
79
O0290000 Oxymetazoline hydrochloride
80 mg
0943
+5C
79
Y0001044 Oxymetazoline impurity A
15 mg
N-(2-aminoethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy-2,6-dimethylphenyl]
acetamide
0943
+5C
79
O0400000 Oxytetracycline
100 mg
+5C
79
O0500000 Oxytetracycline hydrochloride
20 mg
O0700000 Oxytocin
1 mg
2 mg
about 0.1 mg oxytocin + 0.1 mg desmopressin per vial ; Batch 3 is valid until
30 November 2013
Y0000698 Paclitaxel
40 mg
99.4% CHNO
1794
Y0000699 Paclitaxel impurity C
5 mg
N-debenzoyl-N-hexanoylpaclitaxel
1794
Y0000700 Paclitaxel natural for peak identification
10 mg
1794
Y0000719 Paclitaxel semi-synthetic for peak identification
10 mg
1794
Y0000739 Paclitaxel semi-synthetic for system suitability
1.013 mg
1794
P0090000 Palmitic acid
100 mg
Y0000524 Pamidronate disodium pentahydrate
10 mg
P0100000 Pancreas powder (amylase and lipase) BRP
2000 mg
41.4 Ph. Eur. U. lipolytic activity per mg; 56.3 Ph. Eur. U. amylolytic activity
per mg
P0200000 Pancreas powder (protease) BRP
2000 mg
P0250000 Pancuronium bromide
20 mg
Y0000577 Pancuronium bromide for system suitability
20 mg
Y0000835 Pantoprazole sodium sesquihydrate
20 mg
New O0288005 Oxybutynin impurity A
New O0770000 Oxytocin/Desmopressin validation mixture
New Y0001001 Pantoprazole for system suitability
1354
90.7% CHNO; 4-(diethylamino)but-2-ynyl()-2-(cyclohex-3-enyl)-2cyclohexyl-2-hydroxyacetate ; Batch 3 is valid until 31 December 2013
7,8-didehydro-4,5 alpha-epoxy-14-hydroxy-3-methoxy -17methylmorphinan-6-one (14-hydroxycodeinone)
1354
0198,0199
Yes
0198,1030
+5C
79
0779,0780
-20C
g(c)
90
0712,0779,07
80
-20C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
Yes
+5C
79
+5C
79
+5C
79
Yes
0229,0882,14
74,
1663,2058,
1779
0350
Yes
+5C
79
1.48 Ph. Eur. U. per mg
0350
Yes
+5C
79
Vecuronium impurity B
0681,1769
+5C
79
0681
+5C
79
2296
+5C
79
0.5055 mg
P0270000 Papaverine hydrochloride
25 mg
P0300000 Paracetamol
50 mg
Y0000780 Paraffin (hard)
10 mg
Y0000058 Paraffin (liquid) - reference spectrum
n/a
0239,0240
Yes

59
+5C
79
0102,0573
2296
Yes
+5C
79
0049
+5C
79
1034
+5C
79
79

Order
Reference Standard
Code
Y0000913 Paraffin (White soft)

Batch n
1
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
Storage
1799
+5C
Extra
Price
charges
79
a
Y0000912 Paraffin (Yellow soft)
10 mg
1554
+5C
79
P0305000 Parnaparin sodium
250 mg
0828,1252
+5C
79
Y0000578 Paroxetine hydrochloride (anhydrous)
100 mg
2283
+5C
79
Y0000281 Paroxetine hydrochloride hemihydrate
200 mg
97.4% CHClFNO
2018,2283
+5C
79
Y0000233 Paroxetine impurity A
15 mg
(3S,4R)-3-[[1,3-benzodioxol-5-yloxy]methyl]-4-phenylpiperidine
(desfluoroparoxetine)
2018,2283
+5C
79
Y0000579 Paroxetine hydrochloride (anhydrous) impurity C
10 mg
(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-1-benzyl-4-(4-fluorophenyl)
piperidine (N-benzylparoxetine)
2283
+5C
79
Y0000256 Paroxetine impurity D
5 mg
(3R,4S)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine
((+)-trans-paroxetine)
2018,2283
+5C
79
Y0000580 Paroxetine impurity E
5 mg
(3RS,4RS)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4fluorophe- nyl)piperidine
(cis-paroxetine)
2283
+5C
79
Y0000581 Paroxetine hydrochloride (anhydrous) impurity H
10 mg
[(3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl]methanol
2283
+5C
79
Y0000630 Paroxetine for system suitability
5 mg
2018
+5C
79
P0309000 Pefloxacin mesilate dihydrate
200 mg
1460
+5C
79
P0309020 Pefloxacin impurity B
10 mg
1-ethyl-6-chloro-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3carboxylic acid (chlorinated homologue of pefloxacin)
1460
+5C
79
P0309030 Pefloxacin impurity C
0.01 mg
1-ethyl-6-fluoro-5-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3carboxylic acid (isopefloxacin)
1460
+5C
79
Y0001539 Pemetrexed disodium heptahydrate
200 mg
78.6 %
2637
+5C
79
Y0001538 Pemetrexed for system suitability
20 mg
2637
+5C
79
Y0001535 Pemetrexed impurity mixture
0.002 mg
2637
+5C
79
P0307000 Penbutolol sulfate
100 mg
1461
+5C
79
P0307005 Penbutolol impurity A
20 mg
1461
+5C
79
P0310000 Penicillamine
100 mg
0566
+5C
79
P0320000 Penicillamine disulfide
100 mg
93.0% CHNOS; 3,3-(disulphanediyl)bis[(2S)-2-amino-3methylbutanoic] acid
0566
+5C
79
P0400100 Pentaerythrityl tetranitrate diluted
600 mg
10.0% CHNO
1355
+5C
79
P0405000 Pentamidine diisetionate
30 mg
1137,1436
+5C
79
P0405500 Pentazocine - reference spectrum
n/a
1462
79
P0405510 Pentazocine hydrochloride - reference spectrum
n/a
1463
79
Y0000417 Pentazocine lactate - reference spectrum
n/a
2000
Y0001051 Pentetate sodium calcium
100 mg
2353
+5C
P0500000 Pentobarbital - * psy
500 mg
0200,0419
P0510000 Pentoxifylline
100 mg
0851
Y0000076 Pentoxyverine hydrogen citrate - reference spectrum
n/a
1621
(2S)-1-[2-(cyclopent-1-enyl)phenoxy]-3-[(1,1-dimethylethyl) amino]
propan-2-ol ; Batch 1 is valid until 7 February 2013
60
Yes
Yes
79
79
+5C
79
+5C
79
79

Order
Reference Standard
Code
Y0000098 Pentoxyverine impurity A
Y0000099 Pentoxyverine impurity B
Quantity Sale
Information
per vial Unit
10 mg
1 1-phenylcyclopentanecarboxylic acid
10 mg
1 2-(diethylamino)ethyl 1-phenylcyclopentanecarboxylate (caramiphen)
P0525000 Pepsin powder
2000 mg
0.99 Ph. Eur. U. per mg
0682
Y0000010 Pergolide mesilate
150 mg
99.9% CHNOS
1555
Y0000237 Perindopril impurity A
10 mg
(2S,3aS,7aS)-octahydro-1Hindole-2-carboxylic acid ; Batch 1 is valid until 1

May 2013
2019
Y0000207 Perindopril for stereochemical purity
40 mg
2019
Y0000238 Perindopril tert-butylamine
40 mg
2019
Y0000771 Perindopril for peak identification
5 mg
2019
P0550000 Perphenazine
100 mg
0629,0904
Y0001045 Perphenazine for system suitability
5 mg
0629
Yes
Y0000021 Pertussis toxin BRP
0.05 mg
See leaflet,
1356, 1595,
1931, 1932,
1933, 1934,
2065, 2067,
2329
Yes
P0600000 Pethidine hydrochloride - reference spectrum
n/a
P0600002 Pethidine impurity A
20 mg
P0800000 Phenazone
20 mg
Y0001138 Phenazone impurity A
20 mg
P0850000 Pheniramine maleate
250 mg
Y0001428 Pheniramine impurity A
20 mg
P0900000 Phenobarbital - * psy
200 mg
Y0001350 Phenobarbital impurity A
15 mg
Y0001351 Phenobarbital impurity B
15 mg
P0950000 Phenoxyethanol
1 mL
P1000000 Phenoxymethylpenicillin
250 mg
P1100000 Phenoxymethylpenicillin potassium
250 mg
Y0001127 Phentolamine mesilate
10 mg
1138
Y0001251 Phentolamine mesilate for system suitability
10 mg
1138
P1109000 Phentolamine mesilate - reference spectrum
n/a
1138
P1150000 Phenylalanine
60 mg
P1200000 Phenylbutazone
100 mg
Y0000147 Phenylbutazone impurity B
20 mg
P1240000 Phenylephrine
60 mg
Batch n
1
Monograph
Leaflet
1621
Storage
+5C
1621
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
-20C
g(d)
90
79
0420
+5C
79
0421
+5C
79
0421
+5C
79
1357
+5C
79
1357
+5C
79
0189,0201,06
30
+5C
79
Yes
Yes
Yes
0420
1-methyl-4-phenylpiperidine (MPP)
5-methyl-2-phenyl-2,4-dihydro-3-pyrazol-3-one
2-benzylpyridine
79.1% CHNO
99.2% CHKNOS
(4-butyl-4-hydroxy-1,2-diphenyl-3,5)-pyrazolidinedione
61
Extra
Price
charges
79
a
0201
+5C
79
0201
+5C
79
0781
+5C
79
0148
+5C
79
+5C
79
+5C
79
+5C
79
79
0782,0796,11
61,2575
+5C
79
0422,1574
+5C
79
0422
+5C
79
1035
+5C
79
0113,0114,01
48, 0149
Yes
Yes
Yes

Order
Reference Standard
Code
P1250000 Phenylephrine hydrochloride

Batch n
3
Quantity Sale
per vial Unit
50 mg
1
Information
Monograph
+5C
0632,1035
+5C
2 mg
Y0000229 Phenylmercuric acetate - reference spectrum
n/a
P1255100 Phenylmercuric borate - reference spectrum
n/a
P1260000 Phenylpropanolamine hydrochloride - * Drug Precursor
50 mg
P1290000 Phenytoin
100 mg
1253,1988
Y0001167 Phenytoin for system suitability
20 mg
0521,1253
P1300000 Phenytoin sodium
250 mg
Y0000493 Phloroglucinol (anhydrous)
210 mg
Y0000761 Pholcodine - * narc
10 mg
0522
Y0000798 Pholcodine for peak identification - * narc
10 mg
0522
Y0000766 Phthalic acid
20 mg
P1500000 Phthalylsulfathiazole
100 mg
P1600000 Physostigmine salicylate
100 mg
P1605000 Physostigmine sulfate
100 mg
P1609000 Phytomenadione
150 mg
P1609010 trans-Epoxyphytomenadione
10 mg
P1645000 Picotamide monohydrate
125 mg
P1645005 Picotamide impurity A
25 mg
Y0001508 Picrotin
40 mg
Y0001528 Picrotoxinin
40 mg
Y0000124 Pidolate impurity B
60 mg
Y0000123 Pidolic acid
125 mg
P1650000 Pilocarpine hydrochloride
50 mg
P1700000 Pilocarpine nitrate
50 mg
Y0000106 Pilocarpine nitrate for system suitability
20 mg
Y0000525 Pimobendan
Y0000401 Pimobendan for system suitability
P1750000 Pimozide
150 mg
P1800000 Pindolol
100 mg
Y0001520 Pioglitazone hydrochloride
120 mg
Y0001519 Pioglitazone for system suitability
15 mg
Y0001476 Pipemidic acid trihydrate
15 mg
Y0000061 Pipemidic acid trihydrate - reference spectrum
n/a
P1890000 Piperacillin
100 mg
Storage
0632,1205
Y0000683 Phenylephrine hydrochloride for peak identification
Leaflet
2042
0103
Extra
Price
charges
79
a
a
79
79
79
+5C
79
+5C
79
+5C
79
0521
+5C
79
2301,2302
+5C
79
+5C
79
+5C
79
2348
+5C
79
0352
+5C
79
0286
+5C
79
0684
+5C
79
+5C
79
1036
+5C
79
1358
+5C
79
0683
Norephedrin hydrochloride
benzene-1,2-dicarboxylic acid
87.0% trans-phytomenadione, 12.6% cis-phytomenadione, 0.09% transepoxyphytomenadione CHO; Vitamin K1
1036
Yes
Yes
Yes
1358
+5C
79
2486
Yes
+5C
79
98.3 % CHO
2486
Yes
+5C
79
(2S)-2-[[[(2S)-5-oxopyrrolidin-2-yl]carbonyl]amino]pentane-dioic acid
1619
+5C
79
1619
+5C
79
0633
+5C
79
0104
+5C
79
0104,0633
+5C
79
10 mg
2179
+5C
79
0.1 mg
2179
+5C
79
1254
+5C
79
0634,0871,17
89
+5C
79
4-methoxybenzene-1,3-dicarboxylic acid
2601
Yes
+5C
79
2601
Yes
+5C
79
1473
+5C
79
79
+5C
79
99.8% CHClNOS
1743
94.5% CHNOS
62
1168,1169

Order
Reference Standard
Code
P1900000 Piperazine adipate

Batch n
1
Quantity Sale
per vial Unit
250 mg
1
Information
Monograph
Leaflet
Storage
0423
+5C
Extra
Price
charges
79
g
P2000000 Piperazine citrate
250 mg
0424
+5C
79
P2100000 Piperazine hydrate
250 mg
0425
+5C
79
Y0001217 Piperine
30 mg
99.0% CHNO
+5C
79
150 mg
+5C
79
Y0000038 Pirenzepine dihydrochloride monohydrate
250 mg
2001
+5C
79
P2120000 Piretanide
100 mg
1556
+5C
79
Y0001458 Piretanide for system suitability
10 mg
+5C
79
P2120002 Piretanide impurity A
20 mg
4-phenoxy-3(1H-pyrrol-1-yl)-5-sulphamoylbenzoic acid
1556
+5C
79
P2130000 Piroxicam
50 mg
0944
+5C
79
Y0001475 Piroxicam for system suitability
15 mg
Y0001475 replaces P2130100
0944
+5C
79
P2150000 Pivampicillin
50 mg
99.2% CHNOS
0808,0852
+5C
79
P2152000 Pivmecillinam hydrochloride
100 mg
99.6% CHClNOS
1359
-20C
79
P2152015 Pivmecillinam impurity C
10 mg
methylene 2,2-dimethylpropanoate (2RS,4S)-2-[[[(hexahydo- 1H-azepin-1-yl)

methylene]amino]methyl]-5,5-dimethylthiazolidin-4-carboxylate
1359
+5C
79
P2155001 Plastic additive 01
2 ml
(2RS)-2-ethylhexyl) benzene-1,2-dicarboxylate
90001,90002,
30114
+5C
79
100 mg
N,N'-ethylenedialcanamide
90001,30114
+5C
79
E0800000 Plastic additive 04
500 mg
Epoxidised soya oil
90001,30114
+5C
79
500 mg
Epoxidised linseed oil
90001,30114
+5C
79
500 mg
ethylene bis[3,3-bis[3-(1,1-dimethylethyl)-4-hydroxyphenyl]butanoate]
30103,30104,
30105,30106
+5C
79
250 mg
pentaerythrityl tetrakis[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate]
30103,30105,
30106,30107
+5C
79
250 mg
4,4',4''-(2,4,6-trimethylbenzene-1,3,5-triyltrismethylene)trio[2,6-bis(1,1dimethylethyl)phenol]
30103,30105,
30106,30107
+5C
79
500 mg
Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate
30103,30105,
30106,30107
+5C
79
250 mg
Tris (2,4-di-1,1-dimethylethylphenyl) phosphite R
30103,30105,
30106,30107
+5C
79
250 mg
1,3,5-tris(3,5-di-1,1-dimethylethyl-4-hydroxybenzyl)-1H,3H,5H-1,3,5triazine-2,4,6-trione
30103,30105,
30106
+5C
79
250 mg
2,2'-Di(octadecycloxy)-5,5'-spirobi(1,3,2-dioxaphosphorinane) R
30103,30105,
30106
+5C
79
500 mg
Dioctadecyl disulphide ; Batch 1 is valid until 29 August 2012
30103,30104,
30105,30106
+5C
79
250 mg
Didodecyl 3,3'-thiodipropionate R
30103,30105,
30106
+5C
79
250 mg
Dioctadecyl 3,3'-thiodipropionate R
New Y0000288 Piracetam
2453,2477
1733
1556
63
Yes
Yes
Yes
Yes
79
30103,30105,
+5C
a
30106

Order
Reference Standard
Code

Batch n
1
Quantity Sale
per vial Unit
100 mg
1
Information
Monograph
Leaflet
Storage
30103
+5C
Extra
Price
charges
79
a
O0140000 Plastic additive 20
100 mg
Oleamide R
30103,30105,
30106,30107
+5C
79
E1260000 Plastic additive 21
100 mg
Erucamide R
30103,30107
+5C
79
100 mg
Copolymer of dimethyl butanedioate and 1-(2-hydroxyethyl)-2,2,6,6tetramethylpiperidin-4-ol

Synonyms: copolymer of dimethyl succinate and (4-hydroxy-2,2,6,6tetramethylpiperidin-1-yl)ethanol
30103
+5C
79
200 mg
di(isooctyl)2,2'-[(dioctylstannylene)bis(thio)]diacetate
containing about 27% of (tri(isooctyl)2,2',2''- [monooctyl- stannylidyne)tris
(thio)] triacetate.
Tin-content of 15.4%
30110,30111
+5C
79
P2160000 Poliomyelitis vaccine (inactivated) BRP
0.5 ml
320-67-282 Ph. Eur. D-Antigen Units per ml for types 1-2-3, respectively
0214,2066,20
65,
2328,2061,20
67,
1934,2329,20
720
Yes
-80C
90
P2161000 Poliomyelitis vaccine (oral) BRP
1 ml
log CCID50/ml for types 1,2,3 and total virus content: 6.99, 6.06, 6.83 and
7.20, respectively
See leaflet,
0215
Yes
-20C
90
P2163920 Poloxamer 124
30 mg
1464
+5C
79
100 mg
1464
+5C
79
100 mg
1464
+5C
79
100 mg
1464
+5C
79
100 mg
1464
+5C
79
P2170000 Polyacrylate - reference spectrum
n/a
79
P2400000 Polymyxin B sulfate
25.1 mg
65.1% polymyxin B1, 12.5% polymyxin, 3.3% polymyxin B3, 9.1% polymyxin
B1-I
0203
+5C
79
Y0000355 Polymyxin B sulfate for microbiological assay
25 mg
205000 IU per vial
20702
-20C
79
Y0000289 Polysorbate 20 - reference spectrum
n/a
0426
79
n/a
1914
79
n/a
0427
79
n/a
0428
79
Y0001557 Poly (vinyl acetate)
100 mg
1962
+5C
79
Y0000792 Poly(vinyl acetate) dispersion 30 per cent
1500 mg
2152
+5C
79
Y0001550 Poly(vinyl alcohol)
100 mg
1961
+5C
79
P2600000 Poly(vinyl chloride)
100 mg
90001,90002,
30114
+5C
79
P2649610 Potassium clavulanate - reference spectrum
n/a
1140
79
Y0001168 Potassium clavulanate impurity G
5 mg
1653
g(c)
79
0733
64
Yes
-20C

Order
Reference Standard
Code
Y0000315 Potassium hydrogen aspartate hemihydrate

Batch n
1
Quantity Sale
per vial Unit
50 mg
1
Information
Monograph
2076
P2650000 Potassium sorbate
100 mg
0618
Y0001275 Potassium sucrose octasulfate
100 mg
92.6% CHKOS
1796
P2660000 Povidone
50 mg
Y0000466 Povidone (iodinated)
10 mg
Y0001266 Pramipexole dihydrochloride monohydrate
5 mg
2416
Y0001187 Pramipexole for system suitability
15 mg
2416
Y0001267 Pramipexole impurity D
5 mg
Y0000215 Pravastatin sodium - reference spectrum
n/a
Y0000223 Pravastatin impurity A
0.1 mg
(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6R,8S,8aR)-6-hydroxy-2-methyl-8[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]
heptanoic acid (6'-epipravastatin)
2059
Y0000204 Pravastatin 1,1,3,3-tetramethylbutylamine
30 mg
76.4% CHO
2059
P2669000 Prazepam -* psy
50 mg
P2670000 Praziquantel
200 mg
Y0001533 Praziquantel for system suitability
10 mg
P2675000 Praziquantel impurity A
10 mg
P2680000 Prazosin hydrochloride
50 mg
P2698000 Prednicarbate
100 mg
Y0001443 Prednicarbate for system suitability
10 mg
P2700000 Prednisolone
150 mg
Y0001359 Prednisolone for peak identification
10 mg
Y0001355 Prednisolone for system suitability
10 mg
P2800000 Prednisolone acetate
120 mg
Y0000582 Prednisolone acetate for peak identification
10 mg
0734
P2804000 Prednisolone hexanoate
10 mg
1212
P2805000 Prednisolone pivalate
100 mg
P2810000 Prednisolone sodium phosphate
100 mg
P2900000 Prednisone
100 mg
P2920000 Pregnenolone isobutyrate
200 mg
Y0000263 Prekallikrein activator in albumin BRP
1 mL
Leaflet
(6R)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine
Storage
+5C
+5C
79
+5C
79
0685
+5C
79
1142
+5C
79
+5C
79
+5C
79
+5C
79
79
-20C
79
-20C
79
Yes
Yes
2416
2059
99.8% CHNO
Yes
1466
+5C
79
0855
+5C
79
0855
(11bRS)-2-benzoyl-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]
isoquinolin-4-one
Extra
Price
charges
79
a
+5C
79
0855
Yes
+5C
79
0856
+5C
79
1467
+5C
79
1467
Yes
+5C
79
0335,0353,03
54, 0735
Yes
+5C
79
0353
Yes
+5C
79
0353
Yes
+5C
79
+5C
79
+5C
79
+5C
79
0734,0736
+5C
79
0549,0735,08
10
+5C
79
0354
+5C
79
0593,0993,23
97
-20C
79
-20C
90
99.1% CHO
99.2% CHO; Prednisolone CRS 6 is suitable for monographs
01/2011:0335, 01/2008:0353, 01/2008:0354 and 01/2008:0735 only.
0734,0736,09
33,
0975,1467,03
34
See leaflet,
20615
30 IU per vial
65
Yes
Yes

Order
Code
P2939000 Prilocaine
Reference Standard

Batch n
1
Quantity Sale
per vial Unit
150 mg
1
Information
Monograph
Leaflet
Storage
1362
+5C
Extra
Price
charges
79
a
P2939060 Prilocaine hydrochloride
100 mg
1363
+5C
79
Y0001408 Prilocaine impurity B
80 mg
2-methylbenzenamine hydrochloride
1362,1363
+5C
79
P2939025 Prilocaine impurity E
25 mg
(RS)-N-(methylphenyl)-2-(propylamino)propanamide
1362,1363
+5C
79
P2940000 Primaquine diphosphate
500 mg
0635
+5C
79
P2950000 Primidone
150 mg
99.9% CHNO
0584
Yes
+5C
79
Y0000369 Primidone for peak identification
5 mg
0584
Yes
+5C
79
P3000000 Probenecid
100 mg
0243
+5C
79
P3050000 Procainamide hydrochloride
100 mg
0567
+5C
79
P3090000 Procaine benzylpenicillin
250 mg
0115
+5C
79
P3100000 Procaine hydrochloride
100 mg
0050
+5C
79
P3200000 Prochlorperazine maleate
100 mg
0244,20303
+5C
79
P3300000 Progesterone
50 mg
0429
+5C
79
Y0000148 Progesterone impurity C
10 mg
0429
+5C
79
Y0000179 Proguanil hydrochloride - reference spectrum
n/a
79
Y0000181 Proguanil impurity C
10 mg
1,5-bis(4-chlorophenyl)biguanide
2002
+5C
79
Y0000182 Proguanil impurity D
10 mg
1,5-bis(1-methylethyl)biguanide
2002
+5C
79
P3350000 Proline
60 mg
0785,0910,09
11, 1049
+5C
79
P3390000 Promazine hydrochloride
100 mg
0475,1365,20
303
+5C
79
P3400000 Promethazine hydrochloride
50 mg
0524
+5C
79
Y0000769 Promethazine impurity D
10 mg
0524
+5C
79
Y0000797 Promethazine for peak identification
10 mg
0524
+5C
79
P3490000 Propacetamol hydrochloride - reference spectrum
n/a
1366
79
Y0000455 Propafenone hydrochloride
10 mg
Y0000456 Propafenone impurity B
10 mg
Y0000278 Propanol - reference spectrum
n/a
Y0000016 Propofol
370 mg
Y0000017 Propofol for peak identification
0.1 ml
Y0000018 Propofol impurity J
20 mg
P3500000 Propranolol hydrochloride
30 mg
P3600000 Propranolol hydrochloride for performance test
20 mg
0568
Y0001547 Propylene glycol
150 mg
1804,2645
Y0000318 Propylene glycol dilaurate
100 mg
Y0000319 Propylene glycol monolaurate
100 mg
39.7% CHNO (procaine); 96.3% CHNOS
(20R)-20-hydroxypregn-4-en-3-one
2002
(2RS)-N,N-dimethyl-1-(10H-phenothiazin-10-yl)propan-2-amine S-oxide
(2E)-1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3phenylprop-2-en-1-one
Yes
2103
+5C
79
2103
+5C
79
79
2036
99.8% CHO ; Batch 4 is valid until 1 May 2013
2,6-bis (1-methylethyl)-1,4-benzoquinone
66
1558
+5C
79
1558
Yes
+5C
79
1558
+5C
79
0568,0923
+5C
79
+5C
79
+5C
79
2087
+5C
79
1915
+5C
79
Yes

Order
Code
P3640000 Propyl gallate
Reference Standard

Batch n
2
Quantity Sale
per vial Unit
50 mg
1
Information
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
1039
+5C
0431,0852,12
63
+5C
79
P3650000 Propyl parahydroxybenzoate
150 mg
P3700000 Propylthiouracil
100 mg
0525
+5C
79
P3750000 Propyphenazone
200 mg
0636
+5C
79
P3760000 Protirelin
5.03 mg
5.03 mg per vial of pure protirelin peptide CHNO
1144
-20C
79
P3760020 D-His-Protirelin
0.1 mg
approx. 0.1 mg per vial
1144
-20C
79
P3800000 Proxyphylline
100 mg
0526
+5C
79
P3850000 Pseudoephedrine hydrochloride - * Drug Precursor
50 mg
0487,1367
+5C
79
Y0000387 Pseudoisoeugenyl 2-methylbutyrate for peak identification
100 mg
Star anise oil
2108
Yes
+5C
79
Y0001537 Purified quillaia saponins
30 mg
1843
Yes
-20C
79
P3900000 Purpureaglycoside A
25 mg
0117
+5C
79
P4000000 Purpureaglycoside B
25 mg
0117
+5C
79
Y0000402 Pyrantel embonate
10 mg
1680
+5C
79
Y0000403 Pyrantel impurity A
20 mg
1680
+5C
79
P4050000 Pyrazinamide
30 mg
0859
+5C
79
P4099900 Pyridostigmine bromide
30 mg
1255
+5C
79
P4099910 Pyridostigmine impurity A
20 mg
pyridin-3-yl-dimethylcarbamate
1255
+5C
79
Y0001486 Pyridostigmine impurity B
10 mg
3-hydroxy-1-methylpyridinium
1255
+5C
79
P4100000 Pyridoxine hydrochloride
100 mg
0245
+5C
79
Y0001226 Pyridoxine impurity A
5 mg
0245
+5C
79
P4200000 Pyrimethamine
250 mg
0288
+5C
79
Y0000659 Pyrrolidone
20 mg
2180
+5C
79
Y0001009 Quercetin dihydrate
25 mg
1827
Yes
+5C
79
Y0001564 Quillaia saponin assay
30 mg
64.9 % CHNO; monoammonium glycyrrhizate
1843
Yes
+5C
79
Y0001491 Quinapril hydrochloride
30 mg
1763
+5C
79
Y0001502 Quinapril for peak identification
5.075 mg
1763
Yes
+5C
79
Y0001503 Quinapril for system suitability
5.125 mg
1763
Yes
+5C
79
Q0100000 Quinidine sulfate
300 mg
0017,0018,00
19
+5C
79
Q0200000 Quinine sulfate
300 mg
0017,0018,00
19
+5C
79
R0100000 Rabies vaccine (inactivated) for veterinary use BRP
86 mg
11 IU per vial
-20C
90
Y0000896 Racecadotril
110 mg
99.9% CHNOS
2171
+5C
79
Y0000897 Racecadotril impurity A
1.1 mL
92,8% CHCOSH; ethanethioic acid ; Batch 1 is valid until 1 July 2013
2171
+5C
79
Y0000898 Racecadotril impurity G
10 mg
benzyl [[(2RS)-2-benzyl-3-sulfanylpropanoyl]amino]acetate
2171
+5C
79
99.9% CHO
1-methyl-2-[(Z)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine
6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol
See leaflet,
0451
67
Yes
Yes

Order
Reference Standard
Code
Y0000902 Racecadotril for peak identification

Batch n
1
Quantity Sale
per vial Unit
5 mg
1
Information
Y0001134 Raloxifene hydrochloride
110 mg
Y0001135 Raloxifene hydrochloride for peak identification
10 mg
R0145000 Ramipril
20 mg
R0145005 Ramipril impurity A
10 mg
(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(methoxycarbonyl)-3- phenylpropyl]amino]
propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (ramipril
methylester)
R0145010 Ramipril impurity B
10 mg
R0145015 Ramipril impurity C
10 mg
R0145020 Ramipril impurity D
R0150000 Ranitidine hydrochloride

Y0000416 Ranitidine impurity J
Monograph
Leaflet
Storage
2171
Yes
+5C
+5C
79
+5C
79
1368
+5C
79
1368
+5C
79
(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-[(methylethoxy)carbonyl]-3- phenylpropyl]
amino]propanoyl]octahydrocyclopenta[b]pyrrole- 2-carboxylic acid (ramipril
isopropyl ester)
1368
+5C
79
(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-(ethoxycarbonyl)-3-cyclohexylpropyl]amino]
propanoyl]octahydrocyclopenta[b]pyrrole-2- carboxylic acid
(hexahydroramipril)
1368
+5C
79
10 mg
1368
+5C
79
100 mg
ethyl (2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro -1Hcyclopenta[e]pyrrolo[1,2a]pyrazin-2-yl]-4-phenylbutanoate (ramipril

diketopiperazine)
0946,1453
+5C
79
0.00025
mg
0946
-20C
79
Y0000411 Ranitidine for system suitability
20 mg
0946
+5C
79
Y0000457 Repaglinide
20 mg
2135
+5C
79
Y0000458 Repaglinide for system suitability
6 mg
2135
+5C
79
Y0000459 Repaglinide impurity E
10 mg
2-ethoxy-4-[2-[[(1R)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2oxoethyl]benzoic acid
+5C
79
R0200000 Reserpine
100 mg
99.8% CHNO
R0250000 Residual solvents solution class 1
1.4 mL
Y0000767 Resorcinol
20 mg
benzene-1,3-diol
R0300000 Retinol acetate
1000 mg
1 050 000 IU per g
R0290000 Retinol esters
100 mg
R0500500 Reviparin sodium
250 mg
Y0000377 Ribavirin
150 mg
99.9% CHNO
R0600000 Riboflavin
130 mg
Vitamin B2 ; Batch 3 is valid until 31 August 2013
Y0000757 Riboflavin for peak identification
0.12 mg
R0630000 Riboflavin sodium phosphate
250 mg
Y0000662 Ribonucleic acid
100 mg
Y0000149 Rifabutin
150 mg
Y0000184 Rifabutin impurity A
20 mg
R0700000 Rifampicin
100 mg
2375
Extra
Price
charges
79
a
99.7% CHClNOS
2375
1,1'-N-[methylenebis(sulphanediylethylene)]bis(N'-methyl-2-nitroethene-1,1diamine)
Yes
Yes
Yes
2135
0528
+5C
79
Yes
+5C
79
+5C
79
Yes
-20C
79
0217,0218,02
19, 0220
+5C
79
0828
+5C
79
+5C
79
+5C
79
20424
2348
0218,0219,02
20, 1192,1193
2109
Yes
0292,0786
+5C
79
0786
+5C
79
100.0 %
2090
+5C
79
95.5% CHNO
1657
+5C
79
1-(2-methylpropyl)piperidin-4-one
1657
+5C
79
0052
+5C
79
68
0292
Yes

Order
Reference Standard
Code
R0800000 Rifampicin quinone

Batch n
4
Quantity Sale
per vial Unit
100 mg
1
Information
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
0052
+5C
0432
+5C
79
0432
+5C
79
0432,20702
-20C
79
2362
+5C
79
+5C
79
79
R0900000 Rifamycin B
50 mg
R0950000 Rifamycin S
50 mg
R1000000 Rifamycin sodium
300 mg
856 IU per mg
Y0001074 Rifaximin
160 mg
98.0% CHNO
Y0001075 Rifaximin for system suitability
10 mg
2362
Y0000250 Rilmenidine dihydrogenophosphate - reference spectrum
n/a
2020
Y0000187 Rilmenidine for system suitability
30 mg
2020
+5C
79
Y0001541 Risedronate sodium 2.5-hydrate
15 mg
2572
+5C
79
Y0001558 Risedronate impurity A
15 mg
78.4 %
2572
+5C
79
Y0001540 Risedronate impurity E
15 mg
2-(pyridin-3-yl)ethane-1,1-diyl]bis(phosphonic acid)
2572
+5C
79
R1000600 Risperidone
50 mg
1559
+5C
79
Y0000370 Risperidone for system suitability
20 mg
1559
+5C
79
Y0001276 Risperidone impurity K
0.015 mg
3-[2-[4-(1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9tetrahydro-4Hpyrido[1,2-a]pyrimidin-4-one (desfluoro risperidone) ; Batch 1

is valid until 30 November 2013
1559
+5C
79
Y0000714 Ritonavir
80 mg
99.6% CHNOS
2136
+5C
79
Y0000706 Ritonavir for peak identification
10 mg
Y0001516 Rivastigmine hydrogen tartrate
350 mg
Y0001485 Rivastigmine for system suitability
1.0114 mg
Y0001515 Rivastigmine impurity D
10 mg
3-[(1R)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate ((R)enantiomer)
Y0001302 Rizatriptan benzoate
200 mg
99.8% CHNO
Y0001303 Rizatriptan for system suitability
15 mg
R1300000 RK 13 cells
1 ml
Y0000594 Rocuronium bromide - reference spectrum
n/a
1764
Y0000527 Rocuronium for peak identification
10 mg
1764
Y0000742 Ropivacaine hydrochloride monohydrate
10 mg
2335
Y0000743 Ropivacaine impurity G
5 mg
(+)-(2R)-N-(2,6-dimethylphenyl)-1-propylpiperidine-2-carboxamide ((R)ropivacaine)
2335
Y0000786 Rosmarinic acid
50 mg
89.5% CHO ; Batch 1 is valid until 28 February 2013
R1500000 Roxithromycin
125 mg
96.7% CHNO
Y0000220 Roxithromycin for system suitability
5 mg
R2000000 Rubella vaccine (live) BRP
90 mg
3.6 log (ie 4000) infective viral units per vial
Y0000494 Ruscogenins
10 mg
38.2% ruscogenin
60.4% neoruscogenin
Rifamycin impurity A
99.9% CHNO
cell lines (kidney, rabbit) titration of live measles, mumps and rubella
vaccines
69
Yes
Yes
Yes
2136
Yes
+5C
79
2629,2630
Yes
+5C
79
2629,2630
Yes
+5C
79
2629,2630
Yes
+5C
79
2585
Yes
+5C
79
2585
Yes
+5C
79
0162,1057
Yes
Liquid
nitrogen
100
79
-20C
g(c)
79
+5C
79
+5C
79
+5C
79
1146
+5C
79
1146
+5C
79
1447,2382,
2524
Yes
Yes
1057,0162
Yes
-80C
90
1847
Yes
+5C
79

Order
Code
S0040000 Saccharin
Reference Standard

Batch n
1
Quantity Sale
per vial Unit
30 mg
1
Information
Monograph
Leaflet
Storage
0947
+5C
Extra
Price
charges
79
a
S0050000 Saccharin sodium
50 mg
0787
+5C
79
S0100000 Salbutamol
50 mg
0529,1033
+5C
79
Y0000030 Salbutamol impurity B
10 mg
(1RS)-2-[(1,1-dimethylethyl)amino]-1-(4-hydroxyphenyl)ethanol
; Batch 4 is valid until 30 September 2013
0529
+5C
79
Y0000071 Salbutamol impurity D
10 mg
5-[(1RS)-2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2hydroxybenzaldehyde ; Batch 4 is valid until 31 January 2013
0529,0687
Yes
+5C
79
Y0000031 Salbutamol impurity F
10 mg
93.4% CHNO x HSO; 1,1'-[oxybis[methylene(4-hydroxy-1,3phenylene)]]bis[2-[(1,1- dimethylethyl)amino]ethanol]
0529,0687
Yes
+5C
79
Y0000034 Salbutamol impurity G
5 mg
2-[benzyl(1,1-dimethylethyl)amino]-1-[4-hydroxy-3-(hydroxymethyl)phenyl]
ethanone
0529
+5C
79
Y0000032 Salbutamol impurity I
0.006 mg
(1RS)-2-[(1,1-dimethylethyl)amino]-1-[3-(hydroxymethyl)-4benzyloxyphenyl]ethanol
0529
+5C
79
Y0001186 Salbutamol impurity J
0687
+5C
79
S0150000 Salbutamol sulfate
50 mg
0687
+5C
79
Y0001288 Salbutamol sulfate for system suitability
10 mg
Y0000669 Salicin
50 mg
S0200000 Salicylic acid
100 mg
Y0000405 Salicylic acid impurity B
10 mg
4-hydroxyisophthalic acid
Y0000422 Salmeterol xinafoate
50 mg
99.6% CHNO
1765
Y0000423 Salmeterol xinafoate for system suitability
25 mg
1765
Y0001559 Salvianolic acid B
15 mg
92.2 % CHO
2663
Y0001052 Santonin
20 mg
99.8% CHO
Y0001049 Saquinavir mesilate
70 mg
99.5% CHNOS
Y0001056 Saquinavir for system suitability
0.3033 mg
Y0001483 Saw palmetto extract HRS
8000 mg
Y0000814 Selamectin
100 mg
Y0000815 Selamectin for system suitability
5 mg
2268
S0360000 Selegiline hydrochloride
50 mg
1260
S0360090 (RS)-Selegiline hydrochloride
25 mg
S0400000 Senna extract
50 mg
S0450000 Serine
50 mg
0788,1027
S0460000 Sertaconazole nitrate
125 mg
1148
Y0000828 Sertraline hydrochloride
200 mg
99.9% CHClN
1705
Yes
Y0001285 Sertraline impurity E
15 mg
Mandelic acid CRS has been labelled as sertraline impurity E CRS in

anticipation of 01/2011:1705 corrected 7.1
1705
Y0000866 Sertraline for peak identification
5.4 mg
1705
0.00045 mg 1
0687
99,6% CHO
Yes
79
+5C
79
0366,1185
+5C
79
0366
+5C
79
Yes
+5C
79
Yes
+5C
79
Yes
+5C
79
+5C
79
+5C
79
+5C
79
1391,1809
2267
2267
Yes
1848
Yes
79
+5C
79
+5C
79
+5C
79
1260
+5C
79
0206,0207,02
08, 1261
-20C
79
+5C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
2268
97.6% CHNO
70
+5C
2312,1583
Yes

Order
Reference Standard
Code
Y0000867 Sertraline for system suitability

Batch n
2
Quantity Sale
per vial Unit
6.18 mg
1
Information
Monograph
Leaflet
1705
Storage
+5C
Extra
Price
charges
79
g
Y0000371 Sestamibi labelling kit
22 mg
1926
Yes
+5C
79
Y0001046 Sevoflurane
1 ml
2269
Yes
+5C
g(b)
79
Y0001578 Sildenafil citrate
100 mg
98.8 % CHNOS
2270
Yes
+5C
79
Y0001579 Sildenafil impurity A
10 mg
5-[2-ethoxy-5[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-(2methylpropyl)-6,7-dihydro-1H-pyrazol[4,3-d]pyrimidin-7-one
2270
+5C
79
S0500000 Silicone elastomer
2000 mg
30109
+5C
79
S0600000 Silicone oil
1 ml
S0650000 Simvastatin
100 mg
Y0001066 Simvastatin for peak identification
10 mg
Y0001208 Sinomenine
20 mg
81.8 % CHNO
S0660000 Sisomicin sulfate
60 mg
Y0000014 Sodium alendronate
150 mg
S0695000 Sodium amidotrizoate
125 mg
Y0000300 Sodium aminosalicylate dihydrate - reference spectrum
n/a
Y0000039 Sodium ascorbate
S0700000 Sodium calcium edetate
S0710000 Sodium cetostearyl sulfate
S0750000 Sodium cromoglicate
Y0001300 Sodium cromoglicate for system suitability

S0760000 Sodium cyclamate
New S0765000 Diclofenac sodium
+5C
79
1538,1563
30108
Yes
-20C
g(c)
79
1563
Yes
-20C
g(c)
79
2450
Yes
+5C
79
77.7% CHNOS
0331,1351
Yes
-20C
79
83.3% CHNNaOP
1564
+5C
79
1150
+5C
79
1993
79
50 mg
1791
+5C
79
100 mg
0231
+5C
79
100 mg
0847
+5C
79
10 mg
0562
+5C
79
20 mg
0562
+5C
79
100 mg
0774
+5C
79
99.4% CHO
100 mg
1002,1281
+5C
79
Y0001410 Sodium fusidate
10 mg
0848
+5C
79
S0781000 Sodium hyaluronate - reference spectrum
n/a
1472
79
S0780000 Sodium hyaluronate BRP
300 mg
0912
+5C
79
Y0001468 Sodium iodohippurate
15 mg
2352
+5C
79
Y0000620 Sodium laurilsulfate
40 mg
0802
+5C
79
Y0000808 Sodium phenylbutyrate
5 mg
2183
+5C
79
Y0000809 Sodium phenylbutyrate impurity C
10 mg
2183
+5C
79
S0785000 Sodium picosulfate
100 mg
1031
+5C
79
Y0001104 Picosulfate for system suitability
0.5 mg
1031
+5C
79
Y0000210 Sodium polystyrene sulfonate - reference spectrum
n/a
1909
79
Y0000268 Sodium propionate - reference spectrum
n/a
2041
79
S0800000 Sodium salicylate
100 mg
0413
+5C
79
S0808000 Sodium stearyl fumarate
50 mg
1567
+5C
79
S0808060 Sodium stearyl maleate
10 mg
1567
+5C
79
4-cyclohexylbutanoic acid
71
Yes

Order
Reference Standard
Code
S0900000 Sodium taurocholate BRP

Batch n
2
Quantity Sale
per vial Unit
10000 mg 1
Information
Monograph
Leaflet
0350
+5C
S0930000 Sodium valproate
150 mg
S0945000 Somatostatin
2.32 mg
2.32mg somatostatin peptide per vial CHNOS
S0947000 Somatropin
55 mg
3.86 mg somatropin monomer per vial ; Batch 2 is valid until 31 August 2012
Y0000711 Somatropin/desamidosomatropin resolution mixture
33 mg
1.7 mg somatropin per vial
S0950000 Sorbic acid
10 mg
Y0000385 1,4-Sorbitan
50 mg
99,7% CHO ; Batch 1 is valid until 1 April 2013
1250 mg
98,7% CHO ; Batch 3 is valid until 31 December 2013
Y0000114 Sotalol hydrochloride
25 mg
Y0000115 Sotalol impurity B
20 mg
Y0001011 Spanish sage oil for peak identification
250 mg
Y0000597 Spectinomycin hydrochloride
100 mg
Y0000549 Spectinomycin for system suitability
20 mg
1152
Y0000655 Spectinomycin sulfate tetrahydrate
10 mg
1658
Y0001126 Spike lavender oil
400 l
2419
Yes
S1100000 Spiramycin
200 mg
4500 IU per mg
Spiramycin I: 87.3%, Spiramycin II: 0.2%, Spiramycin III: 4.4%
0179,0293,19
82,20702
Yes
Y0000381 Spirapril hydrochloride monohydrate
60 mg
95.9% CHClNOS
Y0000332 Spirapril for system suitability
15 mg
S1200000 Spironolactone
150 mg
Y0001295 Spironolactone for system suitability
2.055 mg
Y0000185 Squalane
250 l
99.7% CH
1630
Y0001050 St. John's wort standardised dry extract
500 mg
0.050% of hypericin; St. John's wort standardised dry extract CRS has been
renamed as St. John's wort dry extract HRS in 01/2013:1874
1874
Y0001091 Artichoke leaf dry extract HRS
60 mg
2389
S1250000 Stanozolol
50 mg
1568
S1250010 Stanozolol impurity A
10 mg
(5,17)-17-hydroxy-17-methylandrostan-3-one
Y0001420 Stanozolol impurity B
10 mg
S1300000 Starch BRP
50000 mg
Y0000408 Stavudine
100 mg
New S1000000 Sorbitol
+5C
79
0949
-20C
90
See leaflet,
0950,
0951,0952
Yes
-20C
150
0950,0951,09
52
Yes
-20C
150
+5C
79
2048
Yes
+5C
79
0435,0436,04
37,
1235,1236,13
37,
1381,1531,20
48
Yes
+5C
79
+5C
79
+5C
79
+5C
79
-20C
79
-20C
79
-20C
79
+5C
79
-20C
79
1766
+5C
79
1766
+5C
79
2004
2004
1849
99.6% CHOS; Spironolactone CRS 2 is suitable for monograph

01/2008:0688 only.
99.6% CHNO
72
Yes
1152
81.3% CHClNO and CHClNO
Extra
Price
charges
79
a
0678
0592
N-[4-[[(1-methylethyl)amino]acetyl]phenyl]methanesulphonamide
Storage
Yes
0688
Yes
+5C
79
0688
Yes
+5C
79
+5C
79
Yes
-20C
79
Yes
-20C
79
+5C
79
1568
+5C
79
1568
+5C
79
0350
+5C
79
2130
+5C
79

Order
Reference Standard
Code
Y0000421 Stavudine for system suitability

Batch n
1
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
Storage
2130
Yes
+5C
S1340000 Stearic acid
100 mg
Plastic additive 19
0229,0882,14
74, 1663,
2058, 30105,
30106,30107,
1663
S1350000 Stearyl alcohol
250 mg
99.5% CHO ; Batch 1 is valid until 30 September 2012
0702,0753,08
01,
0802,0847,09
69,
1123,1340,14
11
Y0000868 Streptokinase for system suitability
30 l
S1400000 Streptomycin sulfate
100 mg
S1500000 Succinylsulfathiazole
100 mg
Y0001324 Sucralfate
10 mg
Y0001344 Sucralose
550 mg
100.0% CHClO
2368
Y0001342 Sucralose impurity B
0.5 mg
1,6-dichloro-1,6-dideoxy-?-D-fructofuranosyl 6-chloro-6-deoxy-?-Dglucopyranoside (1',6,6'-trichloro-1',6,6'-trideoxysucrose)
2368
S1600000 Sucrose
100 mg
0177,0178,01
87,
0188,0204,02
09,
1061,1570,23
18
S1608100 Sufentanil - reference spectrum
n/a
1569
S1609000 Sufentanil citrate - reference spectrum
n/a
1269
Y0000529 Sulbactam sodium
10 mg
2209
Y0000528 Sulbactam
150 mg
2209
Yes
Y0000550 Sulbactam for peak identification
20 mg
2209
Yes
S1700000 Sulfacetamide sodium
50 mg
S1800000 Sulfadiazine
100 mg
Y0001480 Sulfadiazine for identification of impurity F
15 mg
Y0001469 Sulfadiazine impurity A
20 mg
S1900000 Sulfadimidine
100 mg
0295
Y0001495 Sulfadimidine for peak identification
50 mg
0295
S1950000 Sulfadoxine
50 mg
S1975000 Sulfafurazole
100 mg
S1975600 Sulfaguanidine
60 mg
S2000000 Sulfamerazine
100 mg
Extra
Price
charges
79
a
+5C
79
Yes
+5C
79
0356
Yes
-20C
79
Yes
-20C
79
0032,0033,00
53,
0485,20702
0357
+5C
79
1796
+5C
79
+5C
79
+5C
79
+5C
79
79
77 000 IU per vial
99.7% CHNOS
pyrimidin-2-amine

73
Yes
79
79
-20C
79
+5C
79
0107,0295
+5C
79
0294
+5C
79
0294
+5C
79
0294
+5C
79
+5C
79
+5C
79
0740
+5C
79
0741
+5C
79
1476, 0295
+5C
79
0358,1571
+5C
79
+5C
Yes

Order
Code
S2050000 Sulfamethizole
Reference Standard

Batch n
1
Quantity Sale
per vial Unit
100 mg
1
Information
Monograph
Leaflet
Storage
0637
+5C
Extra
Price
charges
79
a
S2100000 Sulfamethoxazole
50 mg
0108
+5C
79
Y0000412 Sulfamethoxazole impurity A
5 mg
N-(4-(5-methyl)-isoxazol-3-ylsulphamoyl)phenylacetamide
0108
+5C
79
Y0000413 Sulfamethoxazole impurity F
5 mg
4-amino-N-(3-methylisoxazol-5-yl)benznesulphonamide
0108
+5C
79
S2150000 Sulfamethoxypyridazine
50 mg
0638
+5C
79
S2151000 Sulfanilamide
100 mg
1571
+5C
79
S2159100 Sulfapyridine
20 mg
0863
+5C
79
S2155000 Sulfasalazine
250 mg
98.1 % CHNOS ; Batch 3 is valid until 28 February 2013
S2155010 Sulfasalazine derivative for resolution
20 mg
2-hydroxy-5-[[4-[[(6-methylpyridin-2-yl)amino]-sulfonyl]phenyl]azo]benzoic
acid
S2158000 Sulfathiazole
100 mg
S2159000 Sulfinpyrazone
Y0001238 Sulfinpyrazone for system suitability
S2159010 Sulfinpyrazone impurity A
20 mg
1,2-diphenyl-4-[2-(phenylsulphonyl)ethyl]pyrazolidine-3,5-dione
S2159015 Sulfinpyrazone impurity B
20 mg
1,2-diphenyl-4-(2-phenylthioethyl)pyrazolidine-3,5-dione
S2160000 Sulfisomidine
50 mg
S2180000 Sulindac
50 mg
Contains 0.3% m/m of E-isomer
S2190000 Sulpiride
100 mg
S2191000 Sulpiride impurity A
20 mg
S2192000 Sulpiride impurity B
20 mg
methyl 2-methoxy-5-sulphamoylbenzoate
Y0000530 Sultamicillin
10 mg
Y0000531 Sultamicillin tosilate
200 mg
Y0000532 Sultamicillin for peak identification
10 mg
Y0000022 Sumatriptan succinate
50 mg
98.8% CHNOS
1573
Y0000026 Sumatriptan impurity mixture
3 mg
1573
Yes
Y0000027 Sumatriptan for system suitability
2.02 mg
1573
Yes
S2200000 Suxamethonium chloride
1000 mg
S2400000 Suxibuzone
50 mg
S2400004 Suxibuzone impurity B
10 mg
(4-butyl-3,5-dioxo-1,2-diphenylpyrazolidin-4-yl)methyl ethyl butanedioate
S2400006 Suxibuzone impurity C
10 mg
4-butyl-4-(hydroxymethyl)-1,2-diphenyl-1,2-dihydro-4H-pyrazole-3,5-dione
S5000001 Swine erysipelas bacteria, serotyp 1 (for vaccines - vet.

use) BRP
1 mg
6.5 x10 Cfu per vial
See leaflet,
0064
Yes
S5000002 Swine erysipelas bacteria, serotyp 2 (for vaccines - vet.

use) BRP
1 mg
2.6 x10 Cfu per vial
See leaflet,
0064
Y0001417 Tadalafil
200 mg
99.9% CHNO
2606
T0010000 Talampicillin hydrochloride
50 mg
T0014000 Tamoxifen citrate
80 mg
0863,1457
+5C
79
0863
+5C
79
0742
+5C
79
30 mg
0790
+5C
79
0.5 mg
0790
+5C
79
0790
+5C
79
0790
+5C
79
0639
+5C
79
0864
+5C
79
1045,1348
+5C
79
[(2RS)-1-ethylpyrrolidin-2-yl]methanamine
1045,1490
+5C
79
1045
+5C
79
2211
+5C
79
+5C
79
+5C
79
-20C
79
-20C
79
Yes
2211,2212
92.5% CHNOS
2211
74
Yes
Yes
-20C
79
0248
+5C
79
1574
+5C
79
1574
+5C
79
+5C
79
+5C
e(b)
90
Yes
+5C
e(b)
90
Yes
+5C
79
0808,0852
+5C
79
1046
+5C
79
1574

Order
Reference Standard
Code
T0015000 Tamoxifen citrate for performance test

Batch n
3
Quantity Sale
per vial Unit
10 mg
1
Information
Monograph
Leaflet
Storage
1046
Yes
+5C
Extra
Price
charges
79
g
Y0000650 Tamsulosin hydrochloride
10 mg
2131
+5C
79
Y0000653 Tamsulosin racemate
10 mg
2131
+5C
79
Y0000651 Tamsulosin impurity D
10 mg
2-methoxy-5-[(2R)-2-[[2-(2-methoxyphenoxy)ethyl]amino]propyl]
benzenesulfonamide ; Batch 1 is valid until 1 June 2013
2131
+5C
79
Y0000652 Tamsulosin impurity H
10 mg
(2R)-N-[2-(2-ethoxyphenoxy)ethyl]-1-(4-methoxyphenyl)propan-2-amine ;
2131
+5C
79
Y0001102 Teicoplanin
52 mg
51550 IU per ampoule
2358
-20C
79
Y0001560 Tanshinone IIa
15 mg
98.4 % CHO
2663
Yes
+5C
79
Y0001047 Teicoplanin for identification
40 mg
2358
Yes
-20C
79
Y0000648 Telmisartan
30 mg
2154
+5C
79
Y0000649 Telmisartan for peak identification
10 mg
2154
Yes
+5C
79
Y0001003 Telmisartan for system suitability
0.26 mg
2154
Yes
+5C
79
T0040000 Temazepam - * psy
50 mg
0954
+5C
79
Y0000344 Temazepam impurity C
5 mg
(3RS)-7-chloro-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4benzodiazepin-3-yl acetate
0954
+5C
79
Y0000345 Temazepam impurity D
5 mg
(3RS)-7-chloro-3-methoxy-1-methyl-5-phenyl-1,3-dihydro-2H-1,4benzodiazepin-2-one
0954
+5C
79
Y0000346 Temazepam impurity F
5 mg
(5RS)-7-chloro-1-methyl-5-phenyl-4,5-dihydro-1H-1,4-benzodiazepine-2,3dione
0954
+5C
79
Y0000347 Temazepam impurity G
5 mg
(5RS)-7-chloro-1,4-dimethyl-5-phenyl-4,5-dihydro-1H-1,4benzodiazepine-2,3-dione
0954
+5C
79
T0040800 Tenoxicam
100 mg
1156
+5C
79
Y0001114 Tenoxicam impurity mixture
0.0042 mg
1156
+5C
79
Y0000621 Terazosin hydrochloride dihydrate
40 mg
2021
+5C
79
Y0000666 Terazosin for system suitability
0.5 mg
+5C
79
Y0000622 Terazosin impurity A
10 mg
2-chloro-6,7-dimethoxyquinazolin-4-amine
2021
+5C
79
Y0000665 Terazosin impurity E
10 mg
2,2'-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine)
2021
+5C
79
Y0000623 Terazosin impurity L
10 mg
1-(furan-2-ylcarbonyl)piperazine
2021
+5C
79
Y0000624 Terazosin impurity N
10 mg
1-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine
2021
+5C
79
Y0000535 Terbinafine hydrochloride
10 mg
1734
+5C
79
Y0001143 Terbinafine for system suitability
10 mg
1734
+5C
79
T0050000 Terbutaline sulfate
100 mg
0690
+5C
79
T0050015 Terbutaline impurity C
15 mg
0690
+5C
79
T0060000 Terconazole
250 mg
1270
+5C
79
T0071000 Terfenadine
100 mg
0955
+5C
79
T0080000 Terfenadine impurity A
20 mg
0955
+5C
79
2021
1-(3,5-dihydroxyphenyl)-2-[(1,1-dimethylethyl)amino]-ethanone
1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl) piperidin-1-yl]
butan-1-one
75
Yes
Yes
Yes
Yes

Order
Code
T0100000 Testosterone
Reference Standard

Batch n
3
Quantity Sale
Information
per vial Unit
30 mg
1 Batch 2 is valid until 31 August 2013
Monograph
1373
T0210000 Testosterone caproate
50 mg
T0240000 Testosterone decanoate
50 mg
Y0000696 Testosterone decanoate for system suitability
0.4 mg
1736
T0250000 Testosterone enantate
100 mg
1048
Y0001317 Testosterone enantate for system suitability
2 mg
1048
Y0001312 Testosterone enantate for peak identification
10 mg
1048
Y0001313 Testosterone enantate impurity H
10 mg
Y0000342 Testosterone for impurity D identification
20 mg
Y0000343 Testosterone for system suitability
20 mg
T0260000 Testosterone isocaproate
50 mg
Y0000716 Testosterone isocaproate for system suitability
5 mg
T0300000 Testosterone propionate
60 mg
Y0001409 Testosterone propionate for system suitability
5 mg
T0400000 Tetanus vaccine (adsorbed)
30 mg
490 IU per ampoule for challenge assays in guinea-pigs

260 IU per ampoule for challenge assays in mice
Y0001087 Tetra-O-acetyl-mannose triflate
60 mg
100.0% CHFOS
T0500000 Tetracaine hydrochloride
100 mg
Y0001002 Tetracaine for system suitability
2 mg
T0550000 Tetracosactide
0.366 mg
366 g per vial of CHNOS
100 mg
97.1% CHClNO ; Batch 2 is valid until 31 December 2013
Y0001165 Tetrandrine
20 mg
99.7% CHNO
Y0000015 Tetrazepam - reference spectrum
n/a
Y0000008 Tetrazepam impurity C
20 mg
Y0000460 Tetryzoline hydrochloride
10 mg
Y0000723 Thebaine - * narc
15 mg
T0700000 Theobromine
100 mg
New T0600000 Tetracycline hydrochloride
Leaflet
99.8% CHO
delta-5-testosterone-3,17-dienantate
99.9% CHO
99.8% CHO; Testosterone propionate CRS 1 is suitable for 01/2008:1048
only
Storage
+5C
1048
+5C
79
1048, 1736
-20C
g(c)
79
-20C
g(c)
79
-20C
g(c)
79
Yes
-20C
g(c)
79
Yes
-20C
g(c)
79
1048
-20C
g(c)
79
1373
+5C
79
1373
+5C
79
1048,1737
+5C
79
Yes
1737
Yes
+5C
79
0297
Yes
+5C
79
0297
Yes
+5C
79
See leaflet,
20708
Yes
-20C
90
2294
-20C
79
0057
+5C
79
0057
Yes
+5C
79
0644
Yes
-20C
79
0173,0198,01
99,
0210,0211,16
54
Yes
+5C
79
+5C
79
79
2478
1738
7-chloro-5-cyclohexyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
99.5% CHNO
Extra
Price
charges
79
g
1738
+5C
79
2101
+5C
79
1839,1841
+5C
79
0298
+5C
79
+5C
79
79
T0800000 Theophylline
100 mg
0300,0301
Y0000294 Theophylline - reference spectrum
n/a
0299,0302
Y0000336 Thiamazole
125 mg
1706,0884
+5C
79
Y0000372 Thiamazole impurity A
15 mg
2,2-dimethoxy-N-methylethanamine
1706
+5C
79
Y0000373 Thiamazole impurity C
20 mg
1-methyl-2-(methylsulphanyl)-1H-imidazole ; Batch 1 is valid until 31 August

2013
1706
+5C
79
Y0000467 Thiamine hydrochloride
10 mg
+5C
79
0303
76
Yes

Order
Reference Standard
Code
Y0000059 Thiamine impurity E

Batch n
2
Quantity Sale
Information
per vial Unit
10 mg
1 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-hydroxyethyl)-4methylthiazol-2(3H)-thione
Y0000060 Thiamine nitrate
n/a
Monograph
Leaflet
Storage
Extra
Price
charges
79
a
0303,0531
+5C
0531
+5C
79
0109
+5C
79
1648
+5C
79
T1100000 Thiamphenicol
125 mg
Y0000546 Thioctic acid
110 mg
Y0000592 Thioctic acid for system suitability
10 mg
1648
+5C
79
Y0000545 Thioctic acid containing impurity B
30 mg
1648
+5C
79
Y0000109 Thiomersal
30 mg
1625
+5C
79
T1200000 Thiopental
500 mg
0212
+5C
79
Y0001478 Thiopental for system suitability
10 mg
0212
+5C
79
Y0000704 Thioridazine
10 mg
2005
+5C
79
+5C
79
+5C
79
99.8% CHOS
Yes
T1300000 Thioridazine hydrochloride
100 mg
0586
Y0000541 Thioridazine for system suitability
0.21 mg
0586, 2005
T1305100 Thioxanthene
20 mg
1347
+5C
79
T1305000 Thioxanthone
10 mg
1347
+5C
79
T1340000 Threonine
50 mg
0785,1049
+5C
79
T1350000 Thymol
50 mg
0791
+5C
79
Yes
T1410000 Tiabendazole
50 mg
Y0000414 Tiamulin for peak identification
10 mg
0866
Y0000333 Tiamulin hydrogen fumarate
500 mg
98.6% CHNOS
Y0000379 Tiamulin - reference spectrum
n/a
1660
Y0000151 Tianeptine sodium - reference spectrum
n/a
2022
Y0000152 Tianeptine for system suitability
30 mg
2022
+5C
Y0000153 Tianeptine impurity A
20 mg
2022
+5C
79
T1405000 Tiapride hydrochloride
60 mg
1575
+5C
79
T1405050 Tiapride N-oxide
20 mg
1575
+5C
79
T1410900 Tiaprofenic acid
50 mg
1157
+5C
79
1157
+5C
79
79
ethyl 7-bromoheptanoate
+5C
79
1659
Yes
+5C
79
1659,1660
Yes
+5C
79
79
79
79
T1410910 Tiaprofenic acid impurity C
20 mg
Y0000748 Tibolone - reference spectrum
n/a
Y0000668 Tibolone for system suitability
10 mg
+5C
79
Y0000465 Ticarcillin monosodium
250 mg
93.2% CHNNaOS
Correction factor 1.054
0956
+5C
79
T1420010 Ticarcillin impurity A
50 mg
89.8% CHNOS; (2S,5R,6R)-3,3-dimethyl-7-oxo-6-[[(thiophen-3-yl)

acetyl]-amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
(decarboxyticarcillin)
0956
+5C
79
T1423000 Ticlopidine hydrochloride
50 mg
1050
+5C
79
T1423025 Ticlopidine impurity F
10 mg
1050
+5C
79
(2RS)-2-(5-benzoylthiophen-3-yl)propanoic acid
1739
1739
6-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
77
Yes

Order
Reference Standard
Code
Y0000325 Tilidine hydrochloride hemihydrate - reference spectrum

Batch n
1
Quantity Sale
per vial Unit
n/a
1
Information
Monograph
Leaflet
Storage
1767
T1450000 Timolol maleate
100 mg
Y0000644 (R)-timolol
20 mg
Y0001270 Timolol for system suitability
5.045 mg
0572
T1470000 Tinidazole
100 mg
1051
Y0000899 Tinidazole impurity A
15 mg
2-methyl-5-nitro-1H-imidazole
T1471000 Tinidazole impurity B
20 mg
1-[2-(ethylsulphonyl)ethyl]-2-methyl-4-nitro-1H-imidazole ; Batch 3 is valid

until 31 July 2012
T1490000 Tinzaparin sodium
250 mg
Y0000292 Tioconazole - reference spectrum
Y0000282 Tioconazole for system suitability
Y0001188 Tiotropium bromide monohydrate
Y0001189 Tiotropium for system suitability
Y0001179 Tiotropium impurity mixture

Y0001216 Tiotropium impurity F
Extra
Price
charges
79
l
0572
+5C
79
0572
+5C
79
+5C
79
+5C
79
1051
+5C
79
1051
+5C
79
0828
+5C
79
n/a
2074
79
50 mg
2074
+5C
79
10 mg
2420
+5C
79
10 mg
2420
+5C
79
0.08 mg
2420
+5C
79
10 mg
dithiophen-2-ylmethanone
2420
+5C
79
Yes
Yes
Yes
T1500000 Tobramycin
49 mg
49 mg per vial of CHNO; Suitable for LC assay only
0645
Yes
+5C
79
Y0000383 All-rac-alpha-tocopherol for peak identification
50 mg
0692
Yes
+5C
79
Y0000384 All-rac-alpha-tocopheryl acetate for peak identification
30 mg
0439
Yes
+5C
79
500 mg
97,7% CHO ; Vitamin E ; Batch 6 is valid until 31 December 2013
0692,1256,20
432
Yes
+5C
79
T1600000 alpha-Tocopheryl acetate
500 mg
97.8% CHO
0439,0691,12
57
+5C
79
Y0001210 Tobramycin for identification
250 mg
Suitable for identification tests only
0645
+5C
79
T1610000 RRR-alpha-Tocopheryl hydrogen succinate
150 mg
98.6% CHO
+5C
79
T1700000 Tolbutamide
100 mg
0304
+5C
79
Y0000154 Tolfenamic acid
100 mg
2039
+5C
79
T1707000 Tolnaftate
60 mg
1158
+5C
79
Y0001123 Tolnaftate for system suitability
10 mg
1158
+5C
79
Y0000461 Torasemide anhydrous
10 mg
2132
+5C
79
Y0001366 Torasemide impurity E
0.0006 mg
+5C
79
Y0000462 Torasemide for system suitability
5 mg
+5C
79
Y0000155 Tramadol hydrochloride
75 mg
1681
+5C
79
Y0000156 Tramadol impurity A
25 mg
(1RS,2SR)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclohexanol ;
1681
+5C
79
Y0000157 Tramadol impurity E
15 mg
(2RS)-2-[(dimethylamino)methyl]cyclohexanone
1681
+5C
79
Y0000072 Tramazoline hydrochloride monohydrate
20 mg
Y0000065 Tramazoline impurity A
15 mg
79
1597
+5C
g
N-(naphthalen-1-yl)-4,5-dihydro-1H-imidazol-2-amine ; Batch 1 is valid until
79
1597
Yes
+5C
g
31 August 2013
78
New T1550000 alpha-Tocopherol
ethyl [[4-[(3-methylphenyl)amino]pyridin-3-yl]sulfonyl]carbamate
1258,1259
Yes
2132
2132
Yes

Order
Reference Standard
Code
Y0000066 Tramazoline impurity B

Batch n
1
Quantity Sale
Information
per vial Unit
10 mg
1 75% CHNO; Mixture of 1-acetyl-N-(5,6,7,8-tetrahydronaphthalen-1yl)-4,5-dihydro-1H-imidazol-2-amine and 1-[(EZ)-1-[(5,6,7,8tetrahydronaphthalen-1-yl)imino]ethyl]imidazolidin-2-one
Monograph
Leaflet
Storage
1597
+5C
Extra
Price
charges
79
g
Y0000501 Trandolapril
10 mg
2245
+5C
79
Y0000495 Trandolapril impurity C
10 mg
(2S,3aR,7aS)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]
propanoyl]octahydro-1H-indole-2-carboxylic acid (hexahydrotrandolapril)
2245
+5C
79
Y0000496 Trandolapril impurity D
10 mg
ethyl (2S)-2-[(3S,5aS,9aR,10aS)-3-methyl-1,4-dioxodecahydro
pyrazino[1,2-a]indol-2(1H)-yl]-4-phenylbutanoate (trandolapril
diketopiperazine)
2245
+5C
79
T1810000 Tranexamic acid
50 mg
0875
+5C
79
T1820000 Trapidil
50 mg
1576
+5C
79
T1820002 Trapidil impurity A
20 mg
5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol
1576
+5C
79
T1820004 Trapidil impurity B
20 mg
1,2,4-triazol-3-amine
1576
+5C
79
Y0001172 Trehalose dihydrate
250 mg
89.8% CHO,2HO
2297
+5C
79
T1850000 Tretinoin
50 mg
0693,1019,13
85
+5C
g(b)
79
T1899000 3,4,6-Tri-O-acetyl-D-glucal - reference spectrum
n/a
1325
79
G0400010 Triacetin - reference spectrum
n/a
1106
T1899990 Triamcinolone
150 mg
1376
T1900000 Triamcinolone acetonide
150 mg
Y0001459 Triamcinolone acetonide for system suitability
10 mg
T1950000 Triamcinolone hexacetonide
100 mg
Y0000050 Triamcinolone impurity C
10 mg
Y0000837 Triamterene
10 mg
Y0000870 Triamterene impurity B
0.5 mg
T1975000 Triazolam - * psy
10 mg
Y0000165 Tribenoside
150 mg
1740
Yes
Y0000166 Tribenoside impurity A
70 mg
90.3% CHO; 3,5,6-tri-O-benzyl-1,2-O-(1-methylethylidene)-alpha-Dglucofuranose ; Batch 3 is valid until 1 May 2013
1740
Yes
Y0001055 Tributyl acetylcitrate
1 mL
1770
Y0000279 Tri-n-butyl phosphate
300 l
1682
Y0000799 Tributyl acetylcitrate for peak identification
25 mg
1770
T1977990 Tricaprin
150 mg
T1977995 Tricaproin
40 mg
79
+5C
79
0533,0867,10
75
Yes
+5C
79
0533
Yes
+5C
79
0533,0867
+5C
79
1376
+5C
79
0058
+5C
79
+5C
79
+5C
79
+5C
79
-20C
g(c)
79
+5C
79
+5C
79
+5C
79
1410
-20C
79
1410
-20C
79
-20C
79
79
79
98.6% CHFO
9-fluoro-11,16alpha,17,21-tetrahydroxypregn-4-ene-3,20-dione
0058
2,7-diamino-6-phenylpteridin-4-ol
Yes
1065
T1978000 Tricaprylin
225 mg
1410
Y0000111 Trichloroacetic acid - reference spectrum
n/a
1967
T1985000 Trichlorotrifluoroethane
2.5 ml
0393
Yes
79
Yes
Yes
+5C

Order
Reference Standard
Code
T1986000 Triethyl citrate - reference spectrum

Batch n
1
Quantity Sale
per vial Unit
n/a
1
Information
Monograph
Leaflet
Storage
1479
Extra
Price
charges
79
l
T2000000 Trifluoperazine hydrochloride
100 mg
0059,20303
+5C
79
T2005000 Triflusal
50 mg
1377
+5C
79
1377
+5C
79
2032
+5C
79
1626
+5C
79
1626
+5C
79
T2005010 Triflusal impurity B
25 mg
Y0000720 Triglycerol diisostearate
200 mg
Y0000108 Trihexyphenidyl hydrochloride
100 mg
Y0000068 Trihexyphenidyl impurity A
20 mg
2-hydroxy-4-(trifluoromethyl)benzoic acid
1-phenyl-3-(piperidin-1-yl)propan-1-one
T2009000 Trilaurin
1250 mg
1410
-20C
79
Y0001319 Trimebutine maleate
10 mg
2182
+5C
79
Y0001260 Trimebutine for system suitability
1.017 mg
2181,2182
+5C
79
Y0000092 Trimetazidine dihydrochloride - reference spectrum
n/a
1741
79
Y0000093 Trimetazidine for system suitability
50 mg
T2100000 Trimethadione
250 mg
100% CHNO
Y0001497 3-Trimethylsilyl-1-propanesulfonic acid sodium salt
120 mg
91.8 % CHOSSi,Na
T2200000 Trimethoprim
50 mg
Y0000684 Trimethoprim for system suitability
T2200010 Trimethoprim impurity B
15 mg
T2450000 Trimethyltetradecylammonium bromide
200 mg
T2500000 Trimipramine maleate
100 mg
Y0000759 Trimipramine for peak identification
T2500100 Trimyristin
T2501200 Tristearin
T2545000 Trolamine
Yes
1741
+5C
79
0440
+5C
79
+5C
79
0060
+5C
79
0060
+5C
79
(2,4-diaminopyrimidin-5-yl)(3,4,5-trimethoxyphenyl)methanone
0060
+5C
79
0378
+5C
79
0534
+5C
79
0.51 mg
0534
+5C
79
500 mg
1410
-20C
79
100 mg
1410
-20C
79
2250 mg
1577
+5C
79
Y0001184 Trolamine impurity A
250 mg
Ethanolamine
1577
+5C
79
Y0001183 Trolamine impurity B
1 ml
Diethanolamine
1577
+5C
79
T2550000 Trometamol
100 mg
T2580000 Tropicamide
50 mg
Y0001247 Tropicamide impurity C
10 mg
Y0001248 Tropicamide impurity D
10 mg
Y0001316 Tropicamide for peak identification
10 mg
Y0000616 Tropisetron hydrochloride
40 mg
Y0000618 Tropisetron impurity B
10 mg
T2580300 Tropine
50 mg
Y0000429 Trospium chloride
10 mg
Y0000432 Trospium impurity A
20 mg
0.00075 mg 1
2645, 2165
Yes
Yes
1053
+5C
79
1159,1197
+5C
79
(2RS)-3-hydroxy-2-phenylpropanoic acid (tropic acid)
1159
+5C
79
Phenylacetic acid
1159
+5C
79
1159
+5C
79
2102
+5C
79
2102
+5C
79
1308
+5C
79
1798
+5C
79
1798
+5C
79
1H-indole-3-carboxylic acid
hydroxydiphenylacetic acid (benzilic acid)
80

Order
Reference Standard
Code
Y0000431 Trospium impurity B

Batch n
2
Y0000430 Trospium impurity C
Y0000497 Troxerutin
T2600000 Trypsin BRP
Quantity Sale
Information
per vial Unit
20 mg
1 (1R,3r,5S)-8-azabicyclo[3.2.1]oct-3-yl hydroxydiphenylacetate ; Batch 1 is
valid until 30 September 2012
Monograph
1798
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
79
+5C
79
30 mg
100 mg
T2610000 Tryptophan
100 mg
T2800000 Tubocurarine chloride
100 mg
87.75% CHClNO
T2880000 Tylosin
150 mg
1025 IU per mg ; Batch 1 is valid until 31 August 2013
T2880100 Tylosin D
5 mg
1273,1274,16
61
Y0000498 Tylosin phosphate for peak identification
10 mg
1273,1274,16
61
T2880200 Tylosin tartrate - reference spectrum
n/a
1274
T2900000 Tyrosine
50 mg
2133
0476,0579,05
80, 0694
Yes
1272
0305
1273,1274,16
61, 20702
0782,0895,11
61,
1272,1384
0907,1662
Yes
Yes
T3000000 Tyrothricin
20 mg
U0020000 Ubidecarenone
50 mg
U0020001 Ubidecarenone for system suitability
1 mg
U0020008 Ubidecarenone impurity D
5 mg
U0100000 Uracil arabinoside
60 mg
U0600000 Urea
100 mg
U0800000 Ursodeoxycholic acid
100 mg
Y0001163 Ursodeoxycholic acid for system suitability
1.26 mg
1275
Yes
Y0000834 Valaciclovir hydrochloride (anhydrous)
100 mg
96.5% CHNOCl
1768
Y0001225 Valaciclovir for system suitability
10 mg
1768
Y0001096 Valaciclovir impurity D
10 mg
2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate
Y0001097 Valaciclovir impurity E
10 mg
2-[(2-amino-6-oxo-1,6dihydro-9H-purin-9-yl)methoxy]ethyl N-[(benzyloxy)
carbonyl]-L-valinate
Y0001098 Valaciclovir impurity F para-toluenesulfonate
12 mg
2-hydroxyethyl L-valinate
Y0001099 Valaciclovir impurity G
10 mg
N,N-dimethylpyridin-4-amine
Y0000583 Valerian standardised dry extract
400 mg
0.43 % of CHO ; Batch 2 is valid until 31 August 2012
V0030000 Valine
50 mg
Y0000584 Valnemulin hydrochloride
10 mg
Extra
Price
charges
79
a
+5C
0.707 microkatal per mg
Storage
1798
5 mg
(1R,3r,5S)-3-hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium]
Leaflet
+5C
79
1578
+5C
79
1578
+5C
79
1578
+5C
79
0760
+5C
79
0743
+5C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
+5C
79
1768
+5C
79
1768
+5C
79
1768
+5C
79

5,6-dimethoxy-3-methyl-2-[(all-E)-3,7,11,15,19,23,27,31,35nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]benzene-1,4dione
Yes
1189,1275
81
1768
+5C
79
-20C
79
0770,0771,07
96
+5C
79
2137
+5C
79
0453,1898,18
99,2400,2526
Yes

Order
Reference Standard
Code
Y0000533 Valnemulin hydrogen tartrate

Batch n
1
Quantity Sale
per vial Unit
120 mg
1 98.7% CHNOS
Information
Monograph
Leaflet
Y0000585 Valnemulin for peak identification
10.25 mg
Y0000586 Valnemulin impurity E
10 mg
V0033000 Valproic acid
100 mg
1378
Y0001422 Valproic acid for system suitability
10 mg
1378,0678
Y0001132 Valsartan
10 mg
2423
Y0001131 Valsartan for peak identification
10 mg
2423
Yes
Y0001145 Valsartan for system suitability
0.202 mg
2423
V0045000 Vancomycin hydrochloride
100 mg
102000 IU per vial
1058,20702
V0050000 Vanillin
100 mg
0747
Y0001198 Varicella vaccine ( live)
420 mg
0648
Y0000561 Vecuronium bromide
10 mg
1769
Y0000625 Vecuronium for peak identification
10 mg
1769
Y0001093 Vedaprofen
5 mg
2248
Y0001118 Vedaprofen impurity mixture
0.006 mg
2248
Y0000587 Venlafaxine hydrochloride
50 mg
Y0000588 Venlafaxine for system suitability
1.002 mg
V0100000 Verapamil hydrochloride
100 mg
V0100018 Verapamil impurity I
5 mg
(2RS)-2-(3,4-dimethoxyphenyl)-2-[2-[[2-(3,4-dimethoxy-phenyl)ethyl]
(methyl)amino]ethyl]-3-methylbutanenitrile hydrochloride
V0100026 Verapamil impurity M
10 mg
Y0000661 Verbenalin
11 mg
V0180000 VERO cells
Y0001400 Vigabatrin
Y0001401 Vigabatrin impurity A
2137
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
+5C
79
Yes
+5C
79
Yes
-20C
79
+5C
79
Yes
-80C
90
+5C
79
+5C
79
+5C
79
+5C
79
2119
+5C
79
2119
+5C
79
0573
+5C
79
0573
+5C
79
5,5'-[[2-(3,4-dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1methylethyl)pentanenitrile]
0573
+5C
79
0.97 mg per vial of CHO
1854
+5C
79
1 ml
Cell lines (kidney, african green monkey, Cercopithecus aethiops) titration of

live measles, mumps and rubella vaccines
Yes
Liquid
nitrogen
100
10 mg
+5C
79
25 mg
94.7% CHNO; (5RS)-5-ethenylpyrrolidin-2-one
2305
Yes
-20C
79
Y0001402 Vigabatrin impurity B
20 mg
(2E)-2-(2-aminoethyl)but-2-enoic acid
2305
+5C
79
Y0001404 Vigabatrin impurity D
50 mg
4-aminobutanoic acid
2305
+5C
79
Y0001403 Vigabatrin impurity E
10 mg
2-[(2RS)-2-aminobut-3-enyl]propanedioic acid
2305
+5C
79
V0300000 Vinblastine sulfate
5.01 mg
0748,0749
-80C
g(d)
79
V0305000 Vinblastine sulfate - reference spectrum
n/a
79
V0400000 Vincristine sulfate
4.96 mg
0748,0749
-80C
79
V0405000 Vincristine sulfate - reference spectrum
n/a
79
V0500000 Vindesine sulfate
5 mg
-80C
g(d)
79
n/a
(3aS,4R,5S,6S,8R,9R,9aR,10R)-6-ethenyl-5-hydroxy-4,6,9,10-tetramethyl-1oxodecahydro-3a,9-propano-3aH-cyclopenta[8]annulen-8-yl 2-hydroxyacetate
(pleuromulin)
Yes
Extra
Price
charges
79
a
+5C
V0500010 Vindesine sulfate - reference spectrum

2137
Storage
2137
0213,0538,10
57
Yes
Yes
Yes
2305
0748
0749
5.19 mg per vial of CHNOS ; Batch 2 is valid until 24 April 2013
82
1276
Yes
79
1276
l

Order
Reference Standard
Code
Y0000463 Vinorelbine tartrate

Batch n
2
Quantity Sale
per vial Unit
50 mg
1
Information
Monograph
Leaflet
Storage
Extra
Price
charges
79
g(d)
2107
-80C
2107
-80C
g(d)
79
2139
+5C
79
Y0000464 Vinorelbine impurity B
7 mg
Y0000589 Vinpocetine
10 mg
Y0000590 Vinpocetine impurity A
10 mg
(12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6, 12,13,13a,13boctahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12carboxylate (ethyl vincaminate)
2139
+5C
79
Y0000591 Vinpocetine impurity B
10 mg
(13aS,13bS)-13a-ethyl-2,3,5,6,13a,13b-hexahydro-1H-indolo[3,2,1-de]pyrido
[3,2,1-ij][1,5]naphthyridine-12-carboxylate (apovincamine)
2139
+5C
79
Y0000790 Vinpocetine impurity C
10 mg
ethyl (13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13b-hexahydro-1Hindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(methoxyvinpocetine)
2139
+5C
79
Y0000760 Vinpocetine impurity D
10 mg
(12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo
[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
(dihydrovinpocetine)
2139
+5C
79
Y0000793 Vinyl acetate
200 mg
2152,2523
+5C
79
Y0001395 Voriconazole
120 mg
100% CHFNO
2576
+5C
79
Y0001396 Voriconazole impurity B
10 mg
(2RS,3SR)-2-(2,4-difluorophenyl)-3-pyrimidin-4-yl-1-(1H-1,2,4-triazol-1-yl)
butan-2-ol
2576
+5C
79
Y0001398 Voriconazole impurity D
10 mg
(2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4triazol-1-yl)butan-2-ol (epi-voriconazole)
2576
+5C
79
Y0001397 Voriconazole impurity E
50 mg
[(1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl]methanesulfonic acid
((+-)-camphorsulfonic acid)
2576
+5C
79
W0100000 Warfarin sodium
10 mg
0698,0699
+5C
79
Y0000778 Warfarin sodium clathrate
10 mg
0699
+5C
79
X0075000 Xylazine hydrochloride
125 mg
1481
+5C
79
Y0000158 Xylazine impurity C
50 mg
2,6-dimethylphenyl isothiocyanate
1481
+5C
79
Y0000159 Xylazine impurity E
15 mg
87.5% CHNS ; methyl (2,6-dimethylphenyl)carbamodithioate
1481
Yes
+5C
79
Y0001224 Xylazine impurity mixture
0.02 mg
1481
Yes
X0080000 Xylitol
500 mg
X0100000 Xylometazoline hydrochloride
100 mg
X0101000 Xylometazoline impurity A
10 mg
X0200000 Xylose
100 mg
Y0000656 Yohimbine hydrochloride
20 mg
99.1% CHClNO
2172
Z1900000 Zidovudine
60 mg
99.5% CHNO
Z1902000 Zidovudine impurity A
10 mg
1-[(2,5)-5-hydroxymethyl-2,5-dihydro-2-furyl]-5-methyl pyrimidine-2,4
(1,3)-dione
Z1904000 Zidovudine impurity B
15 mg
1-(3-chloro-2,3-dideoxy--D-ribofuranosyl)-5-methylpyrimidine-2,4(1,3)dione
Z2000000 Zinc acexamate
50 mg
50 mg
Z2000010 Zinc acexamate impurity A

4-O-deacetylvinorelbine
99.2% CHO
N-(2-aminoethyl)-2-(4-1,1-dimethylethyl-2,6-dimethylphenyl) acetamide
Yes
Yes
+5C
79
1381
+5C
79
0972,1162
+5C
79
1162
+5C
79
+5C
79
+5C
79
1059
+5C
79
1059
+5C
79
1059
+5C
79
1279
+5C
79
1278
6-[[6-(acetylamino)hexanoyl]amino]hexanoic acid
83
Yes
79
1279
+5C
a

Order
Reference Standard
Code
Y0001286 Ziprasidone hydrochloride monohydrate

Batch n
1
Quantity Sale
per vial Unit
100 mg
1 95.6% CHClNOS
Information
Monograph
Leaflet
Storage
2421
Yes
+5C
Extra
Price
charges
79
a
Y0001272 Ziprasidone for system suitability 1
10 mg
2421
Yes
+5C
79
Y0001241 Ziprasidone for system suitability 2
0.465 mg
2421
Yes
+5C
79
Z2500000 Zolpidem tartrate - * psy
200 mg
1280
+5C
79
Z2500010 Zolpidem impurity A
10 mg
N,N'-dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazol[1,2-a] pyridin-3-yl]
acetamide
1280
+5C
79
Z3000000 Zopiclone -* psy
40 mg
1060
+5C
79
Z3001000 Zopiclone oxide
20 mg
1060
+5C
79
Y0000062 Zuclopenthixol decanoate - reference spectrum
n/a
79
Y0000534 Zuclopenthixol for system suitability
0.26 mg
+5C
79
Y0000083 Zuclopenthixol impurity B
10 mg
+5C
79
1707
1707
2-chloro-9H-thioxanthen-9-one
84
1707
Yes

Web Catalog CRS

Caricato da

Informazioni sul documento

Descrizione originale:

Copyright

Formati disponibili

Condividi questo documento

Condividi o incorpora il documento

Opzioni di condivisione

Hai trovato utile questo documento?

Questo contenuto è inappropriato?

Copyright:

Formati disponibili

Web Catalog CRS

Caricato da

Copyright:

Formati disponibili

List of European Pharmacopoeia Reference Standards

Effective from 2013/7/30

Y0001484 Medroxyprogesterone acetate for peak identification

Y0001523 Ursolic acid

Y0001532 Norethisterone acetate for system suitability

Y0001562 Doxylamine hydrogen succinate

Y0001565 Recombinant Major Allergen rBet v 1

10.25 micrograms of rBet v 1

Y0001566 Recombinant Major Allergen rPhl p 5a

8.56 micrograms of rPhl p 5a

Y0001567 Docusate sodium

Y0001570 Nitrofural impurity B

Y0001571 Naloxone impurity D

Y0001573 Atovaquone for system suitability

Y0001574 Mesalazine for system suitability

Y0001575 Bupivacaine impurity F

Y0001577 Isoprenaline impurity A

Y0001580 Rocuronium bromide

94.8 % CHON; (5-nitrofuran-2-yl)methylene diacetate

New Y0001581 Alimemazine for system suitability

New Y0001583 Alimemazine hemitartrate

Y0001585 Cellulose acetate butyrate

New Y0001587 Atomoxetine for impurity A identification

New Y0001588 Atomoxetine impurity B

New Y0001589 Atomoxetine impurity D

New Y0001591 Flutamide for system suitability

New Y0001592 Ivy leaf dry extract HRS

New Y0001594 Megestrol acetate impurity K

New Y0001596 Diacerein impurity B

New Y0001597 Diacerein impurity mixture

New Y0001598 Dutasteride

New Y0001599 Wedelolactone

New Y0001603 Dutasteride for system suitability

New Y0001604 Finasteride for peak identification

New Y0001605 Eucommia bark HRS

Y0001609 Norflurane - reference spectrum

New Y0001612 Esculin

New Y0001633 Ethylcellulose

Y0001561 Abacavir sulfate

For extra charges, please see supply terms and conditions.

List of European Pharmacopoeia Reference Standards

Effective from 2013/7/30

Y0001552 Abacavir for peak identification

Y0000055 Acamprosate calcium - reference spectrum

Y0000116 Acamprosate impurity A

Y0000354 Acarbose for identification

Y0000427 Acarbose for peak identification

A0040000 Acebutolol hydrochloride

Y0000359 Acebutolol impurity B

Y0000127 Acebutolol impurity C

Y0000128 Acebutolol impurity I

Y0000056 Aceclofenac - reference spectrum

Y0001094 Aceclofenac for peak identification

Y0000085 Aceclofenac impurity F

Y0000086 Aceclofenac impurity H

Y0000811 Acemetacin impurity A

Y0000842 Acemetacine impurity mixture

A0070000 Acesulfame potassium

A0070020 Acesulfame potassium impurity B

Y0001084 Acetazolamide for system suitability

Y0000002 Acetylcholine chloride

A0152000 Acetylcysteine impurity C

88.5% CHNOS; N,N'-diacetyl-L-cystine